Devices, cartridges, and sensors for controlling fluid transfer and analyzing biological samples
The cartridge system with electrowetting electrodes and integrated sensors addresses the need for fast, accurate blood analysis by enabling low-voltage liquid handling and precise cell counting/protein quantification, reducing the need for specialized training and equipment.
Patent Information
- Application Number
- JP2020568227
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-11-05
- Filing Date
- 2019-06-05
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2039-06-05
AI Technical Summary
Existing blood analysis systems require specialized training and equipment, leading to high costs and long wait times for accurate medical diagnosis, while home or point-of-care systems lack accuracy and scope.
A cartridge system with electrowetting electrodes for low-voltage liquid handling, integrated sensors, and a device interface for analyzing biological samples, enabling fast, accurate, and convenient blood analysis without specialized training.
The system provides rapid, precise blood analysis capable of counting cell types and quantifying proteins, enzymes, or electrolytes using low-voltage electrowetting electrodes, reducing the need for specialized training and equipment.
Smart Images

Figure 0007586711000006 
Figure 0007586711000007 
Figure 0007586711000008
Abstract
Description
[Technical Field]
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of priority to U.S. Provisional Patent Application No. 62 / 680,989, filed June 5, 2018, U.S. Provisional Patent Application No. 62 / 680,992, filed June 5, 2018, U.S. Provisional Patent Application No. 62 / 680,993, filed June 5, 2018, U.S. Provisional Patent Application No. 62 / 756,007, filed November 5, 2018, and U.S. Provisional Patent Application No. 62 / 756,011, filed November 5, 2018, the disclosures of each of which are incorporated herein by reference in their entirety.
[0002] Some aspects of the present invention relate to cartridges, systems, and methods for analyzing biological samples. Some aspects of the present invention relate to sensors for analyzing cells or analytes in biological samples, and cartridges and systems including such sensors. The present invention further relates to methods of using the sensors, cartridges, and systems, and methods for analyzing biological samples. Systems for controlling liquid movement by electrowetting using low-voltage electrowetting electrodes and methods for controlling liquid movement using low-voltage electrowetting electrodes are also provided. [Background technology]
[0003] Blood analysis for accurate medical diagnosis is typically performed in clinical laboratories by specialized, trained technicians using sophisticated devices. Blood samples must be carefully processed by mixing them with reagents before being analyzed by sensors or cell sorters to determine blood cell counts or quantify protein, electrolyte, or enzyme concentrations. This specialized training and equipment results in significant costs for patients and long wait times for important test results. Home or point-of-care blood analysis systems, such as glucose meters, provide fast and convenient diagnostic results, but are often limited in the accuracy or range of tests that can be performed.
[0004] Digital microfluidics using electrowetting electrodes is a developing field that explores the actuation of droplets by modulating the hydrophobicity of liquids through the application of an electric field. However, digital microfluidics is limited due to the relatively high voltages applied to the electrowetting electrodes to manipulate the liquid.
[0005] There continues to be a need for devices and systems that provide a fast, accurate, and easy-to-use blood analysis system that does not require specialized training.
[0006] The disclosures of all publications, patents, and patent applications referenced herein are each incorporated herein by reference in their entirety. To the extent that any reference incorporated by reference conflicts with the present disclosure, the present disclosure will control. Summary of the Invention
[0007] Described herein is a cartridge for analyzing biological samples, the cartridge comprising a sample receiving port configured to receive a biological sample, a sensor configured to analyze the biological sample, a cartridge space in fluid communication with the biological sample receiving port and the sensor, a plurality of electrowetting electrodes configured to transport the biological sample within the cartridge space and combine the biological sample with one or more reagents, and a device interface configured to receive power from and communicate with a cartridge interface on a device, wherein the sensor and the plurality of electrowetting electrodes are in electrical communication with the device interface.
[0008] In some embodiments of the cartridge, the cartridge space is fluidly connected to one or more reagent reservoirs. In some embodiments, the one or more reagent reservoirs contain reagents. In some embodiments of the cartridge, the cartridge space includes a reagent mixing region.
[0009] In some embodiments of the cartridge, the cartridge is a single-use cartridge.
[0010] In some embodiments of the cartridge, the cartridge includes a waste reservoir configured to receive the biological sample after it has been analyzed by the sensor.
[0011] In some embodiments of the cartridge, the biological sample enters the sample receiving port through capillary action.
[0012] In some embodiments of the cartridge, the plurality of electrowetting electrodes comprises a plurality of coplanar electrodes. In some embodiments, the plurality of electrowetting electrodes further comprises a ground electrode on a surface opposite the coplanar electrodes. In some embodiments, the ground electrode is common to two or more of the electrowetting electrodes. In some embodiments, at least one of the electrowetting electrodes is paired with a respective ground electrode.
[0013] In some embodiments of the cartridge, the electrowetting electrode is coated with an insulating layer. In some embodiments, the insulating layer has a dielectric constant of about 3.9 or greater. In some embodiments, the insulating layer comprises hafnium oxide, strontium barium titanate, or strontium titanate, silica, or silicon nitride. In some embodiments, the insulating layer is coated on the electrode using atomic layer deposition, chemical vapor deposition, reactive ion beam deposition, sputter deposition, evaporation, spray deposition, spin coating, or sol-gel formation. In some embodiments, the insulating layer has a thickness of about 1 nm to about 5 μm. In some embodiments, the insulating layer is a fluid-contacting surface. In some embodiments, the insulating layer comprises a nanostructured surface.
[0014] In some embodiments of the cartridge, the electrowetting electrodes are coated with a hydrophobic layer. In some embodiments, the hydrophobic layer is a fluid contact layer. In some embodiments, the hydrophobic layer comprises a nanostructured surface. In some embodiments, the hydrophobic layer comprises a fluoropolymer, polydimethylsiloxane, parylene, octadecane hydroximic acid, stearic acid, octadecane phosphonic acid, 16-hydrodihexadecane hydrolamic acid, or octadecane thiol. In some embodiments, the hydrophobic layer is coated on an insulating layer.
[0015] In some embodiments of the cartridge, the electrowetting electrodes comprise gold, silver, silver chloride, platinum, indium tin oxide, or conductive carbon.
[0016] In some embodiments of the cartridge, the electrowetting electrodes are separated from the fluid contact surface by about 1 nm to about 25 μm.
[0017] In some embodiments of the cartridge, the plurality of electrowetting electrodes are configured to transport the biological sample using a voltage of less than about 50 volts.
[0018] In some embodiments of the cartridge, the plurality of electrowetting electrodes are configured to transport the biological sample using a voltage between about 0.5V and about 50V.
[0019] In some embodiments of the cartridge, the sensor is an impedance sensor. In some embodiments, the sensor is configured to detect or measure the amount of a protein. In some embodiments, the sensor includes a first sensing electrode functionalized with an affinity moiety and a second sensing electrode paired with the first sensing electrode, and the sensor is configured to detect a change in impedance upon binding of an analyte or protein to the affinity moiety. In some embodiments, the affinity moiety is an antibody, an antibody fragment, or an aptamer. In some embodiments, the first sensing electrode is an electrowetting electrode. In some embodiments, the sensor further includes a first electrowetting electrode and a second electrowetting electrode, the first electrowetting electrode and the second electrowetting electrode being opposite the first sensing electrode or the second sensing electrode. In some embodiments, the first sensing electrode is an electrowetting electrode. In some embodiments, the plurality of electrowetting electrodes are configured to statically position at least a portion of the biological sample between the first sensing electrode and the second sensing electrode. In some embodiments, the first electrowetting electrode, the second electrowetting electrode, and the first sensing electrode are electrically connected to a voltage switching circuit configured to selectively activate one or none of the first electrowetting electrode, the second electrowetting electrode, or the first sensing electrode. In some embodiments, the voltage switching circuit is electrically connected to a switch configured to alternatively select the impedance sensing circuit or the electrowetting electrode supply circuit. In some embodiments, the impedance sensor comprises a pH-sensitive layer or an ion-sensitive layer configured to modulate impedance based on pH or ion concentration. In some embodiments, the impedance sensor includes a metal-oxide-semiconductor capacitor (MOSCap) sensor. In some embodiments, the MOSCap sensor is adjacent to the first sensing electrode and the second sensing electrode.
[0020] In some embodiments of the cartridge, the cartridge further comprises one or more optical windows.
[0021] In some embodiments of the cartridge, the sensor is a channel sensor, the channel sensor including a first channel segment, a second channel segment, a pore or channel fluidly connecting the first channel segment and the second channel segment, and an electrode pair configured to apply a current to the pore or channel and detect impedance within the pore or channel. In some embodiments, the electrode pair is configured to directly contact a liquid flowing through the channel sensor. In some embodiments, the channel sensor is a flow cytometer configured to count cells in a biological sample. In some embodiments, the sensor is configured to distinguish between different cell types. In some embodiments, the sensor is configured to distinguish between red blood cells, white blood cells, and platelets. In some embodiments, the sensor is configured to count red blood cells, white blood cells, or platelets. In some embodiments, the sensor is configured to distinguish between eosinophils, basophils, neutrophils, monocytes, and lymphocytes. In some embodiments, the sensor is configured to count eosinophils, basophils, neutrophils, monocytes, or lymphocytes. In some embodiments, the pore or channel is a micropore or microchannel. In some embodiments, the current is a multiplexed current comprising multiple AC components of different frequencies. In some embodiments, the current is a multiplexed current comprising (1) a DC component or a low-frequency AC component, and (2) multiple AC components of different frequencies. In some embodiments, the multiple AC components comprise at least three AC components. In some embodiments, the multiple AC components comprise a first AC component of about 10 kHz to about 100 kHz, a second AC component of about 100 kHz to about 700 kHz, a third AC component of about 700 kHz to about 5 MHz, and a fourth AC component greater than about 5 MHz. In some embodiments, the multiple AC components comprise at least five different AC components.In some embodiments, the plurality of AC components include a first AC between about 50 kHz and about 250 kHz, a second AC between about 250 kHz and about 700 kHz, a third AC between about 700 kHz and about 5 MHz, a fourth AC between about 5 MHz and about 20 MHz, and a fifth AC between about 20 MHz and about 150 MHz. In some embodiments, the ACs further include an additional AC at about 100 kHz or less, or at about 50 kHz or less. In some embodiments, the electrode pair is configured to detect impedance at a sampling rate of about 100 kHz or more. In some embodiments, the electrode pair is configured to detect real and imaginary impedance components within the pore or channel. In some embodiments, the electrode pair is configured to detect magnitude and phase impedance components within the pore or channel. In some embodiments, the channel sensor is configured to detect an analyte concentration. In some embodiments, the analyte is a protein. In some embodiments, the cartridge includes a reagent including an affinity moiety, and the cartridge is configured to mix the reagent including the affinity moiety with a biological sample or a subsample derived therefrom and transport the biological sample or subsample to the channel sensor. In some embodiments, the pore or channel is a nanopore or nanochannel.
[0022] In some embodiments of the cartridge, the cartridge comprises multiple sensors.
[0023] In some embodiments of the cartridge, the biological sample is a blood sample.
[0024] Also provided herein is a system for analyzing a biological sample, the system comprising any one of the above-described cartridges and a device including a cartridge interface configured to connect with the cartridge, the device configured to power and operate the cartridge. In some embodiments, the device is configured to power and operate two or more different types of cartridges. In some embodiments, the device further includes one or more processors and a non-transitory computer-readable storage medium storing one or more programs configured to be executed by the one or more processors, the one or more programs including instructions for (a) operating a plurality of electrowetting electrodes in the cartridge to transport a biological sample within the cartridge and (b) operating a sensor. In some embodiments, the one or more programs include instructions for operating the plurality of electrowetting electrodes in the cartridge to continuously transport a biological sample through the sensor. In some embodiments, the one or more programs include instructions for operating the plurality of electrowetting electrodes in the cartridge to statically position a biological sample within the sensor. In some embodiments, the one or more programs include instructions for determining a cell count or an analyte concentration based on a multivariate pattern of impedance signals detected at one or more frequencies. In some embodiments, the multivariate pattern includes one or more of impedance peak height, impedance peak width, impedance peak area, or impedance peak width at half maximum peak height. In some embodiments, the multivariate pattern includes real impedance components and imaginary impedance components. In some embodiments, the multivariate pattern includes impedance component magnitude and impedance component phase. In some embodiments, the one or more programs include instructions for calibrating the sensor. In some embodiments, the device is a handheld device.
[0025] Further provided herein are methods for analyzing a biological sample, the methods including placing the biological sample in a cartridge, transporting the biological sample within the cartridge using a plurality of electrowetting electrodes, analyzing the biological sample using one or more sensors within the cartridge to generate analytical data, and transmitting the analytical data from the cartridge. In some embodiments, the method includes mixing the biological sample with one or more reagents within the cartridge. In some embodiments, the biological sample is received by the cartridge using capillary action. In some embodiments, the method further includes transporting the biological sample into a waste reservoir within the cartridge after analyzing the biological sample. In some embodiments, the cartridge is discarded after a single use. In some embodiments, analyzing the biological sample includes counting the number of cells in the biological sample, and the analytical data relates to the cell count. In some embodiments, analyzing the biological sample includes distinguishing between two or more different cell types. In some embodiments, analyzing the biological sample includes distinguishing between red blood cells, white blood cells, and platelets. In some embodiments, analyzing the biological sample includes counting white blood cells, counting red blood cells, or counting platelets. In some embodiments, analyzing the biological sample includes distinguishing between eosinophils, basophils, neutrophils, monocytes, and lymphocytes. In some embodiments, analyzing the biological sample includes enumerating the number of eosinophils, basophils, neutrophils, monocytes, or lymphocytes. In some embodiments, analyzing the biological sample includes applying a current to the biological sample and recording a multiplexed impedance of the current. In some embodiments, the current is a mixed current including multiple AC components at different frequencies. In some embodiments, the current is a mixed current including a direct current component and multiple AC components at different frequencies. In some embodiments, the current is a mixed current including at least five AC components at different frequencies. In some embodiments, the method includes self-calibrating at least one of the sensors to detect different cell sizes, material properties, and / or concentrations.In some embodiments, analyzing the biological sample includes continuously flowing the biological sample through at least one of the sensors during the analysis.
[0026] In some embodiments of the method, the biological sample is transported into the cartridge using a voltage of about 50 V or less. In some embodiments, the biological sample is transported into the cartridge using a voltage of about 0.5 V to about 50 V.
[0027] In some embodiments of the method, analyzing the biological sample includes determining the concentration of an analyte or protein in the biological sample. In some embodiments, analyzing the biological sample includes statically positioning the biological sample on at least one of the sensors. In some embodiments, the biological sample is statically positioned on the sensor using electrowetting electrodes.
[0028] In some embodiments of the method, determining the concentration of an analyte or protein in the biological sample includes binding the analyte or protein to an affinity moiety attached to an electrode within one of the sensors and measuring an impedance change resulting from the analyte or protein binding to the affinity moiety. In some embodiments, the affinity moiety is an antibody, antibody fragment, or aptamer.
[0029] Also described herein are sensors comprising a first channel segment, a second channel segment, a pore or channel fluidly connecting the first and second channel segments, an electrode pair configured to apply a multiplexed current or voltage to the pore or channel, and an electrode pair configured to detect impedance at multiple frequencies within the pore or channel, wherein the detected impedance comprises at least a first multivariate impedance pattern at the first frequency and a second multivariate impedance pattern at the second frequency, and the electrode pair configured to apply the multiplexed current and the electrode pair configured to detect the impedance are the same or different electrode pairs. In some embodiments, the first multivariate impedance pattern and the second multivariate impedance pattern each comprise a real component and an imaginary component. In some embodiments, the first multivariate impedance pattern and the second multivariate impedance pattern each comprise a magnitude and a phase component of the impedance component.
[0030] Also described herein are cartridges, including the above-described sensors, configured to analyze biological samples. In some embodiments, the cartridges include a plurality of electrowetting electrodes configured to transport one or more liquids within the cartridge. In some embodiments, the cartridges are configured to mix a biological sample or a subsample derived therefrom with a reagent and transport the biological sample or subsample to the sensor. In some embodiments, the cartridges include a device interface electrically connected to the sensor.
[0031] Further provided herein is a device configured to interface with and operate the cartridge. In some embodiments, the device comprises one or more processors and a non-transitory computer-readable storage medium storing one or more programs configured to be executed by the one or more processors, the one or more programs including instructions for determining cell count or analyte concentration based on the detected impedance.
[0032] Also described herein is a system comprising: (a) a cartridge configured to analyze a biological sample, the cartridge including: (i) a sensor including a first channel segment, a second channel segment, a pore or channel fluidly connecting the first and second channel segments, an electrode pair configured to apply a multiplexed current or voltage to the pore or channel, and an electrode pair configured to detect impedance at multiple frequencies within the pore or channel, wherein the electrode pair configured to apply the multiplexed current and the electrode pair configured to detect impedance are the same or different electrode pairs; and (ii) a device interface electrically connected to the sensor; and (b) a device configured to interface with and operate the cartridge, the device including one or more processors and a non-transitory computer-readable storage medium storing one or more programs configured to be executed by the one or more processors, the one or more programs including instructions for determining cell number or analyte concentration based on the detected impedance at multiple frequencies. In some embodiments, the detected impedance includes a real component and an imaginary component. In some embodiments, the detected impedance includes a magnitude component and a phase component.
[0033] Also described herein is a system comprising: (a) a cartridge configured to analyze a biological sample, the cartridge including: (i) a sensor including a first channel segment, a second channel segment, a pore or channel fluidly connecting the first channel segment and the second channel segment, an electrode pair configured to apply a multiplexed current or voltage to the pore or channel, and an electrode pair configured to detect impedance at multiple frequencies within the pore or channel, wherein the electrode pair configured to apply the multiplexed current and the electrode pair configured to detect impedance are the same electrode pair or different electrode pairs; and (ii) a device interface electrically connected to the sensor; and (b) a device configured to interface with and operate the cartridge, the device including one or more processors and a non-transitory computer-readable storage medium storing one or more programs configured to be executed by the one or more processors, the one or more programs including instructions for determining cell count or analyte concentration based on the detected impedance, wherein the detected impedance includes at least a first multivariate impedance pattern at a first frequency and a second multivariate impedance pattern at a second frequency. In some embodiments, the first multivariate impedance pattern and the second multivariate impedance pattern each include a real component and an imaginary component. In some embodiments, the first multivariate impedance pattern and the second multivariate impedance pattern each include a magnitude impedance component and a phase component.
[0034] In some embodiments, the cartridge comprises a plurality of electrowetting electrodes configured to transport one or more liquids within the cartridge. In some embodiments, the cartridge is configured to mix a biological sample or a subsample derived therefrom with a reagent and transport the biological sample or subsample to a sensor. In some embodiments, the cartridge comprises a device interface electrically connected to the sensor.
[0035] In some embodiments, the electrode pair configured to apply the multiplexed current and the electrode pair configured to detect impedance are the same electrode pair, hi some embodiments, the electrode pair configured to apply the multiplexed current and the electrode pair configured to detect impedance are different electrode pairs.
[0036] In some embodiments, the multivariate impedance pattern comprises one or more of impedance peak height, impedance peak width, impedance peak area, or impedance peak width at half maximum peak height.
[0037] In some embodiments, the electrode pair is in direct contact with the interior portion of the channel.
[0038] In some embodiments, the sensor is configured to count the number of cells in a biological sample. In some embodiments, the sensor is configured to distinguish between different cell types. In some embodiments, the sensor is configured to distinguish between red blood cells, white blood cells, and platelets. In some embodiments, the sensor is configured to count a number of red blood cells, a number of white blood cells, or a number of platelets. In some embodiments, the sensor is configured to distinguish between eosinophils, basophils, neutrophils, monocytes, and lymphocytes. In some embodiments, the sensor is configured to count a number of eosinophils, basophils, neutrophils, monocytes, and lymphocytes.
[0039] In some embodiments, the pores or channels are micropores or microchannels.
[0040] In some embodiments, the sensor is configured to detect an analyte concentration. In some embodiments, the analyte is a protein. In some embodiments, the pore or channel is a nanopore or nanochannel.
[0041] In some embodiments, the electrode pair configured to detect impedance includes a first electrode in the first channel segment and a second electrode in the second channel segment.
[0042] In some embodiments, the sensor includes a channel, and an electrode pair configured to detect impedance is positioned within the channel. In some embodiments, the electrode pair includes a first electrode proximal to the first channel segment and a second electrode proximal to the second channel segment. In some embodiments, the electrode pair includes a first electrode on an upper surface of the channel and a second electrode on a lower surface of the channel, the first electrode being positioned above the second electrode.
[0043] In some embodiments, the sensor further includes an electrode pair configured to detect liquid flow within the sensor.
[0044] In some embodiments, the sensor includes one or more separate electrodes.
[0045] In some embodiments, the sensor includes an inlet to a first channel segment proximal to the electrowetting electrode, hi some embodiments, the sensor includes an outlet to a second channel segment proximal to the electrowetting electrode.
[0046] In some embodiments, the multiplexed current includes multiple AC components of different frequencies. In some embodiments, the multiplexed current includes (1) a DC component or low-frequency AC, and (2) multiple AC components of different frequencies. In some embodiments, the multiple AC components include at least three AC components. In some embodiments, the multiple AC components include a first AC of about 10 kHz to about 100 kHz, a second AC of about 100 kHz to about 700 kHz, a third AC of about 700 kHz to about 5 MHz, and a fourth AC of greater than about 5 MHz. In some embodiments, the multiple AC components include at least five AC components. In some embodiments, the multiple AC components include a first AC of about 50 kHz to about 250 kHz, a second AC of about 250 kHz to about 700 kHz, a third AC of about 700 kHz to about 5 MHz, a fourth AC of about 5 MHz to about 20 MHz, and a fifth AC of about 20 MHz to about 150 MHz. In some embodiments, the current further comprises an additional alternating current of about 100 kHz or less, such as about 50 kHz or less.
[0047] In some embodiments, the electrode pair configured to detect impedance is configured to detect impedance at a sampling rate of about 100 kHz or greater.
[0048] Also provided herein are methods for determining cell number in a biological sample, the methods comprising transporting the biological sample through a sensor including a channel or pore, applying a multiplexed current or voltage to the channel or pore, detecting the multiplexed impedance in the channel or pore, and determining the cell number based on the detected multiplexed impedance. In some embodiments, the detected multiplexed impedance comprises real and imaginary components at a plurality of different frequencies. In some embodiments, the detected multiplexed impedance comprises magnitude and phase components at a plurality of different frequencies.
[0049] Further provided herein is a method for determining cell number in a biological sample, the method comprising: transporting the biological sample through a sensor including a channel or pore; applying a multiplexed current or voltage to the channel or pore; detecting a multiplexed impedance in the channel or pore, the multiplexed impedance including at least a first multivariate impedance pattern at a first frequency and a second multivariate impedance pattern at a second frequency; and determining the cell number based on the detected multiplexed impedance. In some embodiments, the first multivariate impedance pattern and the second multivariate impedance pattern each include a real component and an imaginary component. In some embodiments, the first multivariate impedance pattern and the second multivariate impedance pattern each include a magnitude impedance component and a phase component. In some embodiments, the multivariate impedance pattern includes one or more of an impedance peak height, an impedance peak width, an impedance peak area, or an impedance peak width at half maximum. In some embodiments, the biological sample is in direct contact with a pair of electrodes that detect the multiplexed impedance. In some embodiments, the method comprises distinguishing between two or more different cell types. In some embodiments, determining the cell count comprises determining a red blood cell count, a white blood cell count, or a platelet count in the biological sample. In some embodiments, determining the cell count comprises determining an eosinophil count, a basophil count, a neutrophil count, a monocyte count, and a lymphocyte count in the biological sample. In some embodiments, the method comprises transporting two or more aliquots of the biological sample through the sensor, wherein the two or more aliquots are treated at different pH levels or different electrolyte concentrations.
[0050] In some embodiments of the above methods, the method includes transporting a marker into the sensor. In some embodiments, the marker is an air bubble or a low-conductivity solution. In some embodiments, the method includes detecting the marker. In some embodiments, the marker triggers starting or stopping recording of the detected multiplexed impedance. In some embodiments, the method includes determining a flow rate of the biological sample. In some embodiments, the method includes determining a cell count using the determined flow rate.
[0051] In some embodiments of the above methods, the method includes filtering the biological sample.
[0052] In some embodiments of the above method, the multiplexed current includes multiple AC components of different frequencies. In some embodiments, the multiplexed current includes (1) a DC component or low-frequency AC, and (2) multiple AC components of different frequencies. In some embodiments, the multiple AC components include at least three AC components. In some embodiments, the multiple AC components include a first AC of about 10 kHz to about 100 kHz, a second AC of about 100 kHz to about 700 kHz, a third AC of about 700 kHz to about 5 MHz, and a fourth AC of greater than about 5 MHz. In some embodiments, the multiple AC components include at least five AC components. In some embodiments, the multiple AC components include a first AC of about 50 kHz to about 250 kHz, a second AC of about 250 kHz to about 700 kHz, a third AC of about 700 kHz to about 5 MHz, a fourth AC of about 5 MHz to about 20 MHz, and a fifth AC of about 20 MHz to about 150 MHz. In some embodiments, the current further comprises an additional AC component of about 100 kHz or less, such as about 50 kHz or less.
[0053] Also provided herein are methods for detecting an analyte in a biological sample, the methods comprising transporting a biological sample through a sensor including a channel or pore, wherein the biological sample contains an analyte bound to an affinity moiety; applying a current or voltage to the channel or pore; detecting impedance within the channel or pore; and detecting the analyte based on the detected impedance. In some embodiments, the analyte is a protein or an electrolyte. In some embodiments, the affinity moiety is a multivalent affinity moiety. In some embodiments, the affinity moiety is charged. In some embodiments, the affinity moiety comprises an aptamer, an antibody, or an antibody fragment. In some embodiments, the affinity moiety comprises an aptamer bound to avidin or an avidin derivative. In some embodiments, the method comprises mixing the biological sample with a reagent including the affinity moiety. In some embodiments, detecting the analyte based on the detected impedance comprises distinguishing between the affinity moiety bound to the analyte and the unbound affinity moiety.
[0054] In some embodiments of the above methods, the method includes transporting a marker into the sensor. In some embodiments, the marker is an air bubble or a low-conductivity solution. In some embodiments, the method includes detecting the marker. In some embodiments, the marker triggers starting or stopping recording of the detected multiplexed impedance. In some embodiments, the method includes determining a flow rate of the biological sample. In some embodiments, the method includes determining a concentration of an analyte using the determined flow rate.
[0055] Also described herein are electrowetting electrode arrays, comprising a plurality of coplanar electrowetting electrodes coated with and spaced apart by an insulating layer, the electrowetting array comprising a hydrophobic liquid contact surface, and the electrowetting array configured to transport an aqueous liquid using a voltage of about 50 volts or less. In some embodiments, the insulating layer comprises a hydrophobic liquid contact surface. In some embodiments, the insulating layer comprises a nanostructured surface. In some embodiments, the insulating layer is coated with a hydrophobic layer comprising the hydrophobic liquid contact surface. In some embodiments, the hydrophobic layer comprises a nanostructured surface. In some embodiments, the hydrophobic layer comprises a fluoropolymer, polydimethylsiloxane, parylene, octadecane hydroximic acid, stearic acid, octadecane phosphonic acid, 16-hydrodihexadecane hydrolamic acid, or octadecanethiol. In some embodiments, the plurality of electrowetting electrodes is configured to transport an aqueous liquid using a voltage of about 0.5 volts to about 50 volts.
[0056] In some embodiments, the insulating layer has a dielectric constant of about 3.9 or greater. In some embodiments, the insulating layer comprises hafnium oxide, strontium barium titanate, strontium titanate, silica, or silicon nitride. In some embodiments, the insulating layer is coated on the electrode using atomic layer deposition, chemical vapor deposition, reactive ion beam deposition, sputter deposition, evaporation, spray deposition, spin coating, or sol-gel formation. In some embodiments, the insulating layer has a thickness of about 1 nm to about 5 μm.
[0057] In some embodiments, the electrowetting electrodes comprise gold, silver, silver chloride, platinum, indium tin oxide, or conductive carbon.
[0058] In some embodiments, the electrowetting electrode is separated from the hydrophobic liquid contact surface by about 1 nm to about 25 μm.
[0059] In some embodiments, the plurality of electrowetting electrodes further includes a ground electrode parallel to the coplanar electrowetting electrodes, and the hydrophobic liquid contact surface is between the ground electrode and the coplanar electrowetting electrodes. In some embodiments, the ground electrode is common to two or more of the electrowetting electrodes. In some embodiments, at least one of the electrowetting electrodes is paired with a respective ground electrode.
[0060] In some embodiments, the electrowetting electrode array includes an impedance sensor including a sensing electrode and a functionalized liquid contact surface, where the functionalized liquid contact surface is functionalized with an affinity moiety that specifically binds to a target analyte. In some embodiments, the sensor further includes a second sensing electrode paired with the first sensing electrode, and the sensor is configured to detect a change in impedance upon binding of the analyte or protein to the affinity moiety. In some embodiments, the target analyte is a protein. In some embodiments, the affinity moiety is an antibody, antibody fragment, or aptamer. In some embodiments, the impedance sensor further includes a metal oxide semiconductor capacitor (MOSCap) sensor including a pH-sensitive layer or an ion-sensitive layer configured to modulate impedance based on pH or ion concentration.
[0061] In some embodiments, the aqueous liquid comprises a biological sample. In some embodiments, the biological sample comprises a blood sample.
[0062] Also provided herein is a cartridge for analyzing a biological sample, the cartridge comprising: a sample receiving port configured to receive a biological sample; a sensor configured to analyze the biological sample; a chamber or channel in fluid communication with the biological sample receiving port and the sensor, the chamber or channel including the electrowetting electrode array described above; and a device interface configured to receive power from and communicate with a cartridge interface on a device, wherein the sensor and the plurality of electrowetting electrodes are in electrical communication with the device interface. In some embodiments, the chamber or channel is fluidly connected to one or more reagent reservoirs, and the electrowetting electrode array extends into the one or more reagent reservoirs. In some embodiments, the electrowetting electrode array includes a reagent mixing region.
[0063] Further provided herein is a system for analyzing a biological sample, the system comprising: the cartridge described above; and a device including a cartridge interface configured to connect with the cartridge, the device configured to operate the electrowetting electrode array. In some embodiments, the device is a handheld device.
[0064] Also provided herein is a method of transporting a liquid, the method comprising: positioning an aqueous liquid on a first hydrophobic liquid contact surface above a deactivated first electrowetting electrode; and activating a second electrowetting electrode by applying a voltage of about 50 volts or less to the second electrowetting electrode, thereby transporting the aqueous liquid from the first hydrophobic liquid contact surface to a second hydrophobic liquid contact surface above the second electrowetting electrode, wherein the first electrowetting electrode and the second electrowetting electrode are coated with and separated by an insulating layer. In some embodiments, the aqueous liquid comprises a biological sample.
[0065] In some embodiments, the method includes transporting the reagent to a second liquid contact surface, thereby mixing the reagent with the aqueous liquid. In some embodiments, the reagent is transported by activating a second electrowetting electrode.
[0066] In some embodiments of the above methods, the biological sample is transported within the cartridge using a voltage of about 0.5V to about 50V.
[0067] In some embodiments of the above method, the first hydrophobic liquid contact surface or the second hydrophobic liquid contact surface is a nanostructured surface.
[0068] In some embodiments of the above method, the insulating layer comprises a first hydrophobic liquid contact surface and a second hydrophobic liquid contact surface.
[0069] In some embodiments of the above method, the insulating layer is coated with a hydrophobic layer comprising a first hydrophobic liquid-contacting surface and a second hydrophobic liquid-contacting surface, and in some embodiments, the hydrophobic layer comprises a fluoropolymer, polydimethylsiloxane, parylene, octadecane hydroximic acid, stearic acid, octadecane phosphonic acid, 16-hydrodihexadecane hydrolamic acid, or octadecanethiol.
[0070] In some embodiments of the above method, the insulating layer has a dielectric constant of about 3.9 or greater. In some embodiments, the insulating layer comprises hafnium oxide, strontium barium titanate, or strontium titanate, silica, or silicon nitride.
[0071] In some embodiments of the above method, the insulating layer has a thickness of about 1 nm to about 5 μm.
[0072] In some embodiments of the above method, the first electrowetting electrode is separated from the first hydrophobic liquid contact surface by about 1 nm to about 25 μm, and the second electrowetting electrode is separated from the second hydrophobic liquid contact surface by about 1 nm to about 25 μm. [Brief explanation of the drawings]
[0073] [Figure 1A] 1 illustrates an exemplary cartridge for analyzing a biological sample. [Figure 1B] 1 illustrates another exemplary embodiment of a cartridge. [Figure 2] FIG. 1 illustrates a block diagram of an exemplary device engaged with a cartridge. [Figure 3] 1 illustrates an exemplary impedance sensor pair configured to measure the concentration of an analyte concentration. [Figure 4A] 1 illustrates an exemplary impedance sensor configured to detect or measure an analyte integrated with multiple electrowetting electrodes. [Figure 4B] 4B illustrates the impedance sensor of FIG. 4A with a hydrophobic layer covering the insulating layer of the sensor. [Figure 5A] 1 illustrates exemplary impedance sensors that can be used for indirect detection or quantification of an analyte, including MOSCap sensors. [Figure 5B] 5B shows a side view of a MOSCap sensor exemplified as part of the impedance sensor of FIG. 5A, along with an electrical model of the impedance sensor. [Figure 6] 5A and 5B illustrate direct and indirect analyte measurements using the sensors illustrated in FIGS. 5A and 5B. [Figure 7] 1 shows an image of an exemplary channel of a channel sensor having a first channel segment, a second channel segment, and a microchannel between the first and second channel segments. [Figure 8A] 1 illustrates a top view and a side view of a channel sensor having a first impedance sensing electrode in a first channel segment and a second impedance sensing electrode in a second channel segment, with a micropore or microchannel between the first and second channel segments. [Figure 8B] 1 illustrates a top view and a side view of a channel sensor having a first impedance sensing electrode in a microchannel adjacent to a first channel segment and a second impedance sensing electrode in a microchannel adjacent to a second channel segment. [Figure 8C] 1 illustrates a top view and a side view of a channel sensor including a first impedance detection electrode and a second impedance detection electrode positioned within a microchannel, with the first impedance detection electrode positioned above the second impedance detection electrode. [Figure 8D] 1 shows an exemplary channel sensor having two sets of sensing electrodes in the same channel. [Figure 8E] 10 shows another exemplary channel sensor with two sets of sensing electrodes in the same channel and with a wavy channel feature in the channel at each electrode location. [Figure 8F] 1 shows an exemplary embodiment of a microchannel between a first channel segment and a second channel segment with multiple detection electrodes positioned along the length of the channel. [Figure 9] 1A-1C show top and side views of a channel sensor including a pair of impedance sensing electrodes, two pairs of flow sensing electrodes, and two separation electrodes. [Figure 10] The bottom plot shows the DC voltage detected by the first pair of flow sensing electrodes, indicating the start of channel sensor operation. [Figure 11] This illustrates how a marker can be used as a trigger for data collection using a sensor, and the cycle can be repeated for different biological aliquot samples. [Figure 12] 1 illustrates an exemplary method for assaying a biological sample using a channel sensor in a cartridge. [Figure 13] 1 illustrates an electrical model of a cell flowing through a pore or channel. [Figure 14]Exemplary relative impedance changes measured by impedance sensing electrodes as a function of time at a single frequency (30 kHz) for a cell of approximately 10 μm are presented. [Figure 15A] Illustrates a target analyte binding to a tetravalent affinity molecule. [Figure 15B] Illustrated are the impedance changes resulting from affinity moieties that are not bound to the target analyte (top panel) and the impedance changes resulting from affinity moieties that are bound to the target analyte (bottom panel) as the affinity moieties pass through the nanochannel of the channel sensor. [Figure 15C] An example of using impedance magnitude to determine the concentration of a target analyte is illustrated. [Figure 16A] 1 illustrates an exemplary electrowetting electrode array in an 8x16 matrix with tracks electrically connecting each electrode with the device interface. [Figure 16B] FIG. 16B shows a close-up of some of the electrowetting electrodes in the array shown in FIG. 16A, highlighting the jagged edges of the roughly square electrodes. [Figure 17A] 1 illustrates an embodiment of a plurality of electrowetting electrodes including an insulating layer fluid contact surface. [Figure 17B] 1 illustrates another embodiment of a plurality of electrowetting electrodes, including an insulating layer covering the electrowetting electrodes, and a hydrophobic layer covering the insulating layer. [Figure 17C] 1 illustrates another embodiment of a plurality of electrowetting electrodes including an insulating layer fluid contact surface. [Figure 17D] 1 illustrates another embodiment of a plurality of electrowetting electrodes, including an insulating layer covering the electrowetting electrodes, and a hydrophobic layer covering the insulating layer. [Figure 18A] Figure 1 shows the voltage change in a flow cytometer when polystyrene beads with diameters of 5 μm, 10 μm, 20 μm, or 30 μm are passed through a 30 kHz current. A significant voltage drop is observed when the beads pass a current, which can be used to measure particle size. [Figure 18B] Normalized curve of measured diameter of polystyrene beads using a flow cytometer (30 kHz current) against the actual size of the polystyrene beads. The measured diameter was linearly fitted as a function of the actual diameter, indicating that this method can be reliably used to estimate particle size. [Figure 19] The real and imaginary components of the multiplexed impedance measured at currents with 107 kHz, 570 kHz, 1.55 MHz, 16 MHz, and 40 MHz components are shown for an eosinophil as it passes the current at −6.19 seconds. [Figure 20A] Plots of the average normalized impedance of the real and imaginary components at various currents (107 kHz, 570 kHz, 1.55 MHz, 16 MHz, and 40 MHz) are shown for basophils (Figure 20A), eosinophils (Figure 20B), lymphocytes (Figure 20C), monocytes (Figure 20D), neutrophils (Figure 20E), platelets (Figure 20F), and red blood cells (Figure 20G). [Figure 20B] Plots of the average normalized impedance of the real and imaginary components at various currents (107 kHz, 570 kHz, 1.55 MHz, 16 MHz, and 40 MHz) are shown for basophils (Figure 20A), eosinophils (Figure 20B), lymphocytes (Figure 20C), monocytes (Figure 20D), neutrophils (Figure 20E), platelets (Figure 20F), and red blood cells (Figure 20G). [Figure 20C] Plots of the average normalized impedance of the real and imaginary components at various currents (107 kHz, 570 kHz, 1.55 MHz, 16 MHz, and 40 MHz) are shown for basophils (Figure 20A), eosinophils (Figure 20B), lymphocytes (Figure 20C), monocytes (Figure 20D), neutrophils (Figure 20E), platelets (Figure 20F), and red blood cells (Figure 20G). [Figure 20D]Plots of the average normalized impedance of the real and imaginary components at various currents (107 kHz, 570 kHz, 1.55 MHz, 16 MHz, and 40 MHz) are shown for basophils (Figure 20A), eosinophils (Figure 20B), lymphocytes (Figure 20C), monocytes (Figure 20D), neutrophils (Figure 20E), platelets (Figure 20F), and red blood cells (Figure 20G). [Figure 20E] Plots of the average normalized impedance of the real and imaginary components at various currents (107 kHz, 570 kHz, 1.55 MHz, 16 MHz, and 40 MHz) are shown for basophils (Figure 20A), eosinophils (Figure 20B), lymphocytes (Figure 20C), monocytes (Figure 20D), neutrophils (Figure 20E), platelets (Figure 20F), and red blood cells (Figure 20G). [Figure 20F] Plots of the average normalized impedance of the real and imaginary components at various currents (107 kHz, 570 kHz, 1.55 MHz, 16 MHz, and 40 MHz) are shown for basophils (Figure 20A), eosinophils (Figure 20B), lymphocytes (Figure 20C), monocytes (Figure 20D), neutrophils (Figure 20E), platelets (Figure 20F), and red blood cells (Figure 20G). [Figure 20G] Plots of the average normalized impedance of the real and imaginary components at various currents (107 kHz, 570 kHz, 1.55 MHz, 16 MHz, and 40 MHz) are shown for basophils (Figure 20A), eosinophils (Figure 20B), lymphocytes (Figure 20C), monocytes (Figure 20D), neutrophils (Figure 20E), platelets (Figure 20F), and red blood cells (Figure 20G). [Figure 21A] Normalized voltage differential signals from 5 μm and 10 μm polystyrene beads flowing through the channel sensor are shown. [Figure 21B] Figure 1 shows a histogram of the number of beads versus the measured voltage difference for 5 µm and 10 µm polystyrene beads flowing through a channel sensor. The results demonstrate that polystyrene beads can be sorted by size based on the impedance resulting from the beads passing through the channel sensor. [Figure 22A]Illustrates the clustering of white blood cells (WBCs), red blood cells (RBCs), and platelets using a machine learning model that sorts particles based on their impedance characteristics. [Figure 22B] 1 shows the clustering of neutrophils, lymphocytes, and monocytes by a machine learning model that sorts particles based on their impedance properties. [Figure 22C] The component voltage differential signal over time is shown as diluted whole blood passes through the sensor. Using a machine learning model, particles passing through the sensor were labeled as red blood cells (R), white blood cells (W), platelets (P), or polystyrene beads (PS) based on the particle's assigned impedance characteristics. DETAILED DESCRIPTION OF THE INVENTION
[0074] Described herein are cartridges and systems for analyzing biological samples (such as blood, serum, saliva, sweat, tears, mucus, urine, or any other biological sample or derivative suspended in a fluid), as well as methods for analyzing biological systems. Different types of cartridges can be used with a control device, and different types of cartridges can be configured to perform different assays or assay panels of biological samples. For example, in some embodiments, a cartridge is configured to perform a complete blood count (CBC) assay. A CBC assay can identify and count different blood cell types, such as red blood cells, platelets, and white blood cells (including eosinophils, basophils, neutrophils, monocytes, and lymphocytes). In some embodiments, a cartridge is configured to perform a comprehensive metabolic panel (CMP). The same control device can engage different cartridges, allowing for a single, versatile device that can be used to perform multiple assays by connecting with selected cartridges.
[0075] The cartridge includes a sample receiving port capable of receiving a biological sample, a sensor for analyzing the sample, and a cartridge space fluidically connecting the biological sample receiving port to the sensor. The electrowetting electrodes can transport the biological sample within the cartridge space and, optionally, divide the sample into smaller volumes and / or further mix the biological sample with one or more reagents to process the biological sample. The cartridge can connect to a device via a device interface on the cartridge, the device interface configured to receive power from and communicate with the device. The sensor and the electrowetting electrodes are in electrical communication with the device interface, thereby enabling the device to operate the cartridge.
[0076] The sensor is used to analyze the biological sample and may be, for example, a sensor configured to detect a protein (which may be, for example, an enzyme) or an electrolyte, or to count the number and / or type of cells in the biological sample. In some embodiments, the cartridge includes two, three, four, or more sensors that may have the same or different functions. For example, the cartridge may include a first sensor for detecting a protein and a second sensor for counting the number of cells, or a hybrid sensor that can both detect a protein and count the number of cells.
[0077] A biological sample can be analyzed by placing the biological sample in a cartridge and transporting the biological sample within the cartridge using multiple electrowetting electrodes. The biological sample is introduced into the cartridge, for example, by placing a fixed volume of the biological sample directly into an input port or through an interface that allows for placement of a blood collection tube, thereby creating a fluid pathway from the tube to the input port. In some embodiments, the biological sample is prepared by dividing a blood sample into multiple droplets of predetermined volume. The sample can be mixed with one or more reagents in the cartridge to process the biological sample, and the biological sample is analyzed using one or more sensors in the cartridge to generate analytical data. The analytical data is then transmitted to the device.
[0078] A plurality of electrowetting electrodes within the cartridge allows the biological sample to be carefully transported within the cartridge using a low voltage force. The cartridge may include a reagent reservoir, and the reagent within the reservoir may be mixed with the biological sample on the electrowetting electrodes before being transported to the sensor for analysis.
[0079] The cartridge is preferably a single-use, disposable cartridge containing the necessary reagents and correct volumes to process a biological sample without user intervention. The user need only apply the biological sample onto the cartridge, and the device can operate the cartridge to properly process and analyze the sample. Once the analysis is complete, the cartridge can be discarded. Different cartridge types can be manufactured containing different analytical tests depending on the sensor or sensors contained within the cartridge, and a single device can interface with different cartridge types.
[0080] Also described herein are sensors that use multiplexed impedance sensing to analyze biological samples. The biological samples can be analyzed, for example, to detect or quantify proteins (e.g., enzymes) or electrolytes, or to count the number and / or type of cells (such as red blood cells, white blood cells, or platelets) in the biological sample. Such biological samples can include, for example, blood, serum, saliva, sweat, tears, mucus, urine, or any other biological sample or derivative suspended in a liquid. In some embodiments, the sensor is included on a cartridge configured to receive and analyze the biological sample. The cartridge can be part of a system that receives and operates the cartridge.
[0081] In some embodiments, the sensor includes an electrode pair configured to detect impedance at multiple frequencies within the pore or channel. The detected impedance may include a multivariate impedance pattern at one or more frequencies, and the one or more multivariate impedance patterns may be analyzed to count cells and / or identify cell types. The multivariate impedance pattern may include, for example, a signal (e.g., amplitude) from the real component of the impedance and a signal (e.g., amplitude) from the imaginary component. Alternatively, the multivariate impedance pattern may include, for example, a signal (e.g., amplitude) from the magnitude component of the impedance and a signal (e.g., amplitude) from the phase component of the impedance.
[0082] Further disclosed herein are methods for determining cell counts in a biological sample. The cell count may include counting multiple different cell types, such as white blood cell counts, red blood cell counts, and / or platelet counts, in the biological sample. In some embodiments, the cell count may include a white blood cell differential, such as a basophil count, an eosinophil count, a lymphocyte count, a neutrophil count, and / or a monocyte count. The method may include transporting a biological sample (or a subsample) through a sensor including a channel or pore. A multiplexed current or voltage may be applied to the channel or pore, and a multiplexed impedance may be detected within the channel or pore. The multiplexed impedance may include at least a first multivariate impedance pattern at a first frequency and a second multivariate impedance pattern at a second frequency. The cell count may then be determined based on the detected multiplexed impedance. As further described herein, the multiplexed impedance pattern may include characteristics of the detected impedance signal as cells or other particles flow through the channel or pore. Such features may include, but are not limited to, one or more of impedance peak height, impedance peak width, impedance peak area, or impedance peak half-width peak height. Features may be derived from the real or imaginary components of the impedance signal. Features may be derived from the magnitude or phase components of the impedance signal.
[0083] Also described herein is a method for detecting an analyte, such as a protein or electrolyte, in a biological sample. The method includes transporting the biological sample through a sensor including a channel or pore, applying a current or voltage to the channel or pore, and detecting impedance within the channel or pore. The biological sample includes an analyte bound to an affinity moiety, and the impedance is affected when the analyte bound to the affinity moiety passes through the channel or pore. Therefore, the analyte can be detected based on the detected impedance.
[0084] In some optional embodiments of the electrowetting electrode array described herein, the electrowetting electrode array is configured to transport an aqueous liquid (such as a biological sample or a processed biological sample) by applying a low voltage (about 50 volts or less) to the electrowetting electrodes. The voltage applied to the electrodes results in a change in the liquid contact angle, actuating the liquid. By using a low voltage to transport the aqueous liquid, the electrowetting electrode array can be used in low-power devices and applications, such as point-of-care assay systems. The point-of-care assay system can include a cartridge with an electrowetting electrode array configured to analyze the biological sample. The cartridge includes an electrowetting array within the cartridge and can be operated by a device, which can be a handheld and / or battery-powered device.
[0085] In some embodiments, the electrowetting electrode array comprises a plurality of coplanar electrowetting electrodes coated with and spaced apart by an insulating layer, the electrowetting array comprising a hydrophobic liquid contact surface, and the electrowetting array configured to transport an aqueous liquid using a voltage of about 50 volts or less. As further described herein, the hydrophobicity (i.e., contact angle) of the liquid contact surface, as well as the distance and / or material separating the liquid contact surface and the electrode, are selected to reduce the voltage required to transport an aqueous liquid sample from one electrowetting electrode to another.
[0086] The liquid can be transported by positioning an aqueous liquid on a first hydrophobic liquid contact surface above a deactivated first electrowetting electrode, and activating a second electrowetting electrode by applying a voltage of about 50 volts or less to the second electrowetting electrode, thereby transporting the aqueous liquid from the first hydrophobic liquid contact surface to a second hydrophobic liquid contact surface above the second electrowetting electrode. The first electrowetting electrode and the second electrowetting electrode are coated with and separated by an insulating layer.
[0087] A cartridge for analyzing a biological sample (such as blood, serum, saliva, sweat, tears, mucus, urine, or any other biological sample or derivative suspended in a fluid) may include an electrowetting electrode array for transporting and / or processing the biological sample within the cartridge. The cartridge may further include one or more sensors for analyzing the biological sample. Different types of cartridges may be used with a control device, and different types of cartridges may be configured to perform different assays or assay panels of biological samples. The same control device may engage different cartridges, allowing for a single, versatile device that can be used to perform multiple assays by connecting with selected cartridges.
[0088] definition As used herein, the singular forms "a," "an," and "the" include plural references unless the context clearly dictates otherwise.
[0089] Reference herein to "about" or "approximately" a value or parameter includes (and describes) variations that are directed to the value or parameter itself. For example, a description that refers to "about X" includes a description of "X."
[0090] As used herein, the term "antibody" includes Fc-containing polypeptides such as, but not limited to, monoclonal antibodies, polyclonal antibodies, chimeric antibodies, CDR-grafted antibodies, humanized antibodies, Fab, Fab', F(ab'), Fv, disulfide-linked Fv, scFv, single-domain antibodies (dAbs), diabodies, multispecific antibodies, dual specific antibodies, antispecific antibodies, bispecific antibodies, functionally active epitope-binding fragments thereof, bifunctional hybrid antibodies, single-chain antibodies, and immunoadhesins. In some embodiments, an antibody may be any heavy chain isotype (e.g., IgG, IgA, IgM, IgE, or IgD). In some embodiments, an antibody may be any light chain isotype (e.g., kappa or gamma). An antibody may be non-human (e.g., from a mouse, goat, or any other animal), fully human, humanized, or chimeric. In some embodiments, an antibody is a derivatized antibody.
[0091] The term "channel" refers to a tube, duct, or other passageway that provides a linear liquid flow path.
[0092] It will be understood that aspects and variations of the invention described herein include "consisting of" and / or "consisting essentially of" aspects and variations.
[0093] A "high kappa" or "high-κ" material is any material that has a dielectric constant of 3.9 or greater.
[0094] A "hydrophobic" material, surface, or layer is any material, surface, or layer that provides a water contact angle of 90 degrees or greater at 25°C.
[0095] When a range of values is provided, it is understood that each intervening value between the upper and lower limits of that range, as well as any other stated or intervening value in that stated range, is encompassed within the scope of the disclosure. Where a stated range includes an upper or lower limit, ranges excluding either of those included limits are also included in the disclosure.
[0096] It should be understood that one, some, or all of the features of the various embodiments described herein may be combined to form other embodiments of the present invention. The section headings used herein are for organizational purposes only and should not be construed as limiting the subject matter described.
[0097] The features and preferences described above with respect to an "embodiment" are separate preferences and are not limited to that particular embodiment; they may be freely combined with features from other embodiments, where technically feasible, to form preferred combinations of features. The description is presented to enable one skilled in the art to make and use the invention and is provided in the context of a patent application and its requirements. Various modifications to the described embodiments will be readily apparent to those skilled in the art, and the generic principles herein may be applied to other embodiments. Thus, the present invention is not intended to be limited to the embodiments shown, but is to be accorded the widest scope consistent with the principles and features described herein.
[0098] Analysis Cartridge The cartridge receives a biological sample, which may be deposited by a user, and processes and analyzes the biological sample. The cartridge includes a sample receiving port configured to receive the biological sample, a sensor configured to analyze the biological sample, a chamber or channel in fluid communication with the biological sample receiving port and the sensor, a plurality of electrowetting electrodes configured to transport the biological sample within the chamber or channel and combine the biological sample with one or more reagents, and a device interface configured to receive power from and communicate with a cartridge interface on the device, such that the sensor and the plurality of electrowetting electrodes are in electrical communication with the device interface. The cartridge is preferably a single-use cartridge, and a new cartridge can be used to analyze a different biological sample. In some embodiments, the plurality of electrowetting electrodes are configured within the cartridge to (1) transport the biological sample within the chamber or channel and (2) combine the biological sample with one or more reagents.
[0099] Fluid actuation within the cartridge may be performed using electrowetting electrodes, although other forms of liquid (e.g., sample) transport within the cartridge are contemplated. For example, in some embodiments, the cartridge includes one or more mechanical pumps (such as syringe pumps, peristaltic pumps, and / or pneumatic pumps) for transporting liquid within the cartridge. The one or more mechanical pumps may be used, for example, in conjunction with one or more electrofluidic valves. Thus, although certain embodiments of the cartridges described herein use electrowetting electrodes for liquid movement and / or sample preparation, other forms of liquid transport may also be used.
[0100] Exemplary biological samples that can be placed in the cartridge include, but are not limited to, blood, plasma, serum, sweat, tears, mucus, urine, or any other suitable liquid biological sample or biological sample derivative. In some embodiments, the sample has a volume of about 20 μL or greater, such as a volume of about 20 μL to about 1 mL. For example, in some embodiments, the sample has a volume of about 20 μL to about 40 μL, about 40 μL to about 80 μL, about 80 μL to about 150 μL, about 150 μL to about 300 μL, about 300 μL to about 600 μL, or about 600 μL to about 1 mL. The biological sample received by the cartridge can be divided within the cartridge to perform different tests or to perform duplicate tests. The biological sample can be divided and / or measured (i.e., up to a predetermined volume) using electrowetting electrodes. In some embodiments, the sample can be divided to perform two, three, four, or more (i.e., duplicate, triplicate, etc.) duplicate tests. In some embodiments, a sample is divided into two, three, four, five, six, seven, eight, nine, ten, or more different tests, each of which may or may not be performed in duplicate. As an example, a 600 μL biological sample may be divided into 30 divided samples, each having 20 μL of biological sample, which may be analyzed in triplicate using 10 different analytical tests.
[0101] The sample receiving port may include an inlet fluidly connected to the sample receiving chamber by a first sample port channel, and the sample receiving chamber may be fluidly connected to a chamber or channel of the cartridge via a second sample port channel. The volume of the sample receiving chamber determines the volume of the sample received by the cartridge. Thus, in some embodiments, the volume of the sample receiving chamber is greater than or equal to about 20 μL, such as from about 20 μL to about 1 mL. For example, in some embodiments, the sample receiving chamber has a volume of from about 20 μL to about 40 μL, from about 40 μL to about 80 μL, from about 80 μL to about 150 μL, from about 150 μL to about 300 μL, from about 300 μL to about 600 μL, or from about 600 μL to about 1 mL. A sample placed in the inlet flows through the first sample port channel into the sample receiving chamber by capillary action. The sample is retained in the sample receiving chamber until the electrowetting electrodes are operated to transport the sample from the sample receiving chamber. As discussed further herein, the electrowetting electrodes are preferably coated with a material that provides a hydrophobic fluid contact surface that prevents the sample from flowing through the second sample port channel into the device's chambers or channels without electrowetting actuation. The second sample port channel and / or the sample receiving chamber may optionally include one or more electrowetting electrodes that can assist in transferring the biological sample from the sample receiving chamber into the main chamber or channel. Optionally, the cartridge may also include a filter configured to filter the biological sample before it enters the main chamber. The filter may, for example, remove foreign matter or larger particles from the biological sample before the sample is processed and analyzed within the cartridge. The filter may be positioned, for example, within the second sample port channel or the first sample port channel.
[0102] The sample receiving port is fluidly connected to a main chamber or channel, which is fluidly connected to one or more sensors or other cartridge components. If the cartridge includes a main channel for transporting the biological sample throughout the cartridge, the channel is preferably sized to limit capillary movement of the sample within the channel. The lower portion of the chamber or channel includes multiple electrowetting electrodes, which may be coated as described herein. The main chamber or channel also includes a top and sidewalls to enclose the channel or chamber, although the sidewalls may optionally be rounded to avoid corners. The multiple electrowetting electrodes are configured to transport the biological sample within the chamber or channel via electrowetting actuation, for example, to a reagent mixing area, a sensor, or a waste reservoir. In some configurations, the multiple electrowetting electrodes are positioned at the bottom of the chamber or channel, and in some embodiments, the multiple electrowetting electrodes are positioned at the bottom and top of the chamber or channel. Having a main chamber within the cartridge with an electrowetting array allows for programmable control of fluid movement within the cartridge using electrowetting electrodes, as opposed to a channel, which forces linear fluid movement.
[0103] The chambers or channels may be fluidly connected to one or more reagent reservoirs, which may be pre-loaded with reagents to process the biological sample. The reagent reservoirs may be sized to contain a desired amount of reagent. The reagent reservoirs are connected to the main chamber or channel via reservoir channels. One or more of the reagent reservoirs and / or reservoir channels may optionally include one or more electrowetting electrodes to transport the reagents from the reagent chamber into the main chamber or channel. The electrowetting electrodes optionally transport the sample and reagents into a reagent mixing region, thereby combining the biological sample with one or more reagents to form a processed biological sample. The reagents may be used, for example, to alter pH, perform chemical and / or biological reactions, or dilute (or serially dilute) the biological sample to form a processed biological sample. In some embodiments, one or more of the reagents are configured to modify or lyse cells in the sample, or a subset of cells in the sample. For example, in some embodiments, a lysis reagent lyses cells in the sample or lyses only red blood cells in the sample. Targeted lysis of red blood cells in a sample is optionally performed, for example, to process the sample to enumerate white blood cells in the sample or to measure hemoglobin content or concentration. In some embodiments, one or more reagents may modify the cell surface (e.g., cell membrane) with a marker (e.g., an affinity moiety marker such as an aptamer or antibody (or fragment) that may be labeled) that specifically binds to the cell type for identification. In some embodiments, one or more reagents include a marker that may be used to identify the cell type, that may modify the interior of the cell (e.g., the cytoplasm or nucleus of the cell), or that may penetrate into the cell or a targeted subset of cells.
[0104] In some embodiments, the one or more reagents include a buffer, an anticoagulant (such as ethylenediaminetetraacetic acid (EDTA)), or a stabilizer (such as a stabilizer protein, e.g., albumin), and / or a viscosity adjuster (such as glycerol, e.g., about 0.1% to about 50% glycerol).
[0105] Several reagents can be used to dilute a sample or a portion of a sample. In some embodiments, one or more reagents are added to a sample or a portion of a sample to dilute the sample at a ratio of sample to dilution reagent of about 1:1 to about 1:2000 (e.g., about 1:1 to about 1:5, about 1:5 to about 1:10, about 1:10 to about 1:20, about 1:20 to about 1:50, about 1:50 to about 1:100, about 1:100 to about 1:300, about 1:300 to about 1:500, about 1:500 to about 1:1000, or about 1:1000 to about 1:2000).
[0106] The cartridge includes one or more sensors fluidly connected to the chambers or channels. The cartridge may include one, two, three, four, five, or more different sensors, and may include one, two, three, four, five, or more duplicate sensors of a given type of sensor. Exemplary sensors that may be used with the cartridge are described in further detail herein. Briefly, exemplary sensors include optical sensors and impedance sensors that may be configured to analyze a biological sample. In some embodiments, the sensor is configured to detect proteins or electrolytes or measure protein or electrolyte concentrations in the biological sample. In some embodiments, the sensor is a channel sensor (e.g., a flow cytometer configured to count cells in a biological sample, or a flow analyte sensor configured to detect or quantify the amount of an analyte, such as a protein or enzyme). The flow cytometer may be able to distinguish between different cell types (e.g., red blood cells, white blood cells, or platelets) and is configured to count one or more different cell types.
[0107] The cartridge may include a waste reservoir configured to receive the biological sample after analysis by one or more sensors. The waste reservoir may be fluidly connected to the main chamber, for example, by a waste channel. Electrowetting electrodes may transport the analyzed biological sample into the waste reservoir through electrowetting actuation. Optionally, the waste channel and / or the waste reservoir may include one or more electrowetting electrodes to control transport of the biological sample into the waste reservoir. In some embodiments, once the biological sample is transported into the waste reservoir, it is retained in the waste reservoir via the hydrophobic effect. The electrowetting electrodes adjacent to the waste reservoir may be coated with a hydrophobic fluid contact layer, and fluid in the waste reservoir remains there to avoid the hydrophobic fluid contact layer when the electrowetting electrodes are not in use.
[0108] The cartridge further includes a device interface configured to receive power from and communicate with a cartridge interface on the device. The device interface includes a plurality of electrodes that electrically communicate with the device electrodes when the cartridge and the device are engaged with each other. One or more sensors and electrowetting electrodes are in electrical communication with the device interface via the electrodes. This enables communication between the device and the cartridge, and the device can operate the electrowetting electrodes to transport a biological sample within the cartridge, including ejecting it from a sample receiving port and / or inserting it into a waste reservoir. The device can further operate the electrowetting electrodes to transport one or more reagents within the cartridge and combine the biological sample with the one or more reagents. The device can further operate one or more sensors within the cartridge. The one or more sensors can generate analytical data by analyzing the biological sample transmitted to the device via the device interface. In this manner, the device can receive analytical data.
[0109] Optionally, the cartridge may include one or more (e.g., one, two, three, four, five, or more) optical windows on the top and / or bottom of the cartridge, which may be optically transparent. These optical windows are used in combination with an impedance sensor or as stand-alone detectors. Both standalone and in combination for detection of reactions with reagents, for selective detection of analyte or protein binding by either color change or fluorescent emission. In some embodiments, when used in combination with an impedance sensor, optical detection can be used to detect interfering substances, including but not limited to lipids, bilirubin C, bilirubin F, kryl, hemolyzed hemoglobin, and glucose, and / or alternatively, to detect sample quality so as to apply a correction factor to the measurement. Sample quality checks include measuring sample turbidity. When the cartridge includes two or more optical windows, the optical windows may be of the same size or different sizes. The optical window is configured to allow light to pass through the sample, for example, to capture an image of the sample or to assay the sample using optical microscopy or spectroscopy (e.g., fluorescence, infrared (IR), Raman, or UV / Vis absorption spectroscopy). The electrowetting electrodes can transport the biological sample, or a portion thereof, to the optical window, where the sample can be assayed or an image of the sample can be captured. In some embodiments, the device for operating the cartridge includes a light source and an optical detector aligned with the optical window when the cartridge is engaged with the cartridge. The device can be different from assaying the biological sample using the light source and the optical detector. In some embodiments, the device includes a camera aligned with the optical window of the cartridge, and the camera can image the biological sample through the optical window when the cartridge is engaged with the device.
[0110] FIG. 1A illustrates an exemplary cartridge for analyzing biological samples. The cartridge includes a sample receiving port including an inlet 102 fluidly connected to a sample receiving chamber 104 via a first sample port channel 106. The biological sample is placed in the inlet 102 and moves by capillary action through the first sample port channel 106 into the receiving chamber 104. The sample receiving chamber 104 is fluidly connected to a main chamber 108 via a second sample port channel 110. Optionally, the cartridge includes a filter (not shown) between the inlet 102 and the main chamber 108, which may be positioned, for example, in the first sample port channel 106 or the second sample port channel 110. The filter may remove larger contaminants in the biological sample, if present. The main chamber 108 includes multiple electrowetting electrodes 112 and continues into the second sample port channel 110. The cartridge further includes multiple reagent reservoirs 114a, 114b, 114c, and 114d, which are fluidly connected to the main chamber 108 via reservoir channels 116a, 116b, 116c, and 116d. While the exemplary cartridge illustrated in FIG. 1A shows four reagent reservoirs, it is understood that the cartridge may include any number of reservoirs as determined by the test(s) to be performed using the cartridge. Multiple electrowetting electrodes 112 extend into reservoir channels 116a, 116b, 116c, and 116d, and the electrowetting electrodes 112 can be operated to transport reagents in reservoir channels 116a, 116b, 116c, and 116d into a mixing region 118 of the main chamber 108. The biological sample and reagents are transported into the mixing region 118 and combined to form a processed biological sample. Optionally, the main chamber 108 of the cartridge may include a filter. The biological sample may be transported through the filter using electrowetting electrodes 112, for example, to separate components of the biological sample (e.g., to separate serum from whole blood).The multiple electrowetting electrodes 112 can be operated to transport the processed biological sample, or a portion of the processed biological sample, to one or more sensors within the cartridge. Optionally, the biological sample is analyzed by the sensors without processing. The exemplary cartridge illustrated in FIG. 1A includes three impedance sensors 120a, 120b, and 120c, which are configured to measure the amount of protein in the biological sample. The impedance sensors can be of the same type (i.e., redundant impedance sensors performing the same assay) or different types. While the exemplary cartridge illustrated in FIG. 1A includes three impedance sensors, it is understood that the cartridge can include any number of impedance sensors, which can depend on the number of assays or assay duplicates for a particular cartridge. The illustrated cartridge further includes four channel sensors 122a, 122b, 122c, and 122d, although other embodiments of the cartridge may have additional or fewer channel sensors, which can be redundant or non-redundant. The channel sensors can be, for example, flow cytometers or configured to detect or quantify proteins. In the illustrated example, the plurality of electrowetting electrodes 112 includes functionalized electrodes that are part of the impedance sensors 120a, 120b, and 120c. However, the plurality of electrowetting electrodes 112 do not extend into the sensor channels 122a, 122b, 122c, and 122d, and instead use capillary action to transport the processed biological sample through the sensors. The cartridge further includes a waste reservoir 124 fluidly connected to the main chamber 108 via a waste channel 126. The plurality of electrowetting electrodes extend into the waste channel 126 and can be operated to transport the processed biological sample into the waste reservoir 124. The cartridge further includes a device interface 128 in electrical communication with the plurality of electrowetting electrodes 112 and the sensors 120a, 120b, 120c, 122a, 122b, 122c, and 122d.
[0111] The cartridge optionally includes an optical window 130. The optical window includes a transparent window at the top of the cartridge and a transparent window at the bottom of the cartridge, allowing light to pass through. The optical window 130 is fluidly connected to the main chamber 108, and a biological sample can be transported to the optical window 130 using electrowetting electrodes 112. When the cartridge is engaged with a device (not shown in FIG. 1A ), a light source and an optical detector are positioned on opposite sides of the optical window 130, and a biological sample positioned within the optical window can be assayed using the device.
[0112] FIG. 1B illustrates another embodiment of the cartridge with a different sensor orientation. The main chamber is illustrated with multiple electrowetting electrodes to indicate an array, but the size and / or spacing of the electrowetting electrodes may vary. The cartridge includes a sample receiving port including an inlet 132 fluidly connected to a sample receiving chamber 134 via a first sample port channel 136. A biological sample is placed in the inlet 132 and moves by capillary action through the first sample port channel 136 into the receiving chamber 134. The sample receiving chamber 134 is fluidly connected to a main chamber 138 via a second sample port channel 140. The receiving chamber 134 and second sample port channel 140 include a first electrowetting electrode 142 and a second electrowetting electrode 144. The electrowetting electrodes can be operated to controllably transfer the biological sample from the sample receiving chamber 134, through the second sample port channel 140, and into the main chamber 138. Optionally, the cartridge includes a filter between the inlet 132 and the main chamber 138, which may be positioned, for example, in the first sample port channel 136 or the second sample port channel 140. For example, if a filter is positioned in the second sample port channel 140, electrowetting electrodes may be used to transfer the biological sample through the filter and into the main chamber 138. The filter may remove larger foreign objects in the biological sample, if present.
[0113] Main chamber 138 includes multiple electrowetting electrodes, which are electrically connected to device interface 146 so that the electrowetting electrodes can be operated using the device when connected to the device. The cartridge further includes multiple reagent reservoirs 148a, 148b, 148c, and 148d, which are fluidly connected to main chamber 138 via reservoir channels 150a, 150b, 150c, and 150d. While the exemplary cartridge illustrated in FIG. 1B shows four reagent reservoirs, it is understood that the cartridge can include any number of reservoirs as determined by the test(s) to be performed using the cartridge. Reagent reservoirs 148a, 148b, 148c, and 148d and / or reservoir channels 150a, 150b, 150c, and 150d can include one or more electrowetting electrodes that can be used to transport reagents contained in the reagent reservoirs into the main chamber. For example, reagent reservoir 148a and reagent channel 150a may include a first electrowetting electrode 152a and a second electrowetting electrode 154a.
[0114] The biological sample and reagents are transported and combined in a mixing region of the main chamber 138 to form a processed biological sample. Optionally, the main chamber 138 of the cartridge may include a filter. The biological sample may be transported through the filter using electrowetting electrodes, for example, to separate components of the biological sample (e.g., to separate serum from whole blood). The multiple electrowetting electrodes may be operated to transport the processed biological sample, or a portion of the processed biological sample, to one or more sensors within the cartridge. Optionally, the biological sample is analyzed by the sensors without processing.
[0115] The exemplary cartridge illustrated in FIG. 1B includes two impedance sensors 156a and 156b, which are configured to measure the amount of protein in a biological sample. The impedance sensors may be configured to perform the same assay (i.e., redundant impedance sensors) or different assays. While the exemplary cartridge illustrated in FIG. 1B includes two impedance sensors, it is understood that the cartridge may include any number of impedance sensors, which may depend on the number of assays or assay redundants for a particular cartridge. The illustrated cartridge further includes two channel sensors 158a and 158b, but other cartridge embodiments may have additional or fewer channel sensors, which may be redundant or non-redundant. The channel sensors may be, for example, flow cytometers or may be configured to detect or quantify proteins. Electrodes from the impedance sensors 156a and 156b and the channel sensors 158a and 158b are electrically connected to the device interface 146. When the device operates the cartridge, the device may transmit current and / or receive data acquired via the electrically connected sensors.
[0116] The cartridge illustrated in FIG. 1B includes optical window 160 and optical window 162, which may be the same size or different sizes. The optical windows include a transparent window at the top of the cartridge and a transparent window at the bottom of the cartridge, allowing light to pass through. The optical windows are each fluidly connected to main chamber 138 through a channel, and biological samples can be transported to the optical windows using electrowetting electrodes. When the cartridge is engaged with a device (not shown in FIG. 1B), a light source and an optical detector are positioned on opposite sides of the optical windows, and biological samples positioned within the optical windows can be assayed using the device.
[0117] 1B further includes a waste reservoir 164 fluidly connected to the main chamber 138 via a waste channel 166. The waste reservoir 164 and the waste channel 166 include electrowetting electrodes so that the analyzed biological sample can be transported from the main chamber 138 into the waste reservoir.
[0118] The cartridge may be configured to include various numbers of sensors and / or sensor types depending on the assay or assay panel the cartridge is used to perform. For example, the cartridge may include one or more of a channel sensor (e.g., a flow cytometer or a channel sensor configured to detect an analyte such as a protein), an optical window, and / or an impedance sensor. The cartridge may be configured to perform one or more assays or assay panels depending on the configuration, reagents, and / or sensors included within the cartridge. For example, the cartridge may be configured to assay one or more of a cell count (e.g., red blood cell count, white blood cell count, and / or platelet count), or the detection or quantification of proteins (or enzymes) or other analytes (such as electrolytes). In some embodiments, the cartridge is configured to test a biological sample for a complete blood count (CBC) or a comprehensive metabolic panel (CMP). In some embodiments, the cartridge is configured to detect or quantify one or more of glucose, calcium, blood urea nitrogen (BUN), creatinine, sodium, potassium, chloride, carbon dioxide, total serum protein, albumin, total bilirubin, alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), red blood cells, white blood cells, platelets, hemoglobin, or hematocrit.
[0119] Device for operating the cartridge The device is configured to interact with and operate the cartridge described herein to form a system for analyzing biological samples. As discussed, the device can connect and operate different cartridge types configured to perform different assays or assay panels on biological samples. The device includes a cartridge interface that engages with a device interface on the cartridge to power and communicate with the cartridge. In this regard, the device is configured to provide power to the cartridge to power one or more sensors and / or electrowetting electrodes, receive analytical data from one or more sensors in the cartridge, and operate one or more sensors in the cartridge. The device may include a processor (e.g., a microcontroller, a finite state machine, etc.) and memory that can be used to operate the device in controlling the electrowetting electrodes or one or more sensors and receive analytical data. In some embodiments, the device interface on the cartridge is configured to insert into a cartridge interface on the device, and in some embodiments, the cartridge interface on the device is configured to insert into a device interface on the cartridge. The device may be a handheld device that can be powered by a battery.
[0120] The device can be configured to power and communicate with different types of cartridges to perform different analyses on biological samples. For example, the device can engage a first type of cartridge with a first sensor, analyze a first biological sample using the first type of cartridge, disengage the first type of cartridge, engage a second type of cartridge with a second type of sensor different from the first sensor, and analyze a second biological sample using the second type of cartridge. The device can be configured to power and operate 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or more different types of cartridges.
[0121] In some embodiments, the device includes one or more processors and a non-transitory computer-readable storage medium storing one or more programs configured to be executed by the one or more processors (e.g., a microcontroller). The one or more programs may include instructions for operating multiple electrowetting electrodes in the cartridge to transport a biological sample and / or mix the biological sample with one or more reagents. The one or more programs may also include instructions for operating one or more sensors. As further described herein, certain sensors may utilize static placement of the biological sample within the sensor, while certain sensors may require a continuous flow of the biological sample through the sensor. Thus, in some embodiments, the one or more programs include instructions for operating multiple electrowetting electrodes in the cartridge to continuously transport the biological sample through the sensor or to statically position the biological sample within the sensor.
[0122] The device includes hardware and circuitry for powering different device components, including multiple electrowetting electrodes and one or more sensors. For example, the device may include one or more power supply circuits that provide energy to various cartridge components to operate them. In some embodiments, the device is configured to operate the multiple electrowetting electrodes using about 0.5 volts to about 1000 volts (e.g., about 0.5 volts to about 1 volt, about 1 volt to about 5 volts, about 5 volts to about 10 volts, about 10 volts to about 20 volts, about 20 volts to about 30 volts, about 30 volts to about 50 volts, about 50 volts to about 100 volts, about 100 volts to about 250 volts, about 250 volts to about 500 volts, or about 500 volts to about 1000 volts). Preferably, the multiple electrowetting electrodes are operated using about 50 volts or less, or more preferably about 20 volts or less. Lower voltages for actuating biological samples using multiple electrowetting electrodes allow for the use of lower power, which may allow the device to be battery powered.
[0123] The device further includes electronic circuitry and / or one or more programs for powering, operating, and receiving data from one or more sensors. For example, the device may include an integrated circuit (e.g., a field programmable gate array (FPGA) or an application specific integrated circuit (ASIC)) for operating the sensor, which may include transmitting and / or receiving data using a data acquisition circuit (DAQ). The device may also include a digital signal processor (DSP) and / or a digital signal synthesizer (DSS).
[0124] The device may further include electronic circuitry to enable information display or data export and / or communication. For example, the device may include an input / output port (I / O port) and / or a wired or wireless communication device (such as a WiFi or Bluetooth communication device).
[0125] The device may be connected to a cartridge as a system for analyzing biological samples. Figure 2 illustrates a block diagram of an exemplary device engaged with a cartridge. The device includes a processor in electrical communication with a memory that may store one or more programs for operating the device and / or cartridge. The device further includes a power supply circuit, which may include a battery or an electrical plug. The power supply circuit is in electrical communication with the processor to provide power to the processor and is in electrical communication with the electrowetting electrode driver. The power supply circuit may provide different power levels to the processor and the electrode driver. For example, the power supply circuit may provide 3.3 volts (or any other suitable voltage) to the processor and about 0.5 volts to about 1000 volts to the electrowetting electrode driver, depending on the configuration of the electrowetting electrodes. The processor is configured to operate an electrowetting electrode driver, which is in electrical communication with the electrowetting electrodes via a cartridge interface on the device and a device interface on the cartridge. The processor may operate an electrowetting driver, which controls electrowetting actuation of fluids (such as a biological sample and one or more reagents) through the cartridge using the electrowetting electrodes. The electrowetting driver operates the electrowetting electrodes to transport the biological sample in the sample inlet to a mixing region of the cartridge. Additionally, the electrowetting driver operates the electrowetting electrodes to transport reagents in the reagent reservoirs into the mixing region to combine the reagent(s) with the biological sample to form a processed biological sample. The electrowetting driver can then operate the electrowetting electrodes to transport the processed biological sample to a sensor (or multiple sensors, e.g., sensor 1 and sensor 2, if present on the cartridge) either sequentially or alternatively (e.g., by splitting the sample) before transporting the processed biological sample to a waste reservoir.
[0126] Continuing with reference to FIG. 2 , the device's processor may be in electrical communication with an integrated circuit (e.g., an FPGA) configured to operate one or more sensors (e.g., sensor 1 and sensor 2). Sensor 1 may be, for example, a flow cytometer configured to count the number of cells or the number of cell types in a biological sample, and sensor 2 may be, for example, an impedance sensor configured to quantify protein or analyte concentrations. The device may include a digital signal synthesizer (DSS) module that uses a direct digital synthesizer (DDS) and a digital-to-analog converter (DAC) to generate and transmit an analog signal (e.g., a multiplexed analog signal) to one or more sensors. Alternatively, the multiplexed signal may also be generated using a direct analog synthesizer (DAS) that does not require a DAC. As illustrated, the DSS is integrated into the FPGA, but it is contemplated that the DSS may be separate from the FPGA. In each of the above two schemes using either a DDS or a DAS, the analog or digital signals must be mixed after generation, requiring a separate mixing stage to generate the multiplexed analog signal. In another embodiment, the signal is generated using an arbitrary waveform generator (AWG), and digital samples of the multiplexed signal stored in memory or a look-up table (LUT) are converted to analog form using a variable frequency clock. Data from the sensor is sent to a data acquisition circuit (DAQ), which may store the data in memory (optionally incorporated in an FPGA) before being acquired by a processor, such as a digital signal processor (DSP), for processing. The DSS may provide a reference signal to the DAQ circuit, which may be used to calibrate the signal received from the sensor. The DSP may optionally be electrically connected to a device processor and may send the data to the device processor. The device processor may store the data in device memory or output the data via an input / output (I / O) port (e.g., via Bluetooth or a network (e.g., WiFi connection)) for display or otherwise communicating the data.Optionally, the DSP may communicate directly with the I / O port to communicate data.
[0127] The biological sample enters the cartridge through a sample inlet and optionally passes through a first filter (Filter 1) before entering the main chamber of the cartridge. The optional filter may be used to prevent large foreign objects from entering the chamber. The main chamber includes electrowetting electrodes operated by the device that can transport the biological sample to a mixing region of the chamber. The device may also operate the electrowetting electrodes to transport one or more reagents in a reagent reservoir to mix with the biological sample in the mixing region. In some embodiments, a second filter (Filter 2) may be included, and electrowetting electrodes operated by the device may transport the sample through the filter before transporting the sample to one of the one or more sensors. The optional second filter may be used to separate components of the biological sample, for example, to isolate serum or to separate red blood cells and platelets from white blood cells.
[0128] Sensor The cartridge may include one or more sensors that can analyze the biological sample. In some embodiments, the electrowetting electrodes are configured to transport the biological sample to one or more sensors that analyze the biological sample. The sensors may transmit data to a device electrically connected to the sensor via a device interface and a cartridge interface. The sensor(s) in the cartridge may vary by cartridge type depending on the desired biological sample analysis. Exemplary sensors include channel sensors and impedance-based sensors. Described herein are sensors for detecting analytes (such as proteins, enzymes, or electrolytes), measuring analyte concentrations (such as protein, enzyme, or electrolyte concentrations), or counting cell numbers or cell types. However, other sensors may be used with the cartridges described herein.
[0129] Analyte Sensor In some embodiments, the cartridge includes an optical window or a pressure sensor configured to detect and / or quantify an analyte (such as a protein, enzyme, or electrolyte).
[0130] An optical sensor, which may be a component of the device that engages with the cartridge, may be aligned with the optical window of the cartridge to assay the biological sample, for example, to detect proteins or measure protein concentration. The optical sensor may assay the biological sample using optical microscopy, or spectroscopy such as fluorescence, infrared (IR), Raman, or UV / Vis absorption, or any other suitable optical spectroscopic method to generate analytical data. Data collected using spectroscopy may be analyzed by the device to determine the presence or concentration of proteins. In some embodiments, the cartridge includes two or more optical windows, and at least one of the optical sensors may be used as a control. For example, a reagent without a biological sample may be analyzed by the control sensor to provide a baseline for calibration. The device may then calibrate the received data to determine an accurate analyte concentration.
[0131] In some embodiments, the sensor is an impedance sensor configured to detect an analyte (e.g., a protein, enzyme, or electrolyte) or measure the amount of the analyte. The impedance sensor can function independently (with other impedance sensors) or in conjunction with one or more optical sensors. In some embodiments, when an optical sensor is used in combination with an electrical impedance-based sensor for analyte detection, the optical sensor can be used to detect interferents or to calculate a calibration factor for the impedance measurement. The impedance sensor can include an electrode pair, where at least one of the two electrodes is functionalized with an affinity moiety that specifically binds to the target analyte. The electrodes can be coated with an insulating layer (i.e., a dielectric layer), and an affinity moiety can be functionalized on the insulating layer, or an optional hydrophobic layer can coat the insulating layer. The insulating layer preferably comprises a high-κ material (i.e., having a dielectric constant of about 3.9 or greater). In some embodiments, the insulating layer comprises silicon dioxide, silicon nitride, or silicon oxynitride, or a combination thereof (e.g., mixed together or in multiple separate layers). The properties (e.g., thickness, dielectric constant, and / or hydrophobicity) of the insulating layer and / or hydrophobic layer may be the same as or similar to the properties of the insulating layer and hydrophobic layer described herein.
[0132] The affinity moiety can be, for example, an antibody, an antibody fragment, or an aptamer (such as a DNA aptamer, an RNA aptamer, or an XNA aptamer). The biological sample can be transported to the sensor, and the target protein binds to the affinity moiety. In some embodiments, the affinity moiety specifically binds to hemoglobin.
[0133] In some embodiments, the biological sample is statically positioned within the impedance sensor during impedance measurements, and in some embodiments, the biological sample flows continuously through the sensor during impedance measurements. The amount of impedance change between the two electrodes resulting from binding of the target molecule to the affinity molecule is correlated with the concentration of the analyte in the biological sample. In some embodiments, the cartridge includes a reference sensor, which includes an electrode pair including at least one functionalized electrode configured in a manner similar to the sensor used to analyze the biological sample. A control fluid, such as a reagent without the biological sample, can be used to detect a baseline pressure, which can be transmitted to the device and used to calibrate the sensor used to analyze the biological sample.
[0134] In some embodiments, the impedance is measured at a sampling rate of about 10 kHz or greater (such as about 20 kHz or greater, about 50 kHz or greater, about 100 kHz or greater, about 200 kHz or greater, about 300 kHz or greater, about 400 kHz or greater, about 500 kHz or greater, about 1 MHz or greater, about 5 MHz or greater, about 10 MHz or greater, about 25 MHz or greater, about 50 MHz or greater, about 75 MHz or greater, about 100 MHz or greater, about 125 MHz or greater, or about 150 MHz or greater). In some embodiments, impedance is measured at a sampling rate of about 10 kHz to about 200 MHz (e.g., about 10 kHz to about 20 kHz, about 20 kHz to about 50 kHz, about 50 kHz to about 100 kHz, about 100 kHz to about 200 kHz, about 200 kHz to about 300 kHz, about 300 kHz to about 400 kHz, about 400 kHz to about 500 kHz, about 500 kHz to about 1 MHz, about 1 MHz to about 2 MHz, about 2 MHz to about 3 MHz, about 3 MHz to about 4 MHz, about 4 MHz to about 5 MHz, about 5 MHz to about 10 MHz, about 10 MHz to about 25 MHz, about 25 MHz to about 50 MHz, about 50 MHz to about 75 MHz, about 75 MHz to about 100 MHz, about 100 MHz to about 125 MHz, about 125 MHz to about 150 MHz, or about 150 MHz to about 200 MHz). In some embodiments, the impedance is measured at a sampling rate of about 100 kHz to about 5 MHz, hi some embodiments, the impedance is measured at a sampling rate of about 125 MHz or greater.
[0135] In some embodiments, impedance is measured at an excitation frequency of about 1 Hz or greater (e.g., 10 Hz), 100 Hz or greater, or 1 kHz or greater, about 10 kHz or greater (e.g., about 20 kHz or greater, about 50 kHz or greater, about 100 kHz or greater, about 200 kHz or greater, about 300 kHz or greater, about 400 kHz or greater, about 500 kHz or greater, about 1 MHz or greater, about 5 MHz or greater, about 10 MHz or greater, about 25 MHz or greater, about 50 MHz or greater, about 75 MHz or greater, about 100 MHz or greater, about 125 MHz or greater, or about 150 MHz or greater). In some embodiments, the impedance is between about 1 Hz and about 100 Hz, about 100 Hz and about 1 kHz, about 1 kHz and about 10 kHz, or about 10 kHz and about 200 MHz (about 10 kHz and about 20 kHz, about 20 kHz and about 50 kHz, about 50 kHz and about 100 kHz, about 100 kHz and about 200 kHz, about 200 kHz and about 300 kHz, about 300 kHz and about 400 kHz, about 400 kHz and about 500 kHz, about 500 kHz). In some embodiments, the impedance is measured at an excitation frequency of about 100 Hz to about 125 MHz. In some embodiments, the impedance is measured at a sampling rate of about 125 kHz or greater.
[0136] FIG. 3 illustrates an exemplary impedance sensor pair configured to measure the concentration of an analyte, such as a protein or enzyme concentration. The impedance sensor pair includes a test sensor and a control sensor. A biological sample is transferred to the test sensor, and a control buffer is transferred to the control sensor. Impedance is measured at the test sensor and the control sensor, and the impedance due to the analyte is the difference between the impedances measured at the test sensor and the control sensor. Both sensors include a first sensing electrode 302 on a bottom substrate 304 and a second sensing electrode 306 on a top substrate 308 opposite the first sensing electrode 302. The first sensing electrode 302 is coated with a first insulating layer 310, and the second sensing electrode 306 is coated with a second insulating layer 312. The first dielectric layer 310 is coated with a first hydrophobic layer 314, and the second dielectric layer 312 is coated with a second hydrophobic layer 316. The first hydrophobic layer 314 is functionalized with an affinity moiety 318, such as an antibody, that specifically binds to an analyte 320 in a biological sample in the test sensor. The first hydrophobic layer 314 of the reference sensor is also functionalized with an affinity moiety 318, but does not bind to the analyte because the biological sample is not transported to the reference sensor. The second hydrophobic layer 316 in the illustrated sensor is not functionalized with an affinity moiety, but in other embodiments, the second hydrophobic layer 316 may be functionalized. A biological sample is transported to the test sensor between the first sensing electrode 302 and the second sensing electrode 306, and the analyte impedance (Z2) can be measured. A control buffer is transported to the reference sensor, and the baseline impedance (Z1) is measured. The difference between the analyte impedance (Z2) and the baseline impedance (Z1) correlates to the concentration of protein in the biological sample. The sensor is in electrical communication with the cartridge's device interface. When the device interface of the cartridge is engaged with the cartridge interface on the device, the device can operate the impedance sensor to detect a change in impedance or a baseline impedance upon binding of the analyte to the affinity moiety. The device can then determine the analyte concentration based on the detected impedance.
[0137] The biological sample is transported to the impedance sensor using multiple electrowetting electrodes. In some embodiments, the first sensing electrode (or the second sensing electrode) is positioned between two electrowetting electrodes within the multiple electrowetting electrodes. In some embodiments, the first sensing electrode and / or the second sensing electrode is an electrowetting electrode within the multiple electrowetting electrodes. In this configuration, the multiple electrowetting electrodes can transport the biological sample to a position between the first sensing electrode and the second sensing electrode, and the first sensing electrode (or the second sensing electrode) can statically hold the biological sample within the sensor by activating the sensing electrode. A voltage switching circuit within or operated by the device is connected to the electrowetting electrodes and can apply a voltage to one of the electrodes to activate the electrode and attract the biological sample, positioning itself on the activated electrode. The voltage switching circuit is electrically connected to a switch configured to alternatively select between the impedance sensing circuit and the electrowetting electrode supply circuit. The impedance sensing circuit is configured to be electrically connected to a processor within the device when the cartridge is engaged with the device, and the electrowetting supply circuit is configured to be electrically connected to an electrowetting electrode driver within the device when the cartridge is engaged with the device, and can supply power to the electrowetting electrodes.
[0138] 4A illustrates an exemplary impedance sensor configured to detect or measure an analyte (e.g., a protein, enzyme, or electrolyte) integrated with multiple electrowetting electrodes. The multiple electrowetting electrodes include a first electrowetting electrode 410, a first sensing electrode 412, and a second electrowetting electrode 414. Opposite the first electrowetting electrode 410, the first sensing electrode 412, and the second electrowetting electrode 414 is a second sensing electrode 416, which also serves as a ground electrode for the multiple electrowetting electrodes. The first electrowetting electrode 410, the first sensing electrode 412, and the second electrowetting electrode 414 are coated with a first insulating layer 418, and the second sensing electrode 416 is coated with a second insulating layer 420. Although the second sensing electrode 416 is shown as a common electrode to electrodes 410, 412, and 414, it is envisioned that electrodes 410, 412, and 414 may be opposed to individual electrodes. At a location above the first sensing electrode 412 at 422, the first insulating layer 418 is functionalized with an affinity moiety that specifically binds to a target analyte in a biological sample. The first electrowetting electrode 410, the first sensing electrode 412, and the second electrowetting electrode 414 are electrically connected to a voltage switching circuit 424. The voltage switching circuit 424 may selectively activate one or none of the first electrowetting electrode 410, the first sensing electrode 412, or the second electrowetting electrode 414 by applying a voltage to the selected electrode. The voltage switching circuit 424 is electrically connected to a switch 426, which is configured to selectively connect the voltage switching circuit 424 to an impedance sensing circuit 428 or an electrowetting electrode supply circuit 430. The impedance sensor may optionally include a first hydrophobic layer 432 covering the first insulating layer 418 and / or a second hydrophobic layer 434 covering the second insulating layer 420 (see FIG. 4B). At a location 436 above the first sensing electrode 412, the first hydrophobic layer 432 is functionalized with an affinity moiety.
[0139] The biological sample can be transported to the first electrowetting electrode 410 by applying a voltage to the first electrowetting electrode 410. A voltage selection circuit 424 selects the first electrowetting electrode 410, and a switch 426 electrically connects the voltage selection circuit 424 to an electrowetting electrode supply circuit 430. With the biological sample positioned on the first electrowetting electrode 410, the voltage selection circuit 424 selects and applies a voltage to the first sensing electrode 412, thereby inactivating the first electrowetting electrode 410. By selecting the first sensing electrode 412, the biological sample is transported to the first sensing electrode 412, and the biological sample can be held statically so that target proteins in the biological sample can bind to the affinity moieties at 422. A switch 426 can electrically connect an impedance sensing circuit 428 to the voltage selection circuit 424, thereby allowing a change in impedance to be detected. The change in impedance can be referenced to a similar reference sensor having a control solution rather than a biological sample. The concentration of the target analyte in the biological sample can then be determined based on the detected impedance. Once analysis of the biological sample is complete, the switch 426 can electrically connect the electrowetting electrode supply circuit 430 to the voltage selection circuit 424, which can select the second electrowetting electrode 414 and deactivate the first sensing electrode 412, thereby transporting the biological sample out of the impedance sensor. The biological sample can then be analyzed by a different sensor or transported to a waste reservoir.
[0140] Impedance sensors for analyte detection or quantification may additionally or alternatively rely on indirect analyte detection or quantification methods. For indirect measurements, an analyte (e.g., a protein, enzyme, or electrolyte) is bound to an affinity moiety, washed with a wash buffer, and bound to a second affinity moiety capable of generating ions or protons (e.g., by catalyzing a compound to generate hydrogen peroxide, which can form protons). The ions or protons can be detected by an ion- or pH-sensitive film, and the concentration of the ions or protons is proportional to the concentration of the analyte. Exemplary pH-sensitive layers may include hafnium oxide, aluminum oxide, iridium oxide, or chromium-tantalum oxide (CrO2 / Ta2O3). In some embodiments, the ions or protons are detected using a metal-oxide-semiconductor capacitor (MOSCap) sensor including a pH- or ion-sensitive layer.
[0141] An exemplary impedance sensor that can be used for indirect detection or quantification of an analyte is shown in FIG. 5A. The impedance sensor illustrated in FIG. 5A includes a functionalized electrowetting electrode adjacent to a MOSCap sensor. The analyte is captured on the functionalized electrowetting electrode using an affinity moiety, and a secondary affinity moiety is bound to the analyte to generate ions or protons that flow to the MOSCap sensor for detection. The electrowetting electrodes include a first electrowetting electrode 502 on a bottom substrate 504 and an optional second (ground) electrowetting electrode 506 on a top substrate 508 opposite the first electrode 502. The first electrowetting electrode 502 is coated with a first insulating layer 510, and the second electrowetting electrode 506 is coated with a second insulating layer 512. Optionally, the first insulating layer 510 is coated by a first hydrophobic layer 514 above the first electrowetting electrode 502, and the second insulating layer 512 is optionally coated by a second hydrophobic layer 516 below the second electrowetting electrode 506. However, the first hydrophobic layer 514 and the second hydrophobic layer 516 do not extend into the MOSCap sensor. The first hydrophobic layer 514 (or the dielectric layer 510 in embodiments omitting the first hydrophobic layer) is functionalized with affinity moieties 518. In some embodiments, the functionalized electrowetting electrodes are configured to directly detect or quantify an analyte based on an impedance change upon binding of the analyte to the affinity moiety.
[0142] The MOSCap sensor includes a first MOSCap electrode 520 on a first substrate 504 and a second MOSCap electrode 522 on a second substrate 508 opposite the first MOSCap electrode 520. The first MOSCap electrode 520 is coated with a first semiconductor layer 524 (e.g., a silicon, germanium, or gallium compound such as gallium arsenide or gallium nitride), and the second MOSCap electrode 522 is coated with a second semiconductor layer 526. In this embodiment, 504 and 508 may be different insulating or semiconducting materials than 524 and 526, or the same insulating or semiconducting material. A first insulating layer 510 extends over the first semiconductor layer 524, and a second insulating layer 512 extends over the second semiconductor layer 526, although it is contemplated that the insulating layer coating the semiconductor layers may be different from the insulating layer coating the electrowetting electrodes. A first sensing layer 528 (e.g., a pH-sensitive layer or an ion-sensitive layer) covers the first insulating layer 510 in the MOSCap sensor, and a second sensing layer 530 (e.g., a pH-sensitive layer or an ion-sensitive layer) covers the second insulating layer 512 in the MOSCap sensor.
[0143] 5B shows a side view of the MOSCap sensor along with an electrical model. The MOSCap sensor includes a reference electrode 532 (which may be, for example, a silver or silver chloride electrode, or any other suitable material) and a counter electrode 534 (which may be, for example, gold or any other suitable material). In some embodiments, the reference electrode 532 and the counter electrode 534 are positioned along the liquid flow (e.g., the reference electrode 532 or the counter electrode 534 may be positioned between the first MOSCap electrode 520 and the first electrowetting electrode 502). In some embodiments, the reference electrode 532 and the counter electrode 534 are positioned adjacent to the liquid flow.
[0144] FIG. 6 illustrates direct and indirect analyte measurement using the sensor illustrated in FIGS. 5A and 5B. In step 602, a biological sample is transported to a functionalized electrowetting electrode through electrowetting actuation, and the analyte to be assayed binds to an affinity moiety attached to the hydrophobic layer (or, if no hydrophobic layer is present, to the insulating layer). Optionally, the biological sample is washed once the analyte is bound. Once the analyte is bound to the affinity moiety, impedance can be measured to directly measure the analyte concentration, as described above. In step 604, a secondary affinity moiety conjugated to a signal enzyme configured to generate protons is transported to the functionalized electrowetting electrode and binds the analyte bound to the primary affinity moiety attached to the electrowetting electrode (via the insulating layer and / or hydrophobic layer). In step 606, a reagent is transported to the electrowetting electrode, which can be catalyzed by the signal enzyme to generate hydrogen peroxide, which decomposes to generate protons. The protons flow to the MOSCap sensor in step 608, and changes in the pH-sensitive layer modulate the impedance in response to the protons. The modulated impedance is detected using the MOSCap sensor and is proportional to the concentration of the analyte in the biological sample.
[0145] In some embodiments, the impedance sensor is a MOSCap sensor in which one of the insulating layers (or the hydrophobic layer covering the insulating layer, if present) is functionalized with an affinity moiety. The opposing insulating layer is covered with a pH- or ion-sensitive layer. This configuration of the MOSCap sensor allows for direct analyte detection or concentration measurement (via the functionalized surface) and indirect analyte detection (via the pH- or ion-sensitive layer) on the same MOSCap sensor.
[0146] Channel Sensor The cartridge may additionally or alternatively include a channel sensor configured to detect or quantify cells (or one or more types of cells) or analytes (such as proteins or enzymes) in a biological sample. In some embodiments, one or more channel sensors in the cartridge include a flow cytometer. The flow cytometer may be configured to detect and distinguish between multiple different cell types, such as, for example, red blood cells, platelets, and / or white blood cells (or one or more different types of white blood cells, such as eosinophils, basophils, neutrophils, monocytes, and / or lymphocytes). In some embodiments, one or more channel sensors in the cartridge include a flow analyte sensor. In some embodiments, one or more channel sensors may be configured as both a flow cytometer and a flow analyte sensor, optionally including multiple different electrode sets (each containing two, three, or more electrodes) separately configured for function within the same channel (i.e., to function as a flow cytometer or a flow analyte sensor).
[0147] In some embodiments, the sample (e.g., a blood sample) is not processed (e.g., by mixing with one or more reagents) before being analyzed by the channel sensor (e.g., to count and / or distinguish different cell types). For example, whole blood (which may, but need not, be diluted or processed) may be passed through the channel sensor to count or distinguish cells within the whole blood sample. In some embodiments, the sample is processed before analysis, for example, by diluting the sample, labeling specific cell types, or lysing specific cell types (e.g., red blood cells) before analysis. In some embodiments, the sample is processed only by diluting the sample before analysis (i.e., no labeling or lysis is required), and no additional processing steps are required before analysis. The sample may be processed, for example, by mixing the sample with one or more reagents.
[0148] Channel sensors are based on impedance sensing using the Coulter principle. Using the Coulter principle, a fluid-filled micropore or microchannel (or nanopore or nanochannel) with paired impedance-sensing electrodes on the side of or within the micropore or microchannel (or nanopore or nanochannel) can detect impedance modulation resulting from the passage of a single particle (such as a cell) through the pore or channel. The change in resistance or low-frequency impedance within the pore or channel is proportional to the size of the particle according to the following equation: TIFF0007586711000001.tif14170, R ch is the resistance of the channel or pore, and ΔR ch where σ is the change in channel or pore resistance when a particle passes through the channel or pore, and d is the diameter of the particle. The multiplexed impedance fluctuations resulting from particles, such as cells, flowing through the pore or channel depend on various characteristics of the particle, such as the particle's size, structure, composition, or surface properties. The impedance includes a real and an imaginary component, and one or both components can be analyzed to determine the type of cell generating the multiplexed impedance signal (i.e., the impedance signal at multiple frequencies). Alternatively, the magnitude and phase components of the multiplexed impedance, which can be measured and / or derived from the real and / or imaginary components, can be analyzed to determine the type of cell generating the multiplexed impedance signal (i.e., the impedance signal at multiple frequencies).
[0149] The channel sensor includes a channel containing micropores or microchannels (or nanopores or nanochannels) through which a biological sample (processed within the cartridge to dilute the sample and / or change the pH or electrolyte concentration of the surrounding buffer) can pass. The micropores or microchannels separate a first channel segment from a second channel segment, and the biological sample flows continuously through the entire channel. The biological sample passes through the sensor by capillary action rather than electrowetting actuation, although electrowetting electrodes can be used to introduce or withdraw the biological sample into or from the channel sensor. The channel sensor further includes an impedance-sensing electrode set (e.g., an impedance-sensing electrode pair) configured to apply a current to the micropore or microchannel and detect impedance within the micropore or microchannel. The impedance-sensing electrodes are configured to contact the liquid flowing through the channel sensor. For example, the impedance-sensing electrodes need not be separated from the sensor by an insulating layer (such as glass). Additionally, as discussed further herein, multivariate analysis of the detected electrical signals provides high-resolution detection of different cell types. Therefore, a reference electrode is not required for the channel sensor.
[0150] Figure 7 shows an image of an exemplary channel of a channel sensor having a first channel segment 702, a second channel segment 704, and a microchannel 706 between the first channel segment 702 and the second channel segment 704. The microchannel is 50 μm in diameter.
[0151] In some embodiments, the diameter of the micropore or microchannel (or nanopore or nanochannel) is about 10 nm to about 1 μm for analyte (e.g., protein) detection, or about 5 μm to about 100 μm for flow cytometry. In some embodiments, the diameter of the micropore or microchannel (or nanopore or nanochannel) is about 5 nm to about 1 μm for analyte (e.g., protein) detection. For example, in some embodiments, the diameter of the nanopore or nanochannel for analyte detection may be about 5 nm to about 10 nm, about 10 nm to about 20 nm, about 20 nm to about 50 nm, about 50 nm to about 100 nm, about 100 nm to about 150 nm, or about 150 nm to about 200 nm. In some embodiments, the flow cytometer includes micropores or microchannels with diameters of about 5 μm to about 100 μm, such as about 5 μm to about 10 μm, about 10 μm to about 25 μm, about 25 μm to about 50 μm, or about 50 μm to about 100 μm. The diameter size can be selected based on the desired analysis, and specific cell types can be counted more accurately using different pore sizes. For example, platelets, which have an average diameter of about 1 to 3 μm, are preferably counted using a channel sensor with micropores or microchannels with diameters of about 5 μm to about 25 μm, although larger diameters may also be used for measurement. For white blood cells, the diameter of the micropores or microchannels is preferably about 40 μm to about 100 μm, such as about 50 μm.
[0152] The channel sensor may include two or more detection electrodes configured to detect impedance within a channel or pore (e.g., a microchannel or nanochannel, or a micropore or nanopore). In some embodiments, the detection electrodes are configured to operate in pairs (e.g., a working electrode and a counter electrode). In some embodiments, the detection electrodes are configured to operate as a triad (e.g., a working electrode, a counter electrode, and a reference electrode). In some embodiments, the detection electrodes are statically positioned within a set of electrodes (e.g., a set of two or three electrodes) that operate to detect impedance. In some embodiments, the electrodes are dynamically grouped (e.g., by a device operating the cartridge) into a set for detecting impedance. For example, the device may operate a switch that selects an electrode within a microchannel or nanochannel, and the selected electrode is used to detect impedance. The electrodes may be selected based, for example, on the electrode spacing and the type of analyte or cell to be detected or measured.
[0153] The length of a microchannel is generally greater than the diameter of the microchannel. The detection electrodes may be located within the microchannel, on an outer portion of the microchannel (i.e., with the microchannel in the space between the detection electrodes), or both. In some embodiments, the length of a microchannel is about 0.001 mm or greater, such as about 0.005 mm or greater, about 0.01 mm or greater, about 0.05 mm or greater, about 0.1 mm or greater, about 0.5 mm or greater, about 1 mm or greater, about 1.5 mm or greater, about 2 mm or greater, about 3 mm or greater, or about 4 mm or greater. In some embodiments, the length of a microchannel is about 5 mm or less, such as about 4 mm or less, about 3 mm or less, about 2 mm or less, about 1.5 mm or less, about 1 mm or less, about 0.5 mm or less, about 0.1 mm or less, about 0.05 mm or less, about 0.01 mm or less, or about 0.005 mm or less. In some embodiments, the length of a microchannel is about 0.001 mm to about 5 mm, such as about 0.001 mm to about 0.05 mm, about 0.05 mm to about 0.1 mm, about 0.1 mm to about 0.5 mm, about 0.5 mm to about 1 mm, about 1 mm to about 1.5 mm, about 1.5 mm to about 2 mm, about 2 mm to about 3 mm, about 3 mm to about 4 mm, or about 4 mm to about 5 mm. A channel (e.g., a microchannel or nanochannel) may include multiple detection electrodes (e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10, or more) along the length of the channel, optionally grouped into two or more sets. Two or more sets of electrodes may be used to obtain overlapping or different impedance measurements. Overlapping impedance measurements may be performed, for example, to improve detection by signal averaging. Different impedance measurements may depend on different spacing of the electrodes, which may improve detection sensitivity for measuring different cell types or sizes, for example.
[0154] The spacing of the detection electrodes for measuring impedance can affect detection sensitivity depending on the size of the particles being measured. Closer electrode spacing is generally preferred for measuring smaller particles, while wider electrode spacing allows for the measurement of larger particles. However, the electrodes should not be spaced too far apart to allow multiple particles between electrodes to be measured. For example, in some embodiments, the detection electrodes are spaced about 5 nm to about 100 nm (e.g., about 5 nm to about 10 nm, about 10 nm to about 25 nm, about 25 nm to about 50 nm, or about 50 nm to about 100 nm) apart to measure or detect an analyte (e.g., a protein such as hemoglobin). In some embodiments, the detection electrodes are spaced about 1 μm to about 5 μm (e.g., about 1 μm to about 1.5 μm, about 1.5 μm to about 2 μm, about 2 μm to about 3 μm, about 3 μm to about 4 μm, or about 4 μm to about 5 μm) apart to detect or detect, for example, platelets. In some embodiments, the detection electrodes are spaced apart by about 5 μm to about 10 μm (e.g., about 5 μm to about 6 μm, about 6 μm to about 7 μm, about 7 μm to about 8 μm, about 8 μm to about 9 μm, or about 9 μm to about 10 μm), for example, to detect or measure red blood cells. In some embodiments, the detection electrodes are spaced apart by about 5 μm to about 25 μm (e.g., about 5 μm to about 10 μm, about 10 μm to about 15 μm, about 15 μm to about 20 μm, or about 20 μm to about 25 μm), for example, to detect or measure white blood cells. Thus, by including differently spaced detection electrodes within a channel, the same channel can be used to detect different analytes and / or cell types.
[0155] In some embodiments, the sensor channel geometry is uniform or near-uniform (i.e., the channel diameter is constant or near-constant). In some embodiments, the sensor channel geometry is tapered (i.e., the channel diameter increases or decreases along the length of the channel). The tapered channel geometry allows a single flow to be analyzed at different locations along the length of the channel using different channel diameters. In some embodiments, the sensor channel geometry includes one or more waves (i.e., an increase in diameter followed by a corresponding decrease in diameter), and optionally, one or more of the detection electrodes can be positioned within the waves.
[0156] The impedance sensing electrode pair may be located within the microchannel (or nanochannel), along the length of the microchannel (or nanochannel), or in a coplanar configuration within the micropore or microchannel (or nanopore or nanochannel), on either side of the micropore or microchannel (or nanopore or nanochannel). For example, FIG. 8A illustrates top and side views of a channel sensor having a first impedance sensing electrode 802 in a first channel segment 804 and a second impedance sensing electrode 806 in a second channel segment 808, with a micropore or microchannel 810 between the first and second channel segments 804 and 808. In the illustrated embodiment, both the first and second impedance sensing electrodes 802 and 806 are positioned on the bottom surface of the channel sensor, although it is contemplated that the first and second impedance sensing electrodes 802 and 806 may also be positioned on the top surface of the channel sensor. 8B illustrates top and side views of a channel sensor having a first impedance sensing electrode 812 in a microchannel 820 adjacent to a first channel segment 814 and a second impedance sensing electrode 816 in a microchannel adjacent to a second channel segment 818. In the illustrated embodiment, both the first impedance sensing electrode 812 and the second impedance sensing electrode 816 are positioned on a lower surface of the microchannel, although it is contemplated that the first impedance sensing electrode 812 and the second impedance sensing electrode 816 may also be positioned on an upper surface of the microchannel.In FIG. 8C, the channel sensor includes a first impedance sensing electrode 822 and a second impedance sensing electrode 824 positioned within a microchannel 826 (or nanopore or nanochannel), with the first impedance sensing electrode 822 positioned above the second impedance sensing electrode 824 (i.e., the first impedance sensing electrode 822 is on the upper surface, the second impedance sensing electrode 824 is on the lower surface, and the first impedance sensing electrode 822 is aligned with the second impedance sensing electrode 824).
[0157] 8D shows an exemplary channel sensor having two sets of sensing electrodes within the same channel. The sensor includes a first channel segment 828 and a second channel segment 830 separated by a channel (e.g., a microchannel) 832. The sensor includes a first set of sensing electrodes 834 and a second set of sensing electrodes 836 positioned along the length of the channel 832 and configured to measure impedance within the channel 832. The first set of sensing electrodes 834 includes a working electrode 838, a counter electrode 840, and an optional reference electrode 842 positioned between the working electrode 838 and the counter electrode 840. Similarly, the second set of sensing electrodes 836 includes a working electrode 844, a counter electrode 846, and an optional reference electrode 848 positioned between the working electrode 844 and the counter electrode 846. The spacing between working electrode 838 and counter electrode 840 in first set of sensing electrodes 834 is different from (and, in the illustrated example, larger than) the spacing between working electrode 844 and counter electrode 846 in second set of sensing electrodes 836. Thus, in the exemplary channel sensor illustrated in FIG. 8D , first set of sensing electrodes 834 is optimized to detect larger particles than second set of sensing electrodes 836. FIG. 8E shows an exemplary channel sensor similar to the channel sensor illustrated in FIG. 8D , except that channel 832 includes waves 850, with electrodes positioned separately within the waves. The diameter of the channel between the waves is narrower than the waves themselves.
[0158] 8F shows an exemplary embodiment of a microchannel 852 between a first channel segment 854 and a second channel segment 856 with multiple sensing electrodes 858a-858p positioned along the length of the channel 852. In the illustrated example, the electrodes 858a-858p are evenly spaced, although in alternative embodiments, the electrodes are unequally spaced. Pairs of electrodes can be dynamically selected to measure impedance.
[0159] In addition to the impedance sensing electrodes, the channel sensor may optionally further include one or more flow sensing electrode pairs and / or one or more separation electrodes. The flow sensing electrode pairs may be positioned on either side of the micropore or microchannel (or nanopore or nanochannel) and configured to detect liquid flow. In some embodiments, the sensor includes a first flow sensing electrode pair on a first side of the micropore or microchannel (or nanopore or nanochannel) (i.e., in the first channel segment) and a second flow sensing electrode pair on a second side of the micropore or microchannel (or nanopore or nanochannel) (i.e., in the second channel segment). The flow sensing electrode pair verifies that the sensor is filled with a liquid, such as a wash buffer, starting buffer, or other control reagent, by applying a current (such as a DC current) and detecting a voltage change (or applying a voltage and detecting a current change). Once the device verifies that the sensor is filled with liquid by electrically communicating with the flow detection electrode pair, the device may operate electrowetting electrodes in the cartridge to transport the biological sample into the channel sensor.
[0160] A marker (such as an air bubble or a low-conductivity solution) can be introduced to separate the control reagent from the biological sample. The air bubble marker can be introduced by interrupting the liquid flow from the inlet of the channel sensor, for example, by operating the electrowetting electrode to stop the liquid flow. Capillary action continues to flow the liquid in the channel through the channel sensor, generating an air bubble. If the marker is an air bubble, a bubble trap can be included in the channel sensor to prevent the air bubble from passing through the pore or channel. The bubble trap can include a selective membrane that allows the diffusion of air but not liquid. In some embodiments, the marker is a miscible liquid such as glycerol or oil (e.g., silicon oil, vegetable oil, or olive oil). Liquid can then be introduced into the channel sensor, causing the air bubble to be positioned between the two fluid flows.
[0161] Detection of the marker then confirms that the biological sample has been introduced into the channel sensor, and data acquisition begins. The marker can also be used to dynamically determine the flow rate of the liquid in the sensor, for example, based on the volume of the marker and the start and end times of the marker crossing the flow sensing electrode. Knowing the flow rate of the liquid in the channel sensor allows for quantification of the particle (e.g., cell) concentration in the biological sample. The particle concentration is determined by dividing the number of particles passing per unit time by the flow rate. The particle concentration can also, or alternatively, be obtained by dividing the total number of particles by the volume passing through the channel sensor. The peak width of the detected impedance signal is also a function of the particle velocity through the channel, which can be calculated from the flow rate and measured from the pulse width. The particle velocity allows for the determination of the particle's translocation path through the channel based on variations in the pulse width of the detected signal. This allows for the application of an error correction to the magnitude of the measured signal, thereby allowing for correction of the signal intensity of particles passing through the channel away from the central axis of the channel. The variations will be more pronounced for smaller particles passing through the channel. For example, if a 1-5 μm particle passes through a 50 μm channel, the particle may take several paths through the channel, either to the center of the channel (representing true size) or to the edge, which causes a larger signal amplitude. Alternatively, the particle or cell may take a path between the center and the edge of the channel, resulting in an increased amplitude between the two signal intensities.
[0162] The isolation electrode may be positioned proximal to the inlet or outlet of the channel sensor and function as a ground electrode. The ground (isolation) electrode isolates the channel sensor from electrical activity elsewhere in the cartridge, such as electrical activity resulting from operation of the electrowetting electrodes. Therefore, the isolation electrode minimizes electrical noise within the channel sensor.
[0163] FIG. 9 shows top and side views of a channel sensor including a pair of impedance sensing electrodes, two pairs of flow sensing electrodes, and two separation electrodes. A first set of electrowetting electrodes 902 is adjacent to the sensor's inlet so that a control reagent or biological sample can be transported into the sensor, and a second set of electrowetting electrodes 904 is adjacent to the sensor's outlet so that the control reagent or biological sample can be transported away from the sensor. Within the sensor, the control reagent or biological sample is transported by capillary actuation. The sensor includes a micropore 906 having a first impedance sensing electrode 908 and a second impedance sensing electrode 910 on opposite sides of the micropore 906. While the embodiment illustrated in FIG. 9 shows impedance sensing electrodes on either side of the micropore, other configurations are contemplated (see FIGS. 8A-8C). The sensor further includes a first pair of flow sensing electrodes 912 and 914 and a second pair of flow sensing electrodes 916 and 918 on either side of the micropore 906. The flow sensing electrodes are positioned to form more micropores than the impedance sensing electrodes. The sensor further includes a first separate electrode 920 proximal to the inlet of the sensor and a second separate electrode 922 proximal to the outlet of the sensor.
[0164] FIG. 10 illustrates the start of operation of the channel sensor shown in FIG. 9 , with the bottom plot showing the DC voltage detected by the first pair of flow sensing electrodes 912 and 914. At the start, the electrowetting electrodes transport a fluid (e.g., a control reagent) into the channel. Because the liquid is not in contact with the electrodes, the voltage detected by the flow sensing electrodes in this first step is minimal. As the liquid enters the channel in the second step, electrowetting transport of the liquid into the sensor induces capillary flow through the sensor, which increases the voltage detected by the flow sensing electrodes until the sensor is filled in the third step. A marker (such as an air bubble or a low-conductivity buffer solution for the control reagent) is introduced into the sensor, separating the control reagent from the biological sample. When the marker reaches the flow sensing electrodes in the fourth step, the voltage detected by the flow sensing electrodes decreases. This decrease in voltage can signal the device to introduce the biological sample into the sensor, and data collection can begin.
[0165] The channel sensor can be used and reused for multiple analysis cycles, for example, to measure analytes or cells under different conditions (e.g., different pH or electrolyte concentrations) or different diluents. Different pH or electrolyte concentrations of the reagents surrounding the cells can modulate the surface charge of the cells, and different changes in surface charge can be associated with different cell types. The biological sample can be divided into multiple sub-samples that can be mixed (or serially diluted) with different reagents or different amounts of reagents within the cartridge, and one or more of the processed sub-samples can be circulated through the channel sensor. The sub-samples can be separated by a control buffer, which itself can be separated from the sub-sample by a marker (such as an air bubble or a low-conductivity buffer).
[0166] The biological sample may be diluted in the cartridge by mixing the biological sample with one or more reagents. In some embodiments, the biological sample is diluted to one or more different concentrations, e.g., from about 0.00001-fold to less than about 1-fold (e.g., from about 0.00001-fold to about 0.0001-fold, from about 0.0001-fold to about 0.001-fold, from about 0.001-fold to about 0.01-fold, from about 0.01-fold to about 0.1-fold, or from about 0.1-fold to less than about 1-fold), before being assayed by the channel sensor. The pH of the aliquoted biological sample can be adjusted within the cartridge so that the biological sample can be assayed at one or more pH levels, such as 3.0 to about 9.0 (e.g., about 3.0 to about 3.5, about 3.5 to about 4.0, about 4.0 to about 4.5, about 4.5 to about 5.0, about 5.0 to about 5.5, about 5.5 to about 6.0, about 6.0 to about 6.5, about 6.5 to about 7.0, about 7.0 to about 7.5, about 7.5 to about 8.0, about 8.0 to about 8.5, and / or about 8.5 to about 9.0). In some embodiments, the pH of the assayed biological sample is 7.4. The cartridge can contain several different reagents for adjusting the pH of the biological sample, or it can contain two reagents that are mixed in a certain ratio with the biological sample to obtain the desired pH. In some embodiments, the biological sample is divided and processed to obtain 1 to 5 different sample concentrations at 1 to 10 different pH levels for a total of about 1 to about 50 different biological subsamples.
[0167] FIG. 11 illustrates how a marker can be used as a trigger for data collection using a sensor; the cycle can be repeated for different biological sample portions. Before fluid is introduced into the channel sensor ("no flow"), the liquid flow and flow rate are zero, and the voltage measured by the flow detection electrodes is minimal or not measured. As a control reagent is introduced into the channel sensor, the liquid flow rate through the sensor increases, and as the control reagent flows across the flow detection electrode pair, the voltage measured by the flow detection electrode pair near the sensor inlet increases. As shown in FIG. 11, the increase in voltage detected by the flow detection electrode pair triggers data acquisition; however, it is envisioned that the trigger for data acquisition could be the detection of the first marker. The control reagent is separated from the biological sample (or biological sample, if the sensor is used in multiple cycles to analyze multiple processed samples) by the marker. The marker flows through the sensor, and the liquid flow decreases (assuming a bubble marker). A marker passing over the flow detection electrode decreases the measured voltage until the biological sample enters the sensor, as shown in FIG. 11. The entry of the biological sample is detected by the flow detection electrode, as marked by an increase in the measured voltage. A second control reagent (which may be the same as or different from the first control reagent) follows the biological sample, which can be separated from the biological sample by a second marker. The second marker flows through the channel sensor, causing a decrease in liquid flow (assuming the second marker is an air bubble). The marker is also detected by the flow detection electrode by a decrease in the measured voltage. The voltage drop caused by the marker, or the detection of the passage of the marker, can optionally trigger the end of data collection. Once the second control reagent enters the sensor, the voltage measured by the flow detection electrode increases until the next marker is detected, separating the second control reagent from the next cycle of the biological sample. The cycle can then continue repeating in this pattern until the desired number of cycles is reached.
[0168] FIG. 12 illustrates an exemplary method for assaying a biological sample using a channel sensor within a cartridge. The device can determine the test type to be performed based on the cartridge inserted into the device or by manual input of the test type into the device. At the start of a test, the biological sample is added to the input port, and the sample is transferred to the mixing area through electrowetting actuation. Based on the test being performed on the biological sample, the biological sample is processed to obtain a predetermined number of different pH conditions, and the biological sample is divided into the number of different pH conditions. pH-adjusting reagents are prepared within the cartridge, for example, by mixing high-pH and low-pH components in predetermined proportions to obtain the desired number (x) of different pH-adjusting reagents at the desired pH levels. The subsamples are then mixed with the pH-adjusting reagents (i.e., subsample[n] is mixed with pH-adjusting reagent[n], subsample[n+1] is mixed with pH-adjusting reagent[n+1], etc.). In some embodiments, the subsamples are analyzed at an isotonic pH (7.4), and the pH of the subsamples is not adjusted. The sub-sample is then diluted (or serially diluted) to the desired concentration. In addition, a control reagent is prepared, which does not contain a biological sample (cells, analyte, etc.) but resembles the conditions of the processed biological sub-sample. A control reagent is prepared for each of the different pH conditions. The first control reagent (i.e., for sub-sample [n]) is transported into the channel sensor and followed by a marker (such as air bubbles or a low-conductivity fluid). Next, the first sub-sample (i.e., sub-sample [n] at the desired concentration) is transported into the channel sensor and followed by another marker and the next control reagent (or the same control reagent if the next sub-sample has the same reagent conditions with a different dilution ratio). Another marker is introduced into the channel sensor, followed by the next sub-sample. This cycle is repeated until the sub-sample is analyzed by the channel sensor.
[0169] In some embodiments, the channel sensors described herein are flow cytometers configured to detect cell counts or the number of one or more cell types (e.g., white blood cells, platelets, or red blood cells). An electrical model of a cell flowing through a pore or channel is shown in Figure 13. In the model, C p refers to the capacitance from the combination of the cell membrane, cytoplasm, and nucleus, and R p refers to the resistance from the cell and indicates the cell volume, and C f and R f and C refer to the capacitance and resistance, respectively, of the fluid surrounding the cell, which can vary based on the electrolyte concentration or pH of the fluid. dl refers to the double layer capacitance.
[0170] A flow cytometer can operate by applying multiplexed currents and detecting multiplexed impedances across the micropores or microchannels as cells flow through them. The impedance at any given current frequency in the multiplexed currents can include real and imaginary components, and one or both of the impedance components can be analyzed at different frequencies. Alternatively, the impedance at any given current frequency in the multiplexed currents can include magnitude and phase components, and one or both of the impedance components can be analyzed at different frequencies. The flow cytometer channel sensors can be configured to identify different cell types in a biological sample. For example, the impedance to the multiplexed currents can be used to distinguish different cell types in a biological sample, such as white blood cells, red blood cells, and platelets. In some embodiments, the flow cytometer channel sensors can identify eosinophils, basophils, neutrophils, monocytes, and lymphocytes. Different cell types can be distinguished based on the unique impedance characteristics for each cell type, which may include real and / or imaginary impedance components at multiple different current frequencies (e.g., three, four, five, six, seven, eight, or more different current frequencies). Alternatively, different cell types can be distinguished based on the unique impedance characteristics for each cell type, which may include magnitude and phase impedance components measured directly or derived from the measured real and imaginary impedance components at multiple different current frequencies (e.g., three, four, five, six, seven, eight, or more different current frequencies). In some embodiments, the same or different electrode pairs can be used to apply the current and measure the impedance. According to the flow cytometer designs described herein, the cartridge does not need to separate different cell types to obtain a cell count for each cell type.
[0171] The impedance sensing electrode pair is configured to simultaneously provide multiplexed currents through the micropore or microchannel and measure voltages to determine impedance over a period of time during which the biological sample flows through the sensor. The multiplexed currents include (1) a direct current component or a low-frequency alternating current, and (2) multiple (e.g., two, three, four, five, six, seven, eight, or more) alternating current components of different frequencies. Preferably, the multiplexed current includes at least three alternating current components. In another preferred embodiment, the multiplexed current includes at least five alternating current components.
[0172] The impedance detected at one or more frequencies can distinguish cell types passing through the micropores or microchannels (e.g., white blood cells, red blood cells, or platelets, or specific white blood cell types such as eosinophils, basophils, neutrophils, monocytes, or lymphocytes). Different particle sizes, the presence or absence of a nucleus, and other cellular characteristics can affect the impedance at different current components. Direct current or low-frequency current components can be used to determine different cell sizes. Direct current or low-frequency current minimizes or eliminates the effect of voltage drop at the electrode-electrolyte (from the surrounding liquid) interface, thereby minimizing double-layer capacitance within the electrical module. The resulting impedance effect is related to particle (e.g., cell) size. Mid-frequency AC is related to the partial cell capacitance affected by the cytoplasm and cell membrane. High-frequency AC components can be used to characterize the cytoplasm and nucleus (if present), and very high-frequency AC is related to the capacitance of the cell nucleus (if present). The multiplexed current can include additional frequencies to better distinguish different cell types.
[0173] In some embodiments, the AC component is (1) a direct current or low-frequency AC at about 1 kHz to about 100 kHz (e.g., about 1 kHz to about 10 kHz, about 10 kHz to about 20 kHz, about 20 kHz to about 30 kHz, about 30 kHz to about 40 kHz, about 40 kHz to about 50 kHz, about 50 kHz to about 60 kHz, about 60 kHz to about 70 kHz, about 70 kHz to about 80 kHz, about 80 kHz to about 90 kHz, or about 90 kHz to about 100 kHz), or (2) a direct current or low-frequency AC at about 100 kHz to about 700 kHz (e.g., about 100 kHz to about 200 kHz, about 200 kHz to about 300 kHz, about 300 kHz to about 400 kHz, about 400 kHz to about 500 kHz, about 500 kHz to about 600 kHz, about 600 kHz to about 700 kHz, etc.). (3) medium frequency AC in the range of about 700 kHz to about 5 MHz (about 700 kHz to about 800 kHz, about 800 kHz to about 900 kHz, or about 900 kHz to about 1000 kHz, or about 1 MHz to about 2 MHz, about 2 MHz to about 3 MHz, about 3 MHz to about 4 MHz, or about 4 MHz to about 5 MHz, etc.), and (4) ultra-high frequency AC of 5 MHz or higher (about 5 MHz to 10 MHz, about 10 MHz to about 20 MHz, about 20 MHz to about 30 MHz, about 30 MHz to about 40 MHz, about 40 MHz to about 50 MHz, about 50 MHz to about 60 MHz, about 60 MHz to about 70 MHz, about 70 MHz to about 80 MHz, about 80 MHz to about 90 MHz, or about 90 MHz to about 100 MHz, etc.).In another embodiment, the multiplexed current is (1) a direct current or alternating current at about 1 kHz to about 100 kHz (e.g., about 1 kHz to about 10 kHz, about 10 kHz to about 20 kHz, about 20 kHz to about 30 kHz, about 30 kHz to about 40 kHz, about 40 kHz to about 50 kHz, about 50 kHz to about 60 kHz, about 60 kHz to about 70 kHz, about 70 kHz to about 80 kHz, about 80 kHz to about 90 kHz, or about 90 kHz to about 100 kHz), (2) a direct current or alternating current at about 50 kHz to about 250 kHz (e.g., about 50 kHz to about 70 kHz, about 70 kHz to about 90 kHz, or about 90 kHz to about 100 kHz), or (3) a direct current or alternating current at about 50 kHz to about 250 kHz (e.g., about 50 kHz to about 70 kHz, about 70 kHz to about 90 kHz, or about 90 kHz to about 100 kHz). kHz, approximately 90 kHz to approximately 110 kHz, approximately 110 kHz to approximately 130 kHz, approximately 130 kHz to approximately 150 kHz, approximately 150 kHz to approximately 200 kHz, or approximately 200 kHz to approximately 250 kHz, etc.), (3) approximately 250 kHz to approximately 700 kHz (approximately 250 kHz to approximately 300 kHz, approximately 300 kHz to approximately 350 kHz, approximately 350 kHz to approximately 400 kHz, approximately 400 kHz to approximately 500 kHz, approximately 500 kHz to approximately 600 kHz, or approximately 600 kHz to approximately 700 kHz, etc.), (4) approximately 700 kHz to approximately 5 MHz (approximately 700 (4) AC frequencies between about 5 MHz and about 20 MHz (about 5 MHz to 10 MHz, about 10 MHz to about 15 MHz, or about 15 MHz to about 20 MHz, etc.), and (5) AC frequencies between about 20 MHz and above (about 20 MHz to about 30 MHz, about 30 MHz to about 40 MHz, about 40 MHz to about 50 MHz, about 50 MHz to about 60 MHz, etc.). In some embodiments, the plurality of AC components include a first AC frequency of about 50 kHz to about 250 kHz, a second AC frequency of about 250 kHz to about 700 kHz, a third AC frequency of about 700 kHz to about 5 MHz, a fourth AC frequency of about 5 MHz to about 20 MHz, and a fifth AC frequency of about 20 MHz to about 150 MHz.In some embodiments, the alternating current further comprises an additional alternating current of about 100 kHz or less, or about 50 kHz or less, which may be useful for determining cell size. The frequency of the alternating current component may be selected based on salt concentration, channel or pore size, electrode size, spacing or material, or the particular cells to be counted.
[0174] In some embodiments, the multiplexed current is generated as analog current components and mixed in real time using a device before being sent to the impedance sensing electrodes in the cartridge. For example, the device may include a digital signal synthesizer (DSS) module that uses a direct digital synthesizer (DDS) and a digital-to-analog converter (DAC) to generate and send an analog signal (e.g., a multiplexed analog signal). Alternatively, in some embodiments, the multiplexed current signal is generated using an arbitrary waveform generator (AWG), and digital samples of the multiplexed signal stored in memory or a look-up table (LUT) are converted to analog form using a variable frequency clock.
[0175] The cells in the biological sample pass through the micropores or microchannels, and the impedance is measured by the impedance detection electrodes. In some embodiments, the impedance is measured at a sampling rate of about 10 kHz or higher (e.g., about 20 kHz or higher, about 50 kHz or higher, about 100 kHz or higher, about 200 kHz or higher, about 300 kHz or higher, about 400 kHz or higher, about 500 kHz or higher, about 1 MHz or higher, about 5 MHz or higher, about 10 MHz or higher, about 25 MHz or higher, about 50 MHz or higher, about 75 MHz or higher, about 100 MHz or higher, about 125 MHz or higher, or about 150 MHz or higher). In some embodiments, impedance is measured at a sampling rate of about 10 kHz to about 200 MHz (e.g., about 10 kHz to about 20 kHz, about 20 kHz to about 50 kHz, about 50 kHz to about 100 kHz, about 100 kHz to about 200 kHz, about 200 kHz to about 300 kHz, about 300 kHz to about 400 kHz, about 400 kHz to about 500 kHz, about 500 kHz to about 1 MHz, about 1 MHz to about 2 MHz, about 2 MHz to about 3 MHz, about 3 MHz to about 4 MHz, about 4 MHz to about 5 MHz, about 5 MHz to about 10 MHz, about 10 MHz to about 25 MHz, about 25 MHz to about 50 MHz, about 50 MHz to about 75 MHz, about 75 MHz to about 100 MHz, about 100 MHz to about 125 MHz, about 125 MHz to about 150 MHz, or about 150 MHz to about 200 MHz). Alternatively, in some embodiments, the measured signal is downsampled, thereby shifting the frequency response to lower frequencies and allowing the signal to be digitized at a lower sampling rate, for example, when using an analog-to-digital converter (ADC). In some embodiments, the impedance is measured at a sampling rate of about 100 kHz to about 5 MHz. In some embodiments, the impedance is measured at a sampling rate of about 125 MHz or greater.
[0176] Figure 14 presents an exemplary relative impedance change measured by an impedance-sensing electrode as a function of time at a single frequency (30 kHz) for approximately 10 μm Chlorella vulgaris cells (bacteria-free, available from Carolina Biological Supply, NC, USA). Each downward peak corresponds to a particle passing through the microchannel, and various components of the impedance peak, such as peak height, peak width, peak area, and / or full-width-at-half-maximum peak height, can be measured. Multivariate patterns are constructed from multiple current components to identify different cell types. The change in impedance as a function of baseline impedance is measured, and one or more components of the impedance change can be used to describe the detected cells. Such components include, but are not limited to, one or more of impedance peak height, impedance peak width, impedance peak area, and impedance full-width-at-half-maximum peak height, which are indicative of cell size, surface charge, cell shape, and other distinguishing characteristics of cells. Biological samples can also be assayed at different concentrations or different pHs to further identify cell types, as discussed further herein. Because impedance components are affected by the isoelectric point and surface charge of cells, different cell types can be distinguished through multivariate patterns. Therefore, unique multivariate patterns for different cell types can include impedance peak height, impedance peak width, impedance peak area, and / or impedance half-width height, which can be determined at one or more pH levels and / or one or more electrolyte concentrations. In some embodiments, the multivariate pattern can include real and imaginary components of the impedance, e.g., amplitude from the real component and amplitude from the imaginary component. In some embodiments, the multivariate pattern can include magnitude and phase components of the impedance, e.g., amplitude from the magnitude component and amplitude from the phase component. The magnitude and phase components of the impedance can be measured directly or derived from the real and imaginary components. Clustering algorithms can be used to create patterns of different cell types based on multivariate patterns collected at various frequencies.It can also be used to distinguish normal cell populations from abnormal cell populations.
[0177] By analyzing the multivariate pattern of detected impedance, rather than just the impedance amplitude, differentiation of different cell types becomes more accurate. For example, the channel sensor does not need to include a reference electrode to control for impedance fluctuations. Additionally, the flow sensor can be used to assay cell count and / or analyte concentration using whole blood biological samples, rather than analyzing separated components of a biological sample (e.g., serum, plasma, etc.) or labeled cells.
[0178] In some embodiments of the flow cytometer channel sensor, the impedance signal is analyzed for real and imaginary components. For example, a multivariate pattern of the real and imaginary components of the multiplexed impedance may be used to distinguish between cell types. In some embodiments, the amplitude of the real and imaginary components of the multiplexed impedance are used to distinguish between different cell types. In some embodiments of the flow cytometer channel sensor, the impedance signal is analyzed for magnitude and phase components. For example, a multivariate pattern of the magnitude and phase components of the multiplexed impedance may be used to distinguish between cell types. In some embodiments, the amplitude of the magnitude and phase components of the multiplexed impedance are used to distinguish between different cell types. The number of different current frequencies of the multiplexed impedance may be three, four, five, six, seven, eight, or more different current frequencies.
[0179] The detected multiplexed impedance from the flow cytometer channel sensors can be filtered and demodulated to separate each frequency using a filter (e.g., a bandpass filter). This can be done, for example, by a device that operates the cartridge. A processor can analyze the multiplexed impedance signal for each cell passing through the flow cytometer channel sensor and label or count individual cells. This can be done, for example, using a trained machine learning model. The machine learning model can be trained using known impedance characteristics of various cell types. Exemplary machine learning models include naive Bayes classifiers, logistic regression, decision tree models, gradient boosting trees, support vector machines, neural networks, and other deep learning algorithms. In some embodiments, the machine learning model is trained using supervised or semi-supervised methods.
[0180] In one example, label-free impedance signatures from particles or cells within a sample (e.g., whole blood) are used to refine a model through semi-supervised learning, which may involve applying self-training to generate clusters that characterize different particle / cell types within the sample. The generated dataset is compared to a baseline dataset. The error of the label-free dataset is used to calculate calibration weights for nuclear cell types. In addition to using replicate tests of single cell types from different sources, mixed cell types of known types and whole blood samples may be used to adjust baseline weights that account for patient demographic information such as age, gender, and ethnicity to adjust the model's clusters to fit each cell type. For example, the model may establish clusters that distinguish between white blood cells, red blood cells, and / or platelets. In some embodiments, clusters differentiate within white blood cells, e.g., to identify two or more of neutrophils, basophils, eosinophils, monocytes, and / or lymphocytes. Clusters may be validated, for example, by the goodness of fit of one or more generative models (e.g., Gaussian mixture models). Another calibration factor may correct for counting errors when using total counts using known methods such as commercially available hematology analyzers.
[0181] The cartridge additionally or alternatively includes one or more channel sensors configured to measure analyte (e.g., protein or enzyme) concentrations. The pore size of the channel sensor configured to measure analyte concentrations is generally smaller than that used in flow cytometers due to the smaller particle size, but a similar Coulter principle can be applied. The biological sample or subsample may be filtered before being transported to the channel sensor because cells in the biological sample may clog the nanopore or nanochannel. Prior to introducing the biological sample (or subsample) into the channel sensor, the biological sample (or subsample) is mixed with a reagent containing a charged affinity moiety (e.g., an antibody, antibody fragment, or aptamer) that specifically binds to the target analyte. In some embodiments, the affinity molecule is a multivalent affinity molecule (e.g., bivalent, trivalent, or tetravalent). The charged affinity moiety bound to the target analyte increases the electric field modulation when passing through the nanopore or nanochannel compared to the target analyte alone, thereby increasing the impedance signal.
[0182] In some embodiments of analyzing biological samples using a channel sensor configured to measure analyte concentrations, an affinity molecule (which may include, for example, an aptamer, or an antibody or fragment thereof) is attached to a multivalent tag, such as a protein or nanoparticle. In some embodiments, the multivalent tag is a bivalent tag, a trivalent tag, or a tetravalent tag. For example, in some embodiments, the multivalent tag is avidin or an avidin derivative (e.g., neutravidin or streptavidin), which may bind to a biotin moiety fused to the affinity molecule. For example, in some embodiments, the affinity molecule is an aptamer with a biotin moiety attached (optionally via a linker) to the 5' or 3' end of the aptamer, and the multivalent tag is avidin. By using a multivalent tag, the impedance signal is increased compared to the use of the affinity molecule alone.
[0183] Affinity moieties bound to a target analyte can be distinguished from unbound affinity moieties based on the change in impedance, and the number of bound affinity moieties can be used to determine the concentration of the target analyte in a biological sample. In some embodiments, the change in impedance amplitude is used to distinguish bound affinity moieties from unbound affinity moieties. In some embodiments, a multivariate pattern is constructed from multiple current components to distinguish bound and unbound affinity moieties. The change in impedance as a function of baseline impedance is measured, and one or more components of the impedance change can be used to describe the state (bound or unbound) of the affinity moiety. Such components include, but are not limited to, one or more of the impedance peak height, impedance peak width, impedance peak area, and impedance half-width height.
[0184] Figure 15A illustrates a target analyte binding to a tetravalent affinity molecule. A biological sample (which can be processed by mixing the biological sample with one or more reagents and / or filtered in a cartridge) is mixed with a reagent containing a tetravalent affinity molecule. The tetravalent affinity molecule contains a tetravalent tag (e.g., avidin or an avidin derivative) bound to four aptamer molecules. The aptamer molecules are bound to biotin moieties via linker sequences, and an anchor moiety (e.g., biotin) is bound to the tetravalent tag. When the affinity molecule is mixed with the target analyte, up to four target analyte molecules bind to the tetravalent affinity molecule.
[0185] Figure 15B illustrates the impedance change resulting from an affinity moiety not bound to a target analyte (top diagram) and the impedance change resulting from an affinity moiety bound to a target analyte (bottom diagram) as the affinity moiety passes through the nanopore or nanochannel of a channel sensor. As shown in step 2, an impedance signal can be detected in both situations, but the impedance signal wave has a larger amplitude when the affinity moiety is bound to the target analyte. While the figure illustrates only the change in impedance magnitude, differences in the multivariate pattern between the two instances can be detected. In some embodiments, the impedance magnitude is analyzed to determine the analyte concentration in the biological sample. In some embodiments, the multivariate pattern is analyzed to determine the analyte concentration in the biological sample. The multivariate pattern can include features of the detected impedance peaks, such as impedance peak height, impedance peak width, peak area, and / or half-width peak height.
[0186] Figure 15C illustrates an example of using impedance magnitude to determine the concentration of a target analyte. Two impedance signal thresholds can be established. If the impedance signal exceeds a lower threshold but not an upper threshold, it is determined that the affinity moiety passing through the nanopore or nanochannel is not bound to the target analyte. If the impedance signal exceeds both the lower and upper thresholds, it is determined that the affinity moiety passing through the nanopore or nanochannel is not bound to the target analyte. The percentage of bound affinity moieties can be used to determine the analyte concentration in a biological sample.
[0187] A channel sensor (e.g., a flow cytometer or a channel sensor configured to measure analyte concentration) can be calibrated using particles with standardized size, surface charge, and / or material. Calibration can be performed during the manufacturing process to allow for improved accuracy in cell sizing and typing, taking into account field effects that may otherwise cause errors in particle sizing. Additionally or alternatively, the channel sensor can be calibrated using various reagents with known pH and / or electrolyte concentrations, which can verify the conductivity of the pore.
[0188] In some embodiments, the channel sensors are calibrated during operation of the cartridge, for example, before or after a biological sample is analyzed. This calibration can be performed using reagents stored or mixed on the cartridge and transported to the channel sensors using electrowetting electrodes.
[0189] In some embodiments, the cartridge includes multiple cellular analyzer sensors, such as two, three, four, or more. Different cellular analyzers may be redundant or specialized. Using different cellular analyzers, a biological sample may be dynamically analyzed, for example, by passing the biological sample through a first cellular analyzer and then a second cellular analyzer, with the second cellular analyzer selected based on the results of the first cellular analyzer. For example, if a biological sample is determined to have a low cell count of a particular cell type (e.g., white blood cells, red blood cells, or platelets), the biological sample may then be further processed by mixing with a specific reagent or physically separating the particular cell type, and then analyzed using a differently configured cellular analyzer (e.g., having a different pore size, functionalized with one or more molecules, or having a filter that removes the particular cell type) to more accurately count the particular cell type.
[0190] Electrowetting Electrodes The electrowetting electrodes in the cartridge are configured to transport an aqueous liquid (such as a biological sample or a processed biological sample) by electrowetting actuation (also referred to as digital microfluidics), divide the biological sample into one or more sub-samples, mix one or more reagents together, or mix one or more reagents with the biological sample or sub-sample to treat or dilute the biological sample or sub-sample. The electrowetting electrodes can transport the biological sample, for example, throughout the main chamber or channel of the cartridge. Individual electrodes within the plurality of electrowetting electrodes can be individually controlled, for example, by an electrowetting electrode driver within the device when engaged with the cartridge. The use of electrowetting electrodes to transport the biological sample within the main chamber allows for increased versatility in transporting biological samples compared to channel-based fluid transport, which is linear and typically relies on capillary flow (which allows limited control) or moving parts such as pumps to transport the sample. Electrowetting-based fluid transport allows for precise movement of the biological sample, mixing of reagents, dilution, and sample division.
[0191] Electrowetting actuation is driven by applying a voltage to a fluid positioned over an activated electrode. The voltage changes the contact angle of the fluid by generating a charge on the fluid-contact surface that attracts the fluid to the activated electrode. To reduce the voltage required for electrowetting actuation, the thickness of the insulating and / or hydrophobic layer needs to be reduced without causing dielectric breakdown of the material. Therefore, it is desirable to use thinly applied materials with high dielectric strength and high permittivity to reduce the voltage required for electrowetting actuation and generate the necessary charge on the fluid-contact surface.
[0192] The electrowetting electrodes in the cartridge may be arranged as an array of spaced apart electrodes in electrical communication with a device that operates the electrowetting electrodes. The device may operate the electrowetting electrodes using a switch that selectively activates electrodes in the array to actuate a liquid (e.g., a reagent or biological sample). The electrowetting electrodes are spaced apart from one another with an insulating layer filling the space between the electrowetting electrodes. The spacing between the electrowetting electrodes may vary within the array depending on the size of the electrowetting electrodes. For example, in some embodiments, the spacing between the electrodes is about 10 μm to about 150 μm (e.g., about 10 μm to about 20 μm, about 20 μm to about 50 μm, about 50 μm to about 100 μm, or about 100 μm to about 150 μm). The size of the electrowetting electrodes may also vary within the array depending on the volume of liquid intended to occupy the electrodes. For example, an electrowetting electrode configured to actuate a 20 μL liquid volume is approximately 0.632 mm by approximately 0.632 mm. In some embodiments, the electrowetting electrodes are approximately square or rectangular, while in some embodiments, the electrowetting electrodes may have jagged or protruding circular edges with partial overlap between adjacent electrodes. Figure 16A illustrates an exemplary electrowetting electrode array in an 8 × 16 matrix with tracks electrically connecting each electrode with the device interface. Figure 16B shows a close-up view of several electrowetting electrodes, highlighting the jagged edges of the approximately square electrodes.
[0193] The electrowetting electrodes are coated with an insulating layer (i.e., a dielectric layer), which is preferably a high-κ material (i.e., having a dielectric constant of about 3.9 or greater). The insulating layer may also fill the space between the electrowetting electrodes. In some embodiments, the insulating layer has a dielectric constant of about 3.9 or greater (about 5 or greater, about 10 or greater, about 20 or greater, about 40 or greater, about 60 or greater, about 100 or greater, about 200 or greater, about 400 or greater, about 1000 or greater, or about 2000 or greater). In some embodiments, the insulating layer has a dielectric constant of about 3.9 to about 20,000 (e.g., about 3.9 to about 5, about 5 to about 10, about 10 to about 20, about 20 to about 40, about 40 to about 60, about 60 to about 100, about 100 to about 200, about 200 to about 400, about 400 to about 1000, about 1000 to about 2000, about 2000 to about 4000, about 4000 to about 6000, about 6000 to about 10,000, or about 10,000 to about 20,000). Exemplary materials for the insulating layer include or are hafnium oxide, strontium barium titanate, or strontium titanate, silica, and silicon nitride.
[0194] The insulating layer is preferably a thin layer deposited on the surface of the electrode. Its thickness is minimized to reduce the required voltage without resulting in breakdown of the dielectric material. For example, the insulating layer can be coated on the electrode using atomic layer deposition, chemical vapor deposition, reactive ion beam deposition, sputter deposition, evaporation, spray deposition, spin coating, or sol-gel formation. In some embodiments, the insulating layer has a thickness of about 1 nm to about 5 μm. For example, in some embodiments, the insulating layer has a thickness of about 1 nm to about 10 nm, about 10 nm to about 20 nm, about 20 nm to about 40 nm, about 40 nm to about 100 nm, about 100 nm to about 250 nm, about 250 nm to about 500 nm, about 500 nm to about 1 μm, or about 1 μm to about 5 μm. When the insulating layer comprises a metal oxide, the insulating layer is generally thinner than when the insulating layer comprises a polymeric material. For example, in some embodiments, the insulating layer has a thickness of about 1 nm to about 100 nm. In some embodiments, the insulating layer comprises a polymer material and has a thickness of about 0.1 μm to about 5 μm. In some embodiments, the distance between the electrode and the fluid contact surface is about 1 nm to about 25 μm. For example, in some embodiments, the distance between the electrode and the fluid contact surface is about 1 nm to about 10 nm, about 10 nm to about 20 nm, about 20 nm to about 40 nm, about 40 nm to about 100 nm, about 100 nm to about 250 nm, about 250 nm to about 500 nm, about 500 nm to about 1 μm, about 1 μm to about 5 μm, about 5 μm to about 10 μm, or about 10 μm to about 25 μm.
[0195] In some embodiments, the insulating layer has a surface that contacts the biological sample and / or reagents (i.e., a fluid-contacting layer). The fluid-contacting surface is preferably a hydrophobic surface having a contact angle with water of 90° or greater at 25°C. In some embodiments, the hydrophobic surface has a contact angle with water of about 90° to about 160° (about 90° to about 100°, about 100° to about 110°, about 110° to about 120°, about 120° to about 130°, about 130° to about 140°, about 140° to about 150°, or about 140° to about 150°) at 25°C. In some embodiments, the insulating layer is or includes a hydrophobic material (i.e., a high-κ material that can act as an insulating material that is hydrophobic). To further enhance the hydrophobicity of the fluid-contacting surface of the insulating layer, the insulating layer may optionally include a nanostructured surface, which may be, for example, a woven pattern, a nanopillar pattern, or a nanoturf pattern. The nanostructured pattern can be formed, for example, by etching into the insulating layer.
[0196] In some embodiments, the insulating layer is optionally coated with a hydrophobic material, which can be a fluid contact layer. In some embodiments, the hydrophobic layer is applied, for example, using thin film deposition or spin coating. Optionally, the fluid contact surface of the hydrophobic layer has a nanostructured surface, which can be, for example, a woven pattern, a nanopillar pattern, or a nanoturf pattern. The nanostructured pattern can be formed, for example, by etching into the hydrophobic layer, by wet or dry etching into the fluid contact layer (e.g., the insulating layer or a separate hydrophobic layer). For example, photolithography or ion etching can be used to create the predetermined pattern. Exemplary hydrophobic materials for the hydrophobic layer include fluoropolymers, silanes, fluorinated silanes, polydimethylsiloxanes, or parylene.
[0197] The fluid-contacting surface (which may be, for example, the surface of an insulating layer or a hydrophobic coating) may have a nanostructured surface (i.e., a nanostructured pattern on the fluid-contacting surface). The nanostructured surface may alter the hydrophobicity of the surface, thus reducing the voltage required to actuate the fluid on the electrowetting electrodes. Exemplary nanostructured surfaces include, but are not limited to, a woven pattern, a nanopillar pattern, or a nanoturf pattern. In some embodiments, the hydrophobic nanostructured patterned surface is patterned on the insulating surface so that no additional material coating is required. In other embodiments, the nanostructured hydrophobic surface is formed on top of one or more insulating layers to form a hydrophobic surface on the upper insulating surface.
[0198] In some embodiments, the hydrophobic layer is formed using long-chain molecules that self-assemble on the insulating layer. For example, long-chain molecules for the hydrophobic layer can include molecules with an alkane hydrocarbon head group, with or without a spacer moiety, and an end group such as octadecane hydroximic acid, stearic acid, octadecane phosphonic acid, 16-hydrodihexadecane hydrolamic acid, or octadecane thiol, which specifically assemble on insulating substrates. These materials form a hydrophobic layer on the insulating layer. For example, the hydrophobic layer can be about 2.5 nm to about 30 nm thick. This thin hydrophobic layer adds hydrophobicity to the fluid-contacting surface without adding substantial thickness to the layer covering the electrowetting electrode.
[0199] The thin distance and high hydrophobicity of the surface in contact with the biological sample or reagent allows a lower voltage to be applied to the electrowetting electrodes to enable electrowetting actuation. For example, in some embodiments, the plurality of electrowetting electrodes is configured to transport the biological sample using a voltage of less than about 50 volts. In some embodiments, the plurality of electrowetting electrodes is configured to transport the biological sample using a voltage of about 0.5 volts to about 50 volts (e.g., about 0.5 volts to about 1 volt, about 1 volt to about 5 volts, about 5 volts to about 10 volts, about 10 volts to about 20 volts, about 20 volts to about 30 volts, about 30 volts to about 40 volts, or about 40 volts to about 50 volts).
[0200] The multiple electrowetting electrodes may include multiple coplanar electrodes that may be positioned along the bottom surface of the main chamber or channel of the cartridge. Optionally, the cartridge includes a ground electrode (which may be a continuous ground electrode or multiple separate ground electrodes) on the top surface of the main chamber or channel (i.e., the surface opposite the coplanar electrode). The electrowetting electrodes may be coated with one or more layers, as further described herein, the top layer being a fluid contact layer that contacts the biological sample and / or reagent as it is transported within the cartridge. Activation of an individual electrode adjusts the hydrophobicity of the fluid contact layer above the electrode, thereby actuating fluid (e.g., biological sample or reagent) to a position above the activated electrode.
[0201] The electrowetting electrodes may comprise any suitable conductive material, such as gold, silver, silver chloride, platinum, indium tin oxide (ITO), or conductive carbon. The conductive carbon may include conductive carbon inks, which may include carbon particles (e.g., graphite) mixed with other conductive particles, for example, carbon silver inks.
[0202] 17A illustrates one embodiment of a plurality of electrowetting electrodes including an insulating layer fluid contact surface. The plurality of electrowetting electrodes includes a first electrowetting electrode 1702, a second electrowetting electrode 1704, and a third electrowetting electrode 1706. On the opposite surfaces of the first electrowetting electrode 1702, the second electrowetting electrode 1704, and the third electrowetting electrode 1706, there is a ground electrode 1708 that is common to the three electrowetting electrodes. An insulating layer 1710 covers the first electrowetting electrode 1702, the second electrowetting electrode 1704, and the third electrowetting electrode 1706, along with the spaces between the electrowetting electrodes. The ground electrode 1708 is also covered with an insulating layer 1712. Fluids, such as a biological sample and / or one or more reagents, can be transported through gaps 1714 between ground electrode 1708 and the first, second, and third electrowetting electrodes. Fluid contact surface 1716 of insulating layer 1710 can be nanostructured to improve the hydrophobicity of the fluid contact surface. Fluid contact surface 1718 of insulating layer 1710 and / or fluid contact surface 1719 of insulating layer 1712 can also be nanostructured to improve the hydrophobicity of the fluid contact surface.
[0203] 17B illustrates another embodiment of a plurality of electrowetting electrodes, including an insulating layer covering the electrowetting electrodes and a hydrophobic layer covering the insulating layer. The plurality of electrowetting electrodes includes a first electrowetting electrode 1720, a second electrowetting electrode 1722, and a third electrowetting electrode 1724. On the opposite surfaces of the first electrowetting electrode 1720, the second electrowetting electrode 1722, and the third electrowetting electrode 1724 is a ground electrode 1726 that is common to the three electrowetting electrodes. An insulating layer 1728 covers the first electrowetting electrode 1720, the second electrowetting electrode 1722, and the third electrowetting electrode 1724, along with the spaces between the electrowetting electrodes. The ground electrode 1726 is also covered with an insulating layer 1730. Coating insulating layer 1728 is hydrophobic layer 1732, and coating insulating layer 1730 is hydrophobic layer 1734. Fluids, such as a biological sample and / or one or more reagents, may be transported through gap 1736 between hydrophobic layers 1732 and 1734. Optionally, the fluid contact surface of hydrophobic layer 1732 and / or the fluid contact surface of hydrophobic layer 1734 are nanostructured to improve the hydrophobicity of the fluid contact layers.
[0204] One or more of the electrowetting electrodes may include individual ground electrodes opposite the electrowetting electrodes instead of a common ground electrode. In some embodiments, a portion of the electrowetting electrodes include a common ground electrode and a portion of the electrowetting electrodes include individual ground electrodes. Examples of these configurations are shown in Figure 17C (without a separate hydrophobic layer) and Figure 17D (with a separate hydrophobic layer).
[0205] In some embodiments, there is a method of transporting liquid, the method comprising positioning an aqueous liquid on a first hydrophobic liquid contact surface over a deactivated first electrowetting electrode, and activating a second electrowetting electrode by applying a voltage of about 50 volts or less to the second electrowetting electrode, thereby transporting the aqueous liquid from the first hydrophobic liquid contact surface to a second hydrophobic liquid contact surface over the second electrowetting electrode, wherein the first electrowetting electrode and the second electrowetting electrode are coated with and separated by an insulating layer.
[0206] The aqueous liquid may be a biological sample, such as blood, serum, saliva, sweat, tears, mucus, urine, or any other biological sample or derivative suspended in a liquid. In some embodiments, the liquid is a processed biological sample, which may be processed by mixing the liquid with one or more reagents. The reagents may be mixed with the biological sample using electrowetting electrodes. For example, in some embodiments, the method includes transporting the reagent to a liquid-contacting surface containing the liquid, thereby mixing the reagent with the aqueous liquid.
[0207] The biological sample is transported by the electrowetting electrodes using a voltage of about 50 V or less. For example, in some embodiments, the biological sample is transported using a voltage of about 0.5 V to about 50 V (e.g., about 0.5 V to about 1 V, about 1 V to about 2 V, about 2 V to about 3 V, about 3 V to about 4 V, about 4 V to about 5 V, about 5 V to about 10 V, about 10 V to about 20 V, about 20 V to about 30 V, about 30 V to about 40 V, or about 40 V to about 50 V).
[0208] Method for analyzing biological samples The cartridges and devices described herein can be used to analyze biological samples, for example, to determine blood cell counts or analyte concentrations. To analyze a sample, the biological sample is placed in the cartridge, and the biological sample is transported into the cartridge using multiple electrowetting electrodes (i.e., by electrowetting actuation). The biological sample is analyzed using one or more sensors in the cartridge to generate analytical data, which is transmitted from the cartridge (e.g., to a device engaged with the cartridge). The biological sample can be mixed with one or more reagents in the cartridge to form a processed biological sample that is analyzed, for example, using one or more of the sensors. The cartridge can be disposed of after a single use.
[0209] In some embodiments, the biological sample is received by the cartridge using capillary action. The biological sample may fill a receiving chamber, which may determine the volume of biological sample entering the cartridge. After analysis by one or more sensors, the biological sample may be transported to a waste reservoir (e.g., through electrowetting actuation) and stored until the cartridge is discarded.
[0210] The biological sample can be transported within the cartridge (e.g., from the sample receiving port to the mixing area, one or more of the sensors, or the waste reservoir) by electrowetting actuation. The electrowetting electrodes can be coated with an insulating layer and / or a hydrophobic layer, either of which can include a hydrophobic fluid-contacting surface that can have a nanostructured pattern. To transport the biological sample, a first electrowetting electrode is activated by applying a voltage potential to the first electrowetting electrode to attract the biological sample to a position above the first electrode. Once the biological sample is in position above the first electrode, a second electrowetting electrode is activated by applying a voltage to the second electrowetting electrode, deactivating the first electrowetting electrode, thereby transporting the biological sample to a position above the second electrowetting electrode. In some embodiments, the voltage is from about 0.5 volts to about 1000 volts (e.g., from about 0.5 volts to about 1 volt, from about 1 volt to about 5 volts, from about 5 volts to about 10 volts, from about 10 volts to about 20 volts, from about 20 volts to about 30 volts, from about 30 volts to about 50 volts, from about 50 volts to about 100 volts, from about 100 volts to about 250 volts, from about 250 volts to about 500 volts, or from about 500 volts to about 1000 volts). Preferably, the plurality of electrowetting electrodes are operated using about 50 volts or less, or more preferably about 20 volts or less.
[0211] In some embodiments, analyzing the biological sample includes counting the number of cells in the biological sample. The analytical data transmitted by the cartridge may include information regarding the cell number. In some embodiments, counting the number of cells includes distinguishing between two or more different cell types, and the analytical data includes information regarding the cell type and the cell number. The different cell types may be, for example, white blood cells, red blood cells, or platelets. In some embodiments, the different cell types may include eosinophils, basophils, neutrophils, monocytes, and lymphocytes. Thus, in some embodiments, analyzing the biological sample includes counting white blood cells, counting red blood cells, counting platelets, counting eosinophils, counting basophils, counting neutrophils, counting monocytes, and / or counting lymphocytes. Analyzing the biological sample may include applying an electric current to the biological sample and recording a multiplexed impedance of the electric current. The analytical data (i.e., the multiplexed impedance) may be used to determine the number of cells or cell types in the biological sample. In some embodiments, analyzing the biological sample includes self-calibrating at least one of the sensors to detect different cell sizes or different cell types.
[0212] To analyze a biological sample using a cell analysis sensor, the biological sample flows continuously through a microchannel or a channel containing micropores. As the biological sample flows through the micropores or microchannels, a multiplexed current is applied to the micropores or microchannels. The multiplexed electrical impedances in the micropores or microchannels are measured, and analytical data relating to the multiplexed electrical impedances is transmitted from the cartridge. The current may be a mixed current including a direct current component and multiple (e.g., two, three, four, five, six, seven, eight, or more) alternating current components of different frequencies. Preferably, the multiplexed current includes at least three alternating current components. In some embodiments, the AC component is a first AC at about 1 kHz to about 100 kHz (e.g., about 1 kHz to about 10 kHz, about 10 kHz to about 20 kHz, about 20 kHz to about 30 kHz, about 30 kHz to about 40 kHz, about 40 kHz to about 50 kHz, about 50 kHz to about 60 kHz, about 60 kHz to about 70 kHz, about 70 kHz to about 80 kHz, about 80 kHz to about 90 kHz, or about 90 kHz to about 100 kHz), a second AC at about 100 kHz to about 1 MHz (e.g., about 100 kHz to about 200 kHz, about 200 kHz to about 300 kHz, about 300 kHz to about 400 kHz, about 400 kHz to about 500 kHz, a second AC current at about 500 kHz to about 600 kHz, about 600 kHz to about 700 kHz, about 700 kHz to about 800 kHz, about 800 kHz to about 900 kHz, or about 900 kHz to about 1000 kHz, etc.), and a third AC current at about 1 MHz or higher (e.g., about 1 MHz to about 10 MHz, about 10 MHz to about 20 MHz, about 20 MHz to about 30 MHz, about 30 MHz to about 40 MHz, about 40 MHz to about 50 MHz, about 50 MHz to about 60 MHz, about 60 MHz to about 70 MHz, about 70 MHz to about 80 MHz, about 80 MHz to about 90 MHz, or about 90 MHz to about 100 MHz, etc.).In another embodiment, the multiplexed current is (1) a direct current or alternating current at about 1 kHz to about 100 kHz (e.g., about 1 kHz to about 10 kHz, about 10 kHz to about 20 kHz, about 20 kHz to about 30 kHz, about 30 kHz to about 40 kHz, about 40 kHz to about 50 kHz, about 50 kHz to about 60 kHz, about 60 kHz to about 70 kHz, about 70 kHz to about 80 kHz, about 80 kHz to about 90 kHz, or about 90 kHz to about 100 kHz), (2) a direct current or alternating current at about 50 kHz to about 250 kHz (e.g., about 50 kHz to about 70 kHz, about 70 kHz to about 90 kHz, or about 90 kHz to about 100 kHz), or (3) a direct current or alternating current at about 50 kHz to about 250 kHz (e.g., about 50 kHz to about 70 kHz, about 70 kHz to about 90 kHz, or about 90 kHz to about 100 kHz). kHz, approximately 90 kHz to approximately 110 kHz, approximately 110 kHz to approximately 130 kHz, approximately 130 kHz to approximately 150 kHz, approximately 150 kHz to approximately 200 kHz, or approximately 200 kHz to approximately 250 kHz, etc.), (3) approximately 250 kHz to approximately 700 kHz (approximately 250 kHz to approximately 300 kHz, approximately 300 kHz to approximately 350 kHz, approximately 350 kHz to approximately 400 kHz, approximately 400 kHz to approximately 500 kHz, approximately 500 kHz to approximately 600 kHz, or approximately 600 kHz to approximately 700 kHz, etc.), (4) approximately 700 kHz to approximately 5 MHz (approximately 70 (4) AC between about 0 kHz and about 800 kHz, about 800 kHz and about 900 kHz, or about 900 kHz and about 1 MHz, or about 1 MHz and about 2 MHz, about 2 MHz and about 3 MHz, about 3 MHz and about 4 MHz, or about 4 MHz and about 5 MHz, etc.), (5) AC between about 5 MHz and about 20 MHz (about 5 MHz and 10 MHz, about 10 MHz and about 15 MHz, about 15 MHz and about 20 MHz, etc.), and (6) AC between about 20 MHz and above (about 20 MHz and about 30 MHz, about 30 MHz and about 40 MHz, about 40 MHz and about 50 MHz, about 50 MHz and about 60 MHz). MHz, about 60 MHz to about 70 MHz, about 70 MHz to about 80 MHz, about 80 MHz to about 90 MHz, about 90 MHz to about 100 MHz, about 100 MHz to about 125 MHz, or about 125 MHz to about 150 MHz, etc. In some embodiments, the plurality of AC components include a first AC of about 50 kHz to about 250 kHz, a second AC of about 250 kHz to about 700 kHz, a third AC of about 700 kHz to about 5 MHz, a fourth AC of about 5 MHz to about 20 MHz, and a fifth AC of about 20 MHz to about 150 MHz.The number of cells and / or the number of two or more different cell types in a biological sample can be determined based on the measured multiplexed impedance. The analyzed impedance can include real and / or imaginary components. Alternatively, the analyzed impedance can include magnitude and / or phase components.
[0213] In some embodiments, to analyze the sample, a biological sample is placed in a cartridge, and the biological sample is transported into the cartridge using multiple electrowetting electrodes (i.e., by electrowetting actuation). The biological sample is analyzed using one or more sensors in the cartridge to generate analytical data, and the analytical data is transmitted from the cartridge (e.g., to a device engaged with the cartridge). The biological sample may be mixed with one or more reagents in the cartridge to form a processed biological sample that is analyzed, for example, using one or more of the sensors. The cartridge may be discarded after a single use.
[0214] In some embodiments, the biological sample is received by the cartridge using capillary action. The biological sample may fill a receiving chamber, which may determine the volume of biological sample entering the cartridge. After analysis by one or more sensors, the biological sample may be transported to a waste reservoir (e.g., through electrowetting actuation) and stored until the cartridge is discarded.
[0215] The biological sample can be transported within the cartridge (e.g., from the sample reception port to the mixing area, one or more of the sensors, or a waste reservoir) by electrowetting actuation. To transport the biological sample, a first electrowetting electrode is activated by applying a voltage potential to the first electrowetting electrode to attract the biological sample to a position above the first electrode. Once the biological sample is in position above the first electrode, a second electrowetting electrode is activated by applying a voltage to the second electrowetting electrode, deactivating the first electrowetting electrode, thereby transporting the biological sample to a position above the second electrowetting electrode.
[0216] In some embodiments, analyzing a biological sample includes determining the presence or measuring the concentration of an analyte (e.g., a protein) in the biological sample. The biological sample can be statically positioned within a sensor (which can be, for example, an impedance sensor or an optical sensor) using, for example, electrowetting actuation (e.g., using electrowetting electrodes). The presence or concentration of the analyte can be determined by binding the analyte in the biological sample to an affinity moiety coupled to an electrode within the sensor and measuring the impedance change resulting from the analyte binding to the affinity moiety. The impedance change can be calibrated, for example, to the impedance resulting from a reference solution containing no biological sample. The affinity moiety can be, for example, an antibody, antibody fragment, or aptamer (such as a DNA aptamer, RNA aptamer, or XNA aptamer). The impedance detected by the sensor can be transmitted from the cartridge, and the impedance change can be used to determine the presence or concentration of the analyte.
[0217] Although examples of the present disclosure have been fully described with reference to the accompanying drawings, it should be noted that various changes and modifications will be apparent to those skilled in the art, and such changes and modifications are understood to be included within the scope of the examples of the present disclosure as defined by the appended claims.
[0218] Illustrative Embodiments The following embodiments are illustrative and should not be considered limitations of the invention(s) described herein.
[0219] Embodiment 1. A cartridge for analyzing a biological sample, comprising: a sample receiving port configured to receive a biological sample; a sensor configured to analyze a biological sample; a cartridge space in fluid communication with the biological sample receiving port and the sensor; a plurality of electrowetting electrodes configured to transport the biological sample within the cartridge space and combine the biological sample with one or more reagents; a device interface configured to receive power from and communicate with a cartridge interface on the device, wherein the sensor and the plurality of electrowetting electrodes are in electrical communication with the device interface.
[0220] Embodiment 2. The cartridge of embodiment 1, wherein the cartridge space is fluidly connected to one or more reagent reservoirs.
[0221] Embodiment 3. The cartridge of embodiment 2, wherein one or more reagent reservoirs contain a reagent.
[0222] Embodiment 4. A cartridge according to embodiment 2 or 3, wherein the cartridge space comprises a reagent mixing area.
[0223] Embodiment 5. The cartridge according to any one of embodiments 1 to 4, wherein the cartridge is a single-use cartridge.
[0224] Embodiment 6. A cartridge according to any one of embodiments 1 to 5, comprising a waste reservoir configured to receive the biological sample after it has been analyzed by the sensor.
[0225] Embodiment 7. A cartridge according to any one of embodiments 1 to 6, wherein the biological sample enters the sample receiving port through capillary action.
[0226] Embodiment 8. A cartridge according to any one of embodiments 1 to 7, wherein the plurality of electrowetting electrodes comprises a plurality of coplanar electrodes.
[0227] Embodiment 9. A cartridge as described in embodiment 8, wherein the plurality of electrowetting electrodes further comprises a ground electrode on a surface opposite the coplanar electrode.
[0228] Embodiment 10. A cartridge according to embodiment 9, wherein the ground electrode is common to two or more of the electrowetting electrodes.
[0229] Embodiment 11. A cartridge as described in embodiment 9, wherein at least one of the electrowetting electrodes is paired with a respective ground electrode.
[0230] Embodiment 12. A cartridge according to any one of embodiments 1 to 11, wherein the electrowetting electrodes are covered with an insulating layer.
[0231] Embodiment 13. A cartridge according to embodiment 12, wherein the insulating layer has a dielectric constant of about 3.9 or greater.
[0232] Embodiment 14. A cartridge according to embodiment 12 or 13, wherein the insulating layer comprises hafnium oxide, strontium barium titanate, or strontium titanate, silica, or silicon nitride.
[0233] Embodiment 15. A cartridge according to any one of embodiments 12 to 14, wherein the insulating layer is coated on the electrode using atomic layer deposition, chemical vapor deposition, reactive ion beam deposition, sputter deposition, evaporation, spray deposition, spin coating, or sol-gel formation.
[0234] Embodiment 16. A cartridge according to any one of embodiments 12 to 15, wherein the insulating layer has a thickness of about 1 nm to about 5 μm.
[0235] Embodiment 17. A cartridge according to any one of embodiments 12 to 16, wherein the insulating layer is a fluid contact layer.
[0236] Embodiment 18. A cartridge as described in embodiment 17, wherein the insulating layer comprises a nanostructured surface.
[0237] Embodiment 19. A cartridge according to any one of embodiments 1 to 18, wherein the electrowetting electrodes are coated with a hydrophobic layer.
[0238] Embodiment 20. A cartridge according to embodiment 19, wherein the hydrophobic layer is a fluid contact layer.
[0239] Embodiment 21. A cartridge as described in embodiment 20, wherein the hydrophobic layer comprises a nanostructured surface.
[0240] Embodiment 22. A cartridge according to any one of embodiments 19 to 21, wherein the hydrophobic layer comprises a fluoropolymer, polydimethylsiloxane, parylene, octadecane hydroximic acid, stearic acid, octadecane phosphonic acid, 16-hydrodihexadecane hydrolamic acid, or octadecane thiol.
[0241] Embodiment 23. A cartridge according to any one of embodiments 19 to 22, wherein a hydrophobic layer is coated on top of the insulating layer.
[0242] Embodiment 24. A cartridge according to any one of embodiments 1 to 23, wherein the electrowetting electrodes comprise gold, silver, silver chloride, platinum, indium tin oxide, or conductive carbon.
[0243] Embodiment 25. A cartridge according to any one of embodiments 1 to 24, wherein the electrowetting electrode is separated from the fluid contact surface by about 1 nm to about 25 μm.
[0244] Embodiment 26. A cartridge described in any one of embodiments 1 to 25, wherein the plurality of electrowetting electrodes is configured to transport the biological sample using a voltage of less than about 50 volts.
[0245] Embodiment 27. A cartridge described in any one of embodiments 1 to 26, wherein the plurality of electrowetting electrodes are configured to transport the biological sample using a voltage of about 0.5V to about 50V.
[0246] Embodiment 28. A cartridge according to any one of embodiments 1 to 27, wherein the sensor is an impedance sensor.
[0247] Embodiment 29. A cartridge described in any one of embodiments 1 to 29, wherein the sensor is configured to detect a protein or measure the amount of a protein.
[0248] Embodiment 30. A cartridge as described in embodiment 28 or 29, wherein the sensor comprises a first sensing electrode functionalized with an affinity moiety and a second sensing electrode paired with the first sensing electrode, and the sensor is configured to detect a change in impedance upon binding of an analyte or protein to the affinity moiety.
[0249] Embodiment 31. The cartridge of embodiment 30, wherein the affinity moiety is an antibody, antibody fragment, or aptamer.
[0250] Embodiment 32. A cartridge according to embodiment 30 or 31, wherein the first sensing electrode is an electrowetting electrode.
[0251] Embodiment 33. A cartridge as described in embodiment 30 or 31, wherein the sensor further comprises a first electrowetting electrode and a second electrowetting electrode, the first electrowetting electrode and the second electrowetting electrode being on opposite sides of the first sensing electrode or the second sensing electrode.
[0252] Embodiment 34. A cartridge according to embodiment 33, wherein the first sensing electrode is an electrowetting electrode.
[0253] Embodiment 35. A cartridge as described in embodiment 33 or 34, wherein the plurality of electrowetting electrodes are configured to statically position at least a portion of the biological sample between the first sensing electrode and the second sensing electrode.
[0254] Embodiment 36. A cartridge described in embodiment 34 or 35, wherein the first electrowetting electrode, the second electrowetting electrode, and the first sensing electrode are electrically connected to a voltage switching circuit configured to selectively activate one or neither of the first electrowetting electrode, the second electrowetting electrode, or the first sensing electrode.
[0255] Embodiment 37. A cartridge as described in embodiment 36, wherein the voltage switching circuit is electrically connected to a switch configured to alternatively select the impedance sensing circuit or the electrowetting electrode supply circuit.
[0256] Embodiment 38. A cartridge described in any one of embodiments 28 to 37, wherein the impedance sensor comprises a pH-sensitive layer or an ion-sensitive layer configured to modulate impedance based on pH or ion concentration.
[0257] Embodiment 39. A cartridge as described in embodiment 38, wherein the impedance sensor comprises a metal oxide semiconductor capacitor (MOSCap) sensor.
[0258] Embodiment 40. A cartridge as described in embodiment 39, wherein the MOSCap sensor is adjacent to the first sensing electrode and the second sensing electrode.
[0259] Embodiment 41. A cartridge described in any one of embodiments 1 to 40, wherein the cartridge further comprises one or more optical windows.
[0260] Embodiment 42. The sensor is a channel sensor, and the channel sensor is: a first channel segment; a second channel segment; and a pore or channel fluidly connecting the first channel segment and the second channel segment; 42. A cartridge according to any one of embodiments 1 to 41, comprising an electrode pair configured to apply a current to the pore or channel and to detect impedance within the pore or channel.
[0261] Embodiment 43. A cartridge as described in embodiment 42, wherein the electrode pair is configured to directly contact the liquid flowing through the channel sensor.
[0262] Embodiment 44. A cartridge described in embodiment 42 or 43, wherein the channel sensor is a flow cytometer configured to count the number of cells in a biological sample.
[0263] Embodiment 45. A cartridge as described in embodiment 44, wherein the sensor is configured to distinguish between different cell types.
[0264] Embodiment 46. A cartridge as described in embodiment 45, wherein the sensor is configured to distinguish between red blood cells, white blood cells, and platelets.
[0265] Embodiment 47. A cartridge described in embodiment 45 or 46, wherein the sensor is configured to count red blood cells, white blood cells, or platelets.
[0266] Embodiment 48. A cartridge described in any one of embodiments 45 to 47, wherein the sensor is configured to distinguish between eosinophils, basophils, neutrophils, monocytes, and lymphocytes.
[0267] Embodiment 49. A cartridge described in any one of embodiments 45 to 48, wherein the sensor is configured to count the number of eosinophils, basophils, neutrophils, monocytes, or lymphocytes.
[0268] Embodiment 50. A cartridge according to any one of embodiments 42 to 49, wherein the pores or channels are micropores or microchannels.
[0269] Embodiment 51. A cartridge described in any one of embodiments 42 to 50, wherein the current is a multiplexed current containing multiple AC components of different frequencies.
[0270] Embodiment 52. A cartridge described in any one of embodiments 42 to 51, wherein the current is a multiplexed current containing (1) a DC component or a low-frequency AC component, and (2) multiple AC components of different frequencies.
[0271] Embodiment 53. A cartridge according to embodiment 51 or 52, wherein the plurality of alternating current components comprises at least three alternating current components.
[0272] Embodiment 54. The cartridge of embodiment 53, wherein the plurality of AC components includes a first AC of about 10 kHz to about 100 kHz, a second AC of about 100 kHz to about 700 kHz, a third AC of about 700 kHz to about 5 MHz, and a fourth AC above about 5 MHz.
[0273] Embodiment 55. A cartridge described in any one of embodiments 51 to 54, wherein the plurality of alternating currents comprises at least five different alternating current components.
[0274] Embodiment 56. The cartridge of embodiment 55, wherein the plurality of AC components include a first AC of about 50 kHz to about 250 kHz, a second AC of about 250 kHz to about 700 kHz, a third AC of about 700 kHz to about 5 MHz, a fourth AC of about 5 MHz to about 20 MHz, and a fifth AC of about 20 MHz to about 150 MHz.
[0275] Embodiment 57. A cartridge described in any one of embodiments 42 to 56, wherein the electrode pair is configured to detect impedance at a sampling rate of about 100 kHz or more.
[0276] Embodiment 58. A cartridge described in any one of embodiments 42 to 57, wherein the electrode pair is configured to detect real and imaginary impedance components within the pore or channel.
[0277] Embodiment 59. A cartridge described in any one of embodiments 42 to 57, wherein the electrode pair is configured to detect magnitude and phase impedance components within the pore or channel.
[0278] Embodiment 60. A cartridge according to embodiment 42 or 43, wherein the channel sensor is configured to detect an analyte concentration.
[0279] Embodiment 61. The cartridge of embodiment 60, wherein the analyte is a protein.
[0280] Embodiment 62. A cartridge according to embodiment 60 or 61, wherein the cartridge contains a reagent comprising an affinity moiety, and the cartridge is configured to mix the reagent comprising the affinity moiety with a biological sample or a sub-sample derived therefrom, and transport the biological sample or sub-sample to the channel sensor.
[0281] Embodiment 63. A cartridge according to any one of embodiments 60 to 62, wherein the pore or channel is a nanopore or nanochannel.
[0282] Embodiment 64. A cartridge described in any one of embodiments 1 to 63, wherein the cartridge comprises a plurality of sensors.
[0283] Embodiment 65. A cartridge according to any one of embodiments 1 to 64, wherein the biological sample is a blood sample.
[0284] Embodiment 66. A cartridge according to any one of embodiments 1 to 65, wherein the cartridge space is a chamber or a channel.
[0285] Embodiment 67. A system for analyzing a biological sample, comprising: A cartridge according to any one of embodiments 1 to 66; a device including a cartridge interface configured to connect with the cartridge, the device configured to power and operate the cartridge.
[0286] Embodiment 68. A system described in embodiment 67, wherein the device is configured to power and operate two or more different types of cartridges.
[0287] Embodiment 69. A system described in embodiment 67 or 68, wherein the device further includes one or more processors and a non-transitory computer-readable storage medium storing one or more programs configured to be executed by the one or more processors, the one or more programs including instructions for (a) operating a plurality of electrowetting electrodes in the cartridge to transport a biological sample within the cartridge, and (b) operating the sensor.
[0288] Embodiment 70. The system described in embodiment 69, wherein the one or more programs include instructions for operating multiple electrowetting electrodes in the cartridge to continuously transport a biological sample through the sensor.
[0289] Embodiment 71. The system described in embodiment 70, wherein the one or more programs include instructions for operating a plurality of electrowetting electrodes in the cartridge to statically position a biological sample within the sensor.
[0290] Embodiment 72. A system described in any one of embodiments 69 to 71, wherein the one or more programs include instructions for determining cell count or analyte concentration based on a multivariate pattern of impedance signals detected at one or more frequencies.
[0291] Embodiment 73. The system of embodiment 72, wherein the multivariate pattern comprises one or more of impedance peak height, impedance peak width, impedance peak area, or impedance peak width at half maximum peak height.
[0292] Embodiment 74. The system of embodiment 72 or 73, wherein the multivariate pattern includes a real impedance component and an imaginary impedance component.
[0293] Embodiment 75. The system of embodiment 72 or 73, wherein the multivariate pattern includes a magnitude impedance component and a phase impedance component.
[0294] Embodiment 76. A system described in any one of embodiments 67 to 75, wherein the one or more programs include instructions for calibrating the sensor.
[0295] Embodiment 77. A system described in any one of embodiments 67 to 76, wherein the device is a handheld device.
[0296] Embodiment 78. A method for analyzing a biological sample, comprising: placing a biological sample in the cartridge; transporting the biological sample into the cartridge using a plurality of electrowetting electrodes; analyzing the biological sample using one or more sensors in the cartridge to generate analytical data; and transmitting the analytical data from the cartridge.
[0297] Embodiment 79. The method of embodiment 78, comprising mixing the biological sample with one or more reagents in a cartridge.
[0298] Embodiment 80. The method of embodiment 78 or 79, wherein the biological sample is received by the cartridge using capillary action.
[0299] Embodiment 81. The method of any one of embodiments 78 to 80, further comprising transporting the biological sample into a waste reservoir in the cartridge after analyzing the biological sample.
[0300] Embodiment 82. The method of any one of embodiments 78 to 81, wherein the cartridge is discarded after a single use.
[0301] Embodiment 83. The method of any one of embodiments 78 to 82, wherein analyzing the biological sample comprises counting the number of cells in the biological sample, and the analysis data relates to the number of cells.
[0302] Embodiment 84. The method of any one of embodiments 78 to 83, wherein analyzing the biological sample comprises distinguishing between two or more different cell types.
[0303] Embodiment 85. The method of embodiment 84, wherein analyzing the biological sample includes differentiating between red blood cells, white blood cells, and platelets.
[0304] Embodiment 86. The method of any one of embodiments 78 to 85, wherein analyzing the biological sample comprises counting white blood cells, counting red blood cells, or counting platelets.
[0305] Embodiment 87. The method of any one of embodiments 78 to 86, wherein analyzing the biological sample comprises differentiating between eosinophils, basophils, neutrophils, monocytes, and lymphocytes.
[0306] Embodiment 88. The method of any one of embodiments 78 to 87, wherein analyzing the biological sample comprises counting the number of eosinophils, basophils, neutrophils, monocytes, or lymphocytes.
[0307] Embodiment 89. The method of any one of embodiments 78 to 88, wherein analyzing the biological sample comprises applying an electric current to the biological sample and recording the multiplexed impedance of the electric current.
[0308] Embodiment 90. The method of embodiment 89, wherein the current is a mixed current containing multiple alternating current components of different frequencies.
[0309] Embodiment 91. The method of embodiment 89 or 90, wherein the current is a mixed current containing a direct current component and multiple alternating current components of different frequencies.
[0310] Embodiment 92. The method of any one of embodiments 89 to 91, wherein the current is a mixed current containing at least five alternating current components of different frequencies.
[0311] Embodiment 93. The method of any one of embodiments 78 to 92, comprising self-calibrating at least one of the sensors to detect different cell sizes.
[0312] Embodiment 94. The method of any one of embodiments 78 to 93, wherein analyzing the biological sample comprises continuously flowing the biological sample through at least one of the sensors during the analysis.
[0313] Embodiment 95. The method of any one of embodiments 78 to 94, wherein the biological sample is transported into the cartridge using a voltage of about 50 V or less.
[0314] Embodiment 96. The method of any one of embodiments 78 to 95, wherein the biological sample is transported into the cartridge using a voltage of about 0.5 V to about 50 V.
[0315] Embodiment 97. The method of any one of embodiments 78 to 96, wherein analyzing the biological sample comprises determining the concentration of an analyte or protein in the biological sample.
[0316] Embodiment 98. The method of embodiment 97, wherein analyzing the biological sample includes statically positioning the biological sample over at least one of the sensors.
[0317] Embodiment 99. The method of embodiment 98, wherein the biological sample is statically positioned on the sensor using electrowetting electrodes.
[0318] Embodiment 100. Determining the concentration of an analyte or protein in a biological sample comprises: Binding an analyte or protein to an affinity moiety attached to an electrode within one of the sensors; 90. The method of any one of embodiments 78-99, comprising measuring the impedance change resulting from the analyte or protein binding to the affinity moiety.
[0319] Embodiment 101. The method of embodiment 100, wherein the affinity moiety is an antibody, an antibody fragment, or an aptamer.
[0320] Embodiment 102. A system comprising: (a) A cartridge configured to analyze a biological sample, the cartridge comprising: (i) a sensor, a first channel segment; a second channel segment; a pore or channel fluidly connecting the first channel segment and the second channel segment; an electrode pair configured to apply a multiplexed current or voltage to the pore or channel; and a sensor including an electrode pair configured to detect impedance at multiple frequencies within the pore or channel, wherein the electrode pair configured to apply the multiplexed current and the electrode pair configured to detect the impedance are the same electrode pair or different electrode pairs; (ii) a device interface electrically connected to the sensor; and (b) a device configured to interface with and operate the cartridge, the device including one or more processors and a non-transitory computer-readable storage medium storing one or more programs configured to be executed by the one or more processors, the one or more programs including instructions for determining cell count or analyte concentration based on detected impedance, the detected impedance including at least a first multivariate impedance pattern at a first frequency and a second multivariate impedance pattern at a second frequency.
[0321] Embodiment 103. A system as described in embodiment 102, wherein the electrode pair configured to apply the multiplexed current and the electrode pair configured to detect the impedance are the same electrode pair.
[0322] Embodiment 104. A system as described in embodiment 102, wherein the electrode pair configured to apply the multiplexed current and the electrode pair configured to detect the impedance are different electrode pairs.
[0323] Embodiment 105. A system described in any one of embodiments 102 to 104, wherein the first multivariate impedance pattern and the second multivariate impedance pattern each include real and imaginary components of impedance.
[0324] Embodiment 106. A system described in any one of embodiments 102 to 104, wherein the first multivariate impedance pattern and the second multivariate impedance pattern each include a magnitude component and a phase imaginary component of the impedance.
[0325] Embodiment 107. A system described in any one of embodiments 102 to 106, wherein the first multivariate impedance pattern and the second multivariate impedance pattern include one or more of impedance peak height, impedance peak width, impedance peak area, or impedance peak half-width peak height.
[0326] Embodiment 108. A system described in any one of embodiments 102 to 107, wherein the electrode pair is in direct contact with the inner portion of the channel.
[0327] Embodiment 109. A system described in any one of embodiments 102 to 108, wherein the sensor is configured to count the number of cells in a biological sample.
[0328] Embodiment 110. The system described in embodiment 109, wherein the sensor is configured to distinguish between different cell types.
[0329] Embodiment 111. A system described in embodiment 110, wherein the sensor is configured to distinguish between red blood cells, white blood cells, and platelets.
[0330] Embodiment 112. A system described in any one of embodiments 109 to 111, wherein the sensor is configured to count red blood cells, white blood cells, or platelets.
[0331] Embodiment 113. A system described in any one of embodiments 109 to 112, wherein the sensor is configured to distinguish between eosinophils, basophils, neutrophils, monocytes, and lymphocytes.
[0332] Embodiment 114. A system described in any one of embodiments 109 to 113, wherein the sensor is configured to count the number of eosinophils, basophils, neutrophils, monocytes, and lymphocytes.
[0333] Embodiment 115. A system described in any one of embodiments 109 to 114, wherein the pores or channels are micropores or microchannels.
[0334] Embodiment 116. A system described in any one of embodiments 102 to 108, wherein the sensor is configured to detect an analyte concentration.
[0335] Embodiment 117. The system of embodiment 116, wherein the analyte is a protein.
[0336] Embodiment 118. A system described in embodiment 116 or 117, wherein the pore or channel is a nanopore or nanochannel.
[0337] Embodiment 119. A system described in any one of embodiments 102 to 118, wherein the electrode pair configured to detect impedance includes a first electrode in the first channel segment and a second electrode in the second channel segment.
[0338] Embodiment 120. A system described in any one of embodiments 102 to 119, wherein the sensor includes a channel and an electrode pair configured to detect impedance is positioned within the channel.
[0339] Embodiment 121. A system described in embodiment 120, wherein the electrode pair includes a first electrode proximal to the first channel segment and a second electrode proximal to the second channel segment.
[0340] Embodiment 122. A system described in embodiment 121, wherein the electrode pair includes a first electrode on the upper surface of the channel and a second electrode on the lower surface of the channel, the first electrode being positioned above the second electrode.
[0341] Embodiment 123. A system described in any one of embodiments 102 to 122, wherein the sensor further includes an electrode pair configured to detect liquid flow within the sensor.
[0342] Embodiment 124. A system described in any one of embodiments 102 to 123, wherein the sensor comprises one or more separate electrodes.
[0343] Embodiment 125. A system described in any one of embodiments 102 to 124, wherein the sensor includes an inlet to the first channel segment proximal to the electrowetting electrode.
[0344] Embodiment 126. A system described in any one of embodiments 102 to 125, wherein the sensor includes an outlet to a second channel segment proximal to the electrowetting electrode.
[0345] Embodiment 127. A system described in any one of embodiments 102 to 126, wherein the multiplexed current includes multiple AC components of different frequencies.
[0346] Embodiment 128. A system described in any one of embodiments 102 to 127, wherein the multiplexed current includes (1) a DC component or a low-frequency AC component, and (2) multiple AC components of different frequencies.
[0347] Embodiment 129. A system described in embodiment 127 or 128, wherein the multiple AC components include at least three AC components.
[0348] Embodiment 130. The system of embodiment 129, wherein the plurality of AC components includes a first AC of about 10 kHz to about 100 kHz, a second AC of about 100 kHz to about 700 kHz, a third AC of about 700 kHz to about 5 MHz, and a fourth AC above about 5 MHz.
[0349] Embodiment 131. A system described in embodiment 127 or 128, wherein the plurality of AC components includes at least five AC components.
[0350] Embodiment 132. The system described in embodiment 131, wherein the plurality of AC components include a first AC of about 50 kHz to about 250 kHz, a second AC of about 250 kHz to about 700 kHz, a third AC of about 700 kHz to about 5 MHz, a fourth AC of about 5 MHz to about 20 MHz, and a fifth AC of about 20 MHz to about 150 MHz.
[0351] Embodiment 133. A system described in any one of embodiments 102 to 132, wherein the electrode pair configured to detect impedance is configured to detect impedance at a sampling rate of about 100 kHz or more.
[0352] Embodiment 134. A system described in any one of embodiments 102 to 133, wherein the cartridge comprises a plurality of electrowetting electrodes configured to transport one or more liquids within the cartridge.
[0353] Embodiment 135. A system described in any one of embodiments 102 to 134, wherein the cartridge is configured to mix a biological sample or a sub-sample derived therefrom with a reagent and transport the biological sample or sub-sample to the sensor.
[0354] Embodiment 136. A method for determining the number of cells in a biological sample, comprising: Transporting a biological sample through a sensor comprising a channel or pore; applying multiplexed currents or voltages to the channels or pores; detecting a multiplexed impedance in the channel or pore, the multiplexed impedance including at least a first multivariate impedance pattern at a first frequency and a second multivariate impedance pattern at a second frequency; and determining a cell number based on the detected multiplexed impedance.
[0355] Embodiment 137. The method of embodiment 136, wherein the first multivariate impedance pattern and the second multivariate impedance pattern each include a real component and an imaginary component.
[0356] Embodiment 138. The method of embodiment 136, wherein the first multivariate impedance pattern and the second multivariate impedance pattern each include a magnitude component and a phase component.
[0357] Embodiment 139. The method of any one of embodiments 136 to 138, wherein the multivariate impedance pattern comprises one or more of impedance peak height, impedance peak width, impedance peak area, or impedance peak width at half maximum peak height.
[0358] Embodiment 140. The method of any one of embodiments 136 to 139, wherein the biological sample is in direct contact with a pair of electrodes that detect multiplexed impedance.
[0359] Embodiment 141. The method of any one of embodiments 136 to 140, comprising distinguishing between two or more different cell types.
[0360] Embodiment 142. The method of any one of embodiments 136 to 141, wherein determining the cell count comprises determining the red blood cell count, white blood cell count, or platelet count in the biological sample.
[0361] Embodiment 143. The method of any one of embodiments 136 to 142, wherein determining the cell count comprises determining the eosinophil count, the basophil count, the neutrophil count, the monocyte count, and the lymphocyte count in the biological sample.
[0362] Embodiment 144. The method of any one of embodiments 136 to 143, comprising transporting two or more sub-samples of a biological sample through a sensor, wherein the two or more sub-samples are treated at different pH levels or different electrolyte concentrations.
[0363] Embodiment 145. A method according to any one of embodiments 136 to 144, comprising transporting a marker into the sensor.
[0364] Embodiment 146. The method of embodiment 145, wherein the marker is an air bubble or a low-conductivity solution.
[0365] Embodiment 147. The method of embodiment 145 or 146, comprising detecting a marker.
[0366] Embodiment 148. A method according to any one of embodiments 136 to 147, wherein a marker triggers the start or end of recording of the detected multiplexed impedance.
[0367] Embodiment 149. The method of any one of embodiments 136 to 148, comprising determining the flow rate of the biological sample.
[0368] Embodiment 150. The method of embodiment 149, comprising using the determined flow rate to determine the cell number.
[0369] Embodiment 151. The method of any one of embodiments 136 to 150, comprising filtering the biological sample.
[0370] Embodiment 152. A method according to any one of embodiments 136 to 151, wherein the multiplexed current comprises multiple AC components of different frequencies.
[0371] Embodiment 153. A method according to any one of embodiments 136 to 152, wherein the multiplexed current comprises (1) a DC component or a low-frequency AC component, and (2) multiple AC components of different frequencies.
[0372] Embodiment 154. The method of embodiment 152 or 153, wherein the plurality of AC components includes at least three AC components.
[0373] Embodiment 155. The method of any one of embodiments 152 to 154, wherein the plurality of AC components includes a first AC of about 10 kHz to about 100 kHz, a second AC of about 100 kHz to about 700 kHz, a third AC of about 700 kHz to about 5 MHz, and a fourth AC above about 5 MHz.
[0374] Embodiment 156. A system described in embodiment 152 or 153, wherein the plurality of AC components includes at least five AC components.
[0375] Embodiment 157. The system described in embodiment 156, wherein the plurality of AC components include a first AC of about 50 kHz to about 250 kHz, a second AC of about 250 kHz to about 700 kHz, a third AC of about 700 kHz to about 5 MHz, a fourth AC of about 5 MHz to about 20 MHz, and a fifth AC of about 20 MHz to about 150 MHz.
[0376] Embodiment 158. A method for detecting an analyte in a biological sample, comprising: transporting a biological sample through a sensor comprising a channel or pore, the biological sample comprising an analyte bound to an affinity moiety; applying a current or voltage to the channel or pore; detecting impedance within the channel or pore; and detecting the analyte based on the detected impedance.
[0377] Embodiment 159. The method of embodiment 158, wherein the analyte is a protein or an electrolyte.
[0378] Embodiment 160. The method of embodiment 158 or 159, wherein the affinity moiety is a multivalent affinity moiety.
[0379] Embodiment 161. The method of any one of embodiments 158 to 160, wherein the affinity moiety is charged.
[0380] Embodiment 162. The method of any one of embodiments 158 to 151, wherein the affinity moiety comprises an aptamer, an antibody, or an antibody fragment.
[0381] Embodiment 163. The method of any one of embodiments 158 to 162, wherein the affinity moiety comprises an aptamer bound to avidin or an avidin derivative.
[0382] Embodiment 164. The method of any one of embodiments 158 to 163, comprising mixing the biological sample with a reagent comprising an affinity moiety.
[0383] Embodiment 165. The method of any one of embodiments 158 to 164, wherein detecting the analyte based on the detected impedance comprises distinguishing between affinity moieties bound to the analyte and unbound affinity moieties.
[0384] Embodiment 166. A method according to any one of embodiments 158 to 165, comprising transporting a marker into the sensor.
[0385] Embodiment 167. The method of embodiment 166, wherein the marker is an air bubble or a low-conductivity solution.
[0386] Embodiment 168. The method of embodiment 166 or 167, comprising detecting a marker.
[0387] Embodiment 169. A method according to any one of embodiments 166 to 168, wherein a marker triggers the start or end of recording of the detected multiplexed impedance.
[0388] Embodiment 170. The method of any one of embodiments 166 to 169, comprising determining the flow rate of the biological sample.
[0389] Embodiment 171. The method of embodiment 170, comprising using the determined flow rate to determine the concentration of the analyte.
[0390] Embodiment 172. An electrowetting electrode array, comprising: a plurality of coplanar electrowetting electrodes coated with and spaced apart by an insulating layer; An electrowetting electrode array, wherein the electrowetting array includes a hydrophobic liquid contact surface, the electrowetting array being configured to transport aqueous liquids using a voltage of about 50 volts or less.
[0391] Embodiment 173. An electrowetting electrode array as described in embodiment 172, wherein the insulating layer comprises a hydrophobic liquid contact surface.
[0392] Embodiment 174. An electrowetting electrode array as described in embodiment 173, wherein the insulating layer comprises a nanostructured surface.
[0393] Embodiment 175. An electrowetting electrode array as described in embodiment 172, wherein the insulating layer is coated with a hydrophobic layer comprising a hydrophobic liquid contact surface.
[0394] Embodiment 176. An electrowetting electrode array as described in embodiment 175, wherein the hydrophobic layer comprises a nanostructured surface.
[0395] Embodiment 177. An electrowetting electrode array as described in embodiment 175 or 176, wherein the hydrophobic layer comprises a fluoropolymer, polydimethylsiloxane, parylene, octadecane hydroximic acid, stearic acid, octadecane phosphonic acid, 16-hydrodihexadecane hydrolamic acid, or octadecane thiol.
[0396] Embodiment 178. An electrowetting electrode array described in any one of embodiments 172 to 177, wherein a plurality of electrowetting electrodes are configured to transport an aqueous liquid using a voltage of about 0.5 volts to about 50 volts.
[0397] Embodiment 179. An electrowetting electrode array described in any one of embodiments 172 to 178, wherein the insulating layer has a dielectric constant of about 3.9 or greater.
[0398] Embodiment 180. An electrowetting electrode array according to any one of embodiments 172 to 179, wherein the insulating layer comprises hafnium oxide, strontium barium titanate, or strontium titanate, silica, or silicon nitride.
[0399] Embodiment 181. An electrowetting electrode array described in any one of embodiments 171 to 180, wherein the insulating layer is coated on the electrode using atomic layer deposition, chemical vapor deposition, reactive ion beam deposition, sputter deposition, evaporation, spray deposition, spin coating, or sol-gel formation.
[0400] Embodiment 182. An electrowetting electrode array described in any one of embodiments 171 to 181, wherein the insulating layer has a thickness of about 1 nm to about 5 μm.
[0401] Embodiment 183. An electrowetting electrode array according to any one of embodiments 171 to 182, wherein the electrowetting electrodes comprise gold, silver, silver chloride, platinum, indium tin oxide, or conductive carbon.
[0402] Embodiment 184. An electrowetting electrode array described in any one of embodiments 171 to 183, wherein the electrowetting electrodes are separated from the hydrophobic liquid contact surface by about 1 nm to about 25 μm.
[0403] Embodiment 185. An electrowetting electrode array described in any one of embodiments 171 to 184, wherein the plurality of electrowetting electrodes further includes a ground electrode parallel to the coplanar electrowetting electrode, and the hydrophobic liquid contact surface is between the ground electrode and the coplanar electrowetting electrode.
[0404] Embodiment 186. An electrowetting electrode array as described in embodiment 185, wherein the ground electrode is common to two or more of the electrowetting electrodes.
[0405] Embodiment 187. An electrowetting electrode array as described in embodiment 185, wherein at least one of the electrowetting electrodes is paired with a respective ground electrode.
[0406] Embodiment 188. An electrowetting electrode array described in any one of embodiments 171 to 187, comprising an impedance sensor including a sensing electrode and a functionalized liquid contact surface, wherein the functionalized liquid contact surface is functionalized with an affinity moiety that specifically binds to a target analyte.
[0407] Embodiment 189. An electrowetting electrode as described in embodiment 188, wherein the sensor further comprises a second sensing electrode paired with the first sensing electrode, and the sensor is configured to detect a change in impedance upon binding of an analyte or protein to the affinity moiety.
[0408] Embodiment 190. An electrowetting electrode array according to embodiment 188 or 189, wherein the target analyte is a protein.
[0409] Embodiment 191. An electrowetting electrode array according to any one of embodiments 188 to 190, wherein the affinity moiety is an antibody, an antibody fragment, or an aptamer.
[0410] Embodiment 192. An electrowetting electrode array described in any one of embodiments 188 to 191, wherein the impedance sensor further comprises a metal oxide semiconductor capacitor (MOSCap) sensor including a pH-sensitive layer or an ion-sensitive layer configured to modulate impedance based on pH or ion concentration.
[0411] Embodiment 193. An electrowetting electrode array according to any one of embodiments 172 to 192, wherein the aqueous liquid comprises a biological sample.
[0412] Embodiment 194. An electrowetting electrode array as described in embodiment 193, wherein the biological sample comprises a blood sample.
[0413] Embodiment 195. A cartridge for analyzing biological samples, comprising: a sample receiving port configured to receive a biological sample; a sensor configured to analyze a biological sample; A cartridge space in fluid communication with the biological sample receiving port and the sensor, the cartridge space comprising an electrowetting electrode array according to any one of embodiments 172 to 194; a device interface configured to receive power from and communicate with a cartridge interface on the device, wherein the sensor and the plurality of electrowetting electrodes are in electrical communication with the device interface.
[0414] Embodiment 196. A cartridge described in embodiment 195, wherein the cartridge space is fluidly connected to one or more reagent reservoirs, and the electrowetting electrode array extends into the one or more reagent reservoirs.
[0415] Embodiment 197. A cartridge described in embodiment 195 or 196, wherein the electrowetting electrode array comprises a reagent mixing area.
[0416] Embodiment 198. A cartridge according to any one of embodiments 195 to 197, wherein the cartridge space is a chamber or a channel.
[0417] Embodiment 199. A system for analyzing a biological sample, comprising: A cartridge according to any one of embodiments 195 to 198; a device including a cartridge interface configured to connect with the cartridge, the device configured to operate the electrowetting electrode array.
[0418] Embodiment 200. The system described in embodiment 199, wherein the device is a handheld device.
[0419] Embodiment 201. A method for transporting a liquid, comprising: positioning an aqueous liquid on a first hydrophobic liquid contact surface above the passivated first electrowetting electrode; activating the second electrowetting electrode by applying a voltage of about 50 volts or less to the second electrowetting electrode, thereby transporting the aqueous liquid from the first hydrophobic liquid contact surface to a second hydrophobic liquid contact surface over the second electrowetting electrode; A method wherein the first electrowetting electrode and the second electrowetting electrode are coated with and separated by an insulating layer.
[0420] Embodiment 202. The method of embodiment 201, wherein the aqueous liquid comprises a biological sample.
[0421] Embodiment 203. The method of embodiment 201 or 202, comprising transporting the reagent to a second liquid contact surface, thereby mixing the reagent with the aqueous liquid.
[0422] Embodiment 204. The method of embodiment 203, wherein the reagent is transported by activating a second electrowetting electrode.
[0423] Embodiment 205. The method of any one of embodiments 201 to 204, wherein the biological sample is transported into the cartridge using a voltage of about 0.5V to about 50V.
[0424] Embodiment 206. The method of any one of embodiments 201 to 205, wherein the first hydrophobic liquid contact surface or the second hydrophobic liquid contact surface is a nanostructured surface.
[0425] Embodiment 207. The method of any one of embodiments 201 to 206, wherein the insulating layer comprises a first hydrophobic liquid contact surface and a second hydrophobic liquid contact surface.
[0426] Embodiment 208. The method of any one of embodiments 201 to 207, wherein the insulating layer is coated with a hydrophobic layer comprising a first hydrophobic liquid contact surface and a second hydrophobic liquid contact surface.
[0427] Embodiment 209. The method of embodiment 208, wherein the hydrophobic layer comprises a fluoropolymer, polydimethylsiloxane, parylene, octadecane hydroximic acid, stearic acid, octadecane phosphonic acid, 16-hydrodihexadecane hydrolamic acid, or octadecane thiol.
[0428] Embodiment 210. The method of any one of embodiments 201-209, wherein the insulating layer has a dielectric constant of about 3.9 or greater.
[0429] Embodiment 211. The method of any one of embodiments 201-210, wherein the insulating layer comprises hafnium oxide, strontium barium titanate, or strontium titanate, silica, or silicon nitride.
[0430] Embodiment 212. The method of any one of embodiments 201 to 211, wherein the insulating layer has a thickness of about 1 nm to about 5 μm.
[0431] Embodiment 213. A method according to any one of embodiments 201 to 212, wherein the first electrowetting electrode is separated from the first hydrophobic liquid contact surface by about 1 nm to about 25 μm, and the second electrowetting electrode is separated from the second hydrophobic liquid contact surface by about 1 nm to about 25 μm.
[0432] Embodiment 214. A metal oxide semiconductor capacitor (MOSCap) sensor, comprising: a first sensor segment including a first electrode and a first semiconductor layer; a second sensor segment including a second electrode and a second semiconductor layer; a space between the first sensor segment and the second sensor segment configured to allow liquid flow; A metal oxide semiconductor capacitor sensor, wherein the first sensor segment, the second sensor segment, and the space are in a stacked configuration.
[0433] Embodiment 215. A MOSCap sensor as described in embodiment 214, wherein the first semiconductor layer is coated directly on the first electrode and the second semiconductor layer is coated directly on the second electrode.
[0434] Embodiment 216. A MOSCap sensor as described in embodiment 214 or 215, wherein the first sensor segment includes a first insulating layer and the second sensor segment includes a second insulating layer.
[0435] Embodiment 217. A MOSCap sensor as described in embodiment 216, wherein the first insulating layer is coated directly on the first semiconductor layer and the second insulating layer is coated directly on the second semiconductor layer.
[0436] Embodiment 218. A MOSCap sensor described in any one of embodiments 214 to 217, wherein the first sensor segment includes a first impedance modulation layer, the second sensor segment includes a second impedance modulation layer, and the first impedance modulation layer and the second impedance modulation layer are pH-sensitive layers or ion-sensitive layers configured to modulate impedance based on pH or ion concentration.
[0437] Embodiment 219. A MOSCap sensor as described in embodiment 218, wherein the first sensor segment includes a first insulating layer, the second sensor segment includes a second insulating layer, the first impedance modulation layer is coated directly on the first insulating layer, and the second impedance modulation layer is coated directly on the second insulating layer.
[0438] Embodiment 220. A MOS Cap sensor described in any one of embodiments 214 to 219, wherein the first electrode is attached to a first substrate and the second electrode is attached to a second substrate.
[0439] Embodiment 221. A MOSCap sensor described in any one of embodiments 214 to 220, wherein the first sensor segment is adjacent to the reference electrode.
[0440] Embodiment 222. A MOSCap sensor as described in embodiment 221, wherein the first sensor segment is adjacent to the counter electrode.
[0441] Embodiment 223. A MOSCap sensor described in any one of embodiments 214 to 222, wherein the MOSCap sensor is adjacent to an electrowetting electrode.
[0442] Embodiment 224. A MOSCap sensor as described in embodiment 223, wherein the electrowetting electrode is functionalized with an affinity moiety.
[0443] Embodiment 225. The MOSCap sensor of embodiment 224, wherein the affinity moiety specifically binds to hemoglobin. [Example]
[0444] The present application may be better understood by reference to the following non-limiting examples, which are provided as exemplary embodiments of the present application. The following examples are presented to more fully illustrate the embodiments, but should not be construed as limiting the broad scope of the present application in any way. While specific embodiments of the present application have been shown and described herein, it will be apparent that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions may occur to those skilled in the art without departing from the concept and scope of the present invention. It should be understood that various alternatives to the embodiments described herein may be used in implementing the devices and methods described herein.
[0445] Example 1: Cell size differentiation using flow cytometer channel sensors The diameter of cells flowing through a flow cytometer can be determined using a low-frequency current (e.g., <100 Hz), and the voltage signal can be calibrated to the signal modulation detected using polystyrene beads of known size. To calibrate the sensor, polystyrene beads of 5 μm, 10 μm, 20 μm, or 30 μm diameter suspended in phosphate-buffered saline (pH 7.4) were passed through the flow cytometer channel sensor. A 30 kHz current (0.35 V pk ) was passed through the sensor and the impedance was sampled at 460,000 samples / second. The change in voltage versus time is shown in Figure 18A for each particle size, with each peak reflecting the passage of a single particle.
[0446] As shown in Figure 18B, the measured particle size was normalized to the true particle size to calibrate the measurements. Different particle sizes were linearly fitted, and the linear fit was used to establish a calibration for future measurements using this flow cytometer channel sensor. To determine or calculate size from the measured voltage signal, the change in voltage relative to the baseline signal (no particles) was converted to a change in impedance. This change in impedance was converted to particle size using the theoretical relationship between the change in impedance and the channel dimension as follows: TIFF0007586711000002.tif21170 where ΔZ is the change in impedance relative to the baseline impedance Z without particles, and d, L, and D are the particle diameter, channel length, and channel diameter, respectively. TIFF0007586711000003.tif10170 is the correction coefficient.
[0447] Example 2: Determination of multiplexed impedance properties of various cell types The impedance characteristics of red blood cells, platelets, eosinophils, basophils, neutrophils, monocytes, and lymphocytes were measured by separating the various cell types and passing the cells through a flow cytometer channel sensor while measuring impedance. Different cell types were separated using known techniques. The separated cells were suspended in phosphate buffered saline (pH 7.4) and passed through the flow cytometer. A multiplexed current (0.35 V) was measured, which included a low frequency component (30 kHz) for size detection. pk ) and five additional frequencies (107 kHz, 570 kHz, 1.55 MHz, 16 MHz, and 40 MHz) were passed through the flow sensor to detect the real and imaginary components of the impedance. The impedance signal was sampled at a rate of 460,000 samples / second, and the different impedance frequencies were filtered and demodulated using a bandpass filter (8th order, 5 Hz bandwidth). Exemplary real and imaginary impedances of a single eosinophil at all five frequencies are shown in Figure 19, with the cell flowing current through it at -6.19 seconds. Similar plots were collected for other cell types, although the data is not shown. The impedance signal was normalized by dividing the magnitude at the 107 kHz signal across all measurements (although the data could be normalized equally to any of the other frequencies), and the average normalized impedance of the real and imaginary impedance components at five different frequencies for different cell types is shown in Figure 20A (basophils), Figure 20B (eosinophils), Figure 20C (lymphocytes), Figure 20D (monocytes), Figure 20E (neutrophils), Figure 20F (platelets), Figure 20G (red blood cells), and Table 1. In Figures 20A-20G, points A-E on the radar plots correspond to frequencies 107 kHz, 570 kHz, 1.55 MHz, 16 MHz, and 40 MHz, respectively. TIFF0007586711000004.tif71170
[0448] These impedance characteristics are determined under a single environmental condition, such as pH or ionic concentration of the buffer solution. By adjusting and modifying environmental variables such as pH and ionic concentration, the environmental conditions affect both the surface and bulk properties of the cells and the measurements under these conditions. Therefore, additional impedance characteristics can be collected under different buffer conditions to provide more specific characteristics of various cell types.
[0449] Example 3: Particle size selection in a flow sensor A mixture of 5 μm and 10 μm polystyrene beads suspended in 1x PBS solution was pumped through the channel sensor at a constant flow rate of 2.5 μL / min. The channel sensor contained a microchannel (1 mm long, 20 μm wide and high) with three electrodes positioned 12.5 μm apart along the length of the microchannel. As the beads flowed through the channel, an alternating current (0.5 Vpp, 100 kHz) was passed between the electrodes, and the voltage change was measured. The voltage differential signal was normalized (the baseline was removed and the signal demodulated from the alternating current, so that the measured voltage was proportional to the impedance of the fixed alternating current signal). An exemplary normalized voltage signal over time is shown in Figure 21A, showing exemplary signals from 5 μm and 10 μm beads. The smaller pulses correspond to 5 μm beads, and the larger pulses correspond to 10 μm beads as they passed through the microchannel. A histogram of the voltage differential signal is shown in Figure 21B, showing the classification of two different bead sizes.
[0450] Example 4: Clustering of different cell types Impedance signatures were previously collected for all individual cells purified from whole blood drawn from a healthy male, as described in Example 2. This data formed a labeling dataset that enabled the identification of individual cell groups and clusters. A whole blood sample from a healthy adult was diluted in 1x PBS to reduce the cell concentration and measured with a flow sensor. This unknown sample data was clustered into distinct clusters across multiple parameters. These clusters were then further refined into categories or cell types using a labeling dataset from the previously collected dataset. A combination of both unsupervised and supervised learning methods (i.e., semi-supervised learning techniques) was used to refine the classification. The trained model clustered the impedance signatures into platelets, red blood cells (RBCs), and white blood cells (WBCs), as shown in Figure 22A. In Figure 22A, the classified cells are plotted and shown at 107 kHz. Simultaneously, the same trained model allowed white blood cells to be further refined and clustered based on impedance signatures to identify neutrophils, lymphocytes, and monocytes, as shown in Figure 22B. Figure 22B shows a plot of cell types at 1.55 MHz. An exemplary single signal is shown in Figure 22C versus time as particles flow through the sensor, with each peak identified according to cell type (R indicates red blood cells, W indicates white blood cells, PT indicates platelets, and PS indicates 5 μm polystyrene beads added to whole blood to demonstrate differentiation capabilities).
[0451] After clustering the impedance signatures, the counts of each cell type can be obtained. The counts measured are shown in Table 2, along with the reference range for a healthy adult male. TIFF0007586711000005.tif36170
[0452] Example 5: Measurement of hemoglobin in red blood cell lysates The hemoglobin (Hb) content of red blood cell lysates was measured using a metal-oxide semiconductor capacitor (MOSCap) sensor configured for hemoglobin detection. An Hb-specific aptamer bearing a thiol group at the 5' end of the aptamer was attached to an electrode. The Hb-specific aptamer-modified electrode can be referred to as the "detection region" of the sensor. Whole blood was mixed with a red blood cell lysis reagent, and the lysate was positioned in the detection region. The lysate was allowed to incubate in the detection region, allowing hemoglobin in the lysate to bind to the surface-bound Hb-specific aptamer. The detection region was then washed three times with wash buffer to remove unbound lysate. A second Hb-specific aptamer conjugated to glucose oxidase (GOx) was then transferred to the detection region, allowing the GOx-conjugated aptamer to bind to the hemoglobin bound to the surface-bound aptamer. Unbound GOx-conjugated aptamer was then removed by washing the detection region. Glucose in a buffer solution was introduced into the detection region, which GOx uses to generate hydrogen peroxide and gluconic acid. The gluconic acid lowered the pH of the buffer solution, which was then transferred to the pH-sensitive MOScap sensor and into the adjacent region of the sensor. The change in buffer pH was proportional to the concentration of hemoglobin in the sample. The hemoglobin concentration was determined based on calibration data using purified hemoglobin of known concentration.
Claims
1. 1. A system comprising: (a) a cartridge configured for analyzing a biological sample, said cartridge comprising: (i) a sensor comprising: A first channel segment; A second channel segment; a pore or channel fluidly connecting the first channel segment and the second channel segment; an electrode pair configured to apply a multiplexed current or voltage to the pore or channel; and a sensor including an electrode pair configured to detect an electrical signal indicative of impedance at multiple frequencies within the pore or channel, the electrode pair configured to apply the multiplexed current and the electrode pair configured to detect the electrical signal being the same electrode pair or different electrode pairs; (ii) a device interface electrically connected to the sensor; and (b) a device configured to interface with and operate the cartridge, the device including one or more processors and a non-transitory computer readable storage medium storing one or more programs configured to be executed by the one or more processors, the one or more programs including instructions for determining a cell count or an analyte concentration using a machine learning clustering model based on a detected electrical signal, the detected electrical signal including at least a first multivariate electrical signal pattern at a first frequency and a second multivariate electrical signal pattern at a second frequency.
2. The system of claim 1 , wherein the electrical signal is an impedance.
3. The system of claim 1 or 2, wherein the one or more programs include instructions for determining the cell count.
4. The system of any one of claims 1 to 3, wherein the one or more programs include instructions for determining the analyte concentration.
5. 5. The system of claim 1, wherein the electrode pair configured to apply the multiplexed current and the electrode pair configured to detect the electrical signal are the same electrode pair.
6. 5. The system of claim 1, wherein the electrode pair configured to apply the multiplexed current and the electrode pair configured to detect the electrical signal are different electrode pairs.
7. The system of any one of claims 1 to 6, wherein the first multivariate electrical signal pattern and the second multivariate electrical signal pattern each include real and imaginary components of the electrical signal.
8. The system of any one of claims 1 to 7, wherein the first multivariate electrical signal pattern and the second multivariate electrical signal pattern each include a magnitude component and a phase imaginary component of the electrical signal.
9. 9. The system of claim 1, wherein the first multivariate electrical signal pattern and the second multivariate electrical signal pattern comprise one or more of an electrical signal peak height, an electrical signal peak width, an electrical signal peak area, or an electrical signal peak width at half maximum peak height.
10. The system according to any one of claims 1 to 9, wherein the system is configured to distinguish between different cell types.
11. The system of claim 10 , wherein the system is configured to differentiate between red blood cells, white blood cells, or platelets.
12. 12. The system of claim 10 or 11, wherein the system is configured to differentiate between eosinophils, basophils, neutrophils, monocytes, or lymphocytes.
13. The system of any one of claims 1 to 12, wherein the machine learning clustering model distinguishes between different cell types.
14. The system of any one of claims 1 to 13, wherein the electrode pair configured to detect the electrical signal is in direct contact with an inner portion of the channel.
15. 15. The system of claim 1, wherein the electrode pair configured to detect the electrical signal comprises a first electrode in the first channel segment and a second electrode in the second channel segment.
16. The system of any one of claims 1 to 14, wherein the sensor includes a channel and the electrode pair configured to detect the electrical signal is positioned within the channel.
17. The system of any one of claims 1 to 14, wherein the electrode pair configured to detect the electrical signal includes a first electrode proximal to the first channel segment and a second electrode proximal to the second channel segment.
18. 15. The system of claim 1, wherein the electrode pair configured to detect the electrical signal comprises a first electrode on an upper surface of the channel and a second electrode on a lower surface of the channel, the first electrode being positioned above the second electrode.
19. The system of any one of claims 1 to 18, wherein the sensor further comprises an electrode pair configured to detect liquid flow within the sensor.
20. The system of any one of claims 1 to 19, wherein the sensor comprises one or more separate electrodes.
21. A system according to any preceding claim, wherein the multiplexed current comprises a plurality of AC components of different frequencies.
22. The system of any one of claims 1 to 21, wherein the multiplexed current comprises: (1) a DC component or a low frequency AC component; and (2) multiple AC components of different frequencies.
23. The system of claim 22 , wherein the plurality of AC components includes at least three AC components.
24. 24. The system of claim 22 or 23, wherein the plurality of AC components include a first AC between 10 kHz and 100 kHz, a second AC between 100 kHz and 700 kHz, a third AC between 700 kHz and 5 MHz, and a fourth AC above 5 MHz.
25. The system of any one of claims 22 to 24, wherein the plurality of AC components comprises at least five AC components.
26. 26. The system of any one of claims 22, 23, and 25, wherein the plurality of AC components includes a first AC between 50 kHz and 250 kHz, a second AC between 250 kHz and 700 kHz, a third AC between 700 kHz and 5 MHz, a fourth AC between 5 MHz and 20 MHz, and a fifth AC between 20 MHz and 150 MHz.
27. 27. The system of any one of claims 22 to 26, wherein the plurality of AC components comprises at least two different AC components including one or more AC components below 1 MHz and one or more AC components above 1 MHz.
28. The system of any one of claims 1 to 27, wherein the electrode pair configured to detect the electrical signal is configured to detect the electrical signal at a sampling rate of 100 kHz or greater.
29. The system of any one of claims 1 to 28, wherein the system is configured to distinguish normal cell populations from abnormal cell populations.
30. 1. A method for determining cell number in a biological sample, comprising: Transporting the biological sample through a sensor comprising a channel or pore; applying multiplexed currents or voltages to said channels or pores; detecting a multiplexed electrical signal indicative of impedance within the channel or pore, the multiplexed electrical signal including at least a first multivariate electrical signal pattern at a first frequency and a second multivariate electrical signal pattern at a second frequency; and determining cell counts for different cell types based on at least the first multivariate electrical signal pattern at the first frequency and the second multivariate electrical signal pattern at the second frequency using a machine learning clustering model.
31. 31. The method of claim 30, wherein the electrical signal is an impedance.
32. 32. The method of claim 30 or 31, wherein the first multivariate electrical signal pattern and the second multivariate electrical signal pattern each include a real component and an imaginary component.
33. 32. The method of claim 30 or 31, wherein the first multivariate electrical signal pattern and the second multivariate electrical signal pattern each include a magnitude component and a phase component.
34. A method according to any one of claims 30 to 33, comprising distinguishing between two or more different cell types.
35. 35. The method of any one of claims 30-34, wherein the multivariate electrical signal pattern comprises one or more of an electrical signal peak height, an electrical signal peak width, an electrical signal peak area, or an electrical signal peak width at half maximum peak height.
36. The method of any one of claims 30 to 35, wherein the biological sample is in direct contact with an electrode pair that detects the multiplexed electrical signal.
37. 37. The method of any one of claims 30 to 36, wherein determining the cell count comprises determining the number of red blood cells, white blood cells, or platelets in the biological sample.
38. 38. The method of any one of claims 30-37, wherein determining the cell count comprises determining at least one of an eosinophil count, a basophil count, a neutrophil count, a monocyte count, or a lymphocyte count in the biological sample.
39. 39. The method of any one of claims 30 to 38, wherein determining the cell number comprises distinguishing normal cell populations from abnormal cell populations.
40. 40. The method of any one of claims 30 to 39, comprising transporting two or more sub-samples of a biological sample through the sensor, wherein the two or more sub-samples are treated with different pH levels, different electrolyte concentrations, or different diluents.
41. A method according to any one of claims 30 to 40, wherein the multiplexed current comprises a plurality of alternating current components of different frequencies.
42. 42. The method of any one of claims 30 to 41, wherein the multiplexed current comprises: (1) a DC component or a low frequency AC component; and (2) multiple AC components of different frequencies.
43. The method of claim 42 , wherein the plurality of AC components comprises at least three AC components.
44. 44. The method of claim 42 or 43, wherein the plurality of AC components include a first AC between 10 kHz and 100 kHz, a second AC between 100 kHz and 700 kHz, a third AC between 700 kHz and 5 MHz, and a fourth AC above 5 MHz.
45. The method of any one of claims 42 to 44, wherein the plurality of AC components comprises at least five AC components.
46. 46. The method of any one of claims 42, 43, and 45, wherein the plurality of AC components includes a first AC between 50 kHz and 250 kHz, a second AC between 250 kHz and 700 kHz, a third AC between 700 kHz and 5 MHz, a fourth AC between 5 MHz and 20 MHz, and a fifth AC between 20 MHz and 150 MHz.
47. 47. The method of any one of claims 42 to 46, wherein the plurality of AC components comprises at least two different AC components including one or more AC components below 1 MHz and one or more AC components above 1 MHz.
48. 48. The method of any one of claims 42 to 47, wherein the multiple AC components at different frequencies are used to distinguish between different cell types based on electrical signal characteristics unique to each cell type.
49. The method of any one of claims 30 to 48, wherein the sample is processed prior to analysis only by diluting the sample.
50. The method of any one of claims 30 to 48, wherein the sample is treated prior to analysis by labelling or lysing specific cell types.
51. 51. The method of any one of claims 30 to 50, wherein a machine learning clustering model using the electrical signal characteristics specific to each cell type is used to distinguish each cell.
52. 1. A system comprising: (a) a cartridge configured for analyzing a biological sample, the cartridge comprising: (i) a sensor comprising: A first channel segment; A second channel segment; a pore or channel fluidly connecting the first channel segment and the second channel segment; an electrode pair configured to apply a multiplexed current or voltage to the pore or channel; and a sensor including an electrode pair configured to detect an electrical signal indicative of impedance at multiple frequencies within the pore or channel, the electrode pair configured to apply a multiplexed current and the electrode pair configured to detect the electrical signal being the same electrode pair or different electrode pairs; (ii) a device interface electrically connected to the sensor; and (b) a device configured to interface with and operate the cartridge, the device including one or more processors and a non-transitory computer readable storage medium storing one or more programs configured to be executed by the one or more processors, the one or more programs including instructions for distinguishing different cell types based on detected electrical signals using a machine learning model, the detected electrical signals including at least a magnitude and phase component of an electrical signal at a first frequency and a magnitude and phase component of an electrical signal at a second frequency; and Equipped with the system being configured to differentiate between eosinophils, basophils, neutrophils, monocytes, or lymphocytes; system.
53. 53. The system of claim 52, wherein the electrical signal is an impedance.
54. 54. The system of claim 52 or 53, wherein the system is configured to differentiate between red blood cells, white blood cells, or platelets.
55. The system of any one of claims 52 to 54, wherein the system is configured to distinguish normal cell populations from abnormal cell populations.
Citation Information
Patent Citations
Method and device for analyzing particle
JP1994003252A
Electrical detector for fine substance on chip
JP2003202321A
particle impedance sensor
JP2005512042A
Measurement device and measurement method
WO2014155932A1
